# EDGAR Filing Document

**Accession Number:** 0001393726
**File Stem:** 0001193125-25-259809
**Filing Date:** 2025-10
**Character Count:** 338821
**Document Hash:** d4ae371f59b76bdc7fc8a17727a9c0ea
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-259809.hdr.sgml**: 20251031

**ACCESSION NUMBER**: 0001193125-25-259809

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 151

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251031

**DATE AS OF CHANGE**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TIPTREE INC.
- **CENTRAL INDEX KEY:** 0001393726
- **STANDARD INDUSTRIAL CLASSIFICATION:** FIRE, MARINE & CASUALTY INSURANCE [6331]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 383754322
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33549
- **FILM NUMBER:** 251438193

**BUSINESS ADDRESS:**
- **STREET 1:** 660 STEAMBOAT ROAD
- **STREET 2:** 2ND FLOOR
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 212-446-1410

**MAIL ADDRESS:**
- **STREET 1:** 660 STEAMBOAT ROAD
- **STREET 2:** 2ND FLOOR
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TIPTREE FINANCIAL INC.
- **DATE OF NAME CHANGE:** 20130701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Care Investment Trust Inc.
- **DATE OF NAME CHANGE:** 20070320

?xml version='1.0' encoding='ASCII'? 10-Q

[**<u>**Table of Contents**</u>**](#toc_page)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**Form** 10-Q

**(Mark One)**

☒ **Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934** 

**For the Quarterly period ended** **September 30,** 2025

**OR**

☐ **Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**For the transition period from to** 

**Commission File Number:** 001-33549

Tiptree Inc.

**(Exact name of Registrant as Specified in Its Charter)** 

---

| | |
|:---|:---|
| Maryland | 38-3754322 |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |
| 660 Steamboat Road**,** 2nd Floor<br>Greenwich**,** Connecticut | 06830 |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: (**212**)** 446-1400

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, par value $0.001 per share | TIPT | The Nasdaq Stock Market |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-Accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ☒

As of October 28, 2025, there were 37,823,734 shares, par value $0.001, of the registrant's common stock outstanding.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Tiptree Inc.**

**Quarterly Report on Form 10-Q**

**September 30, 2025**

**Table of Contents**

---

| | |
|:---|:---|
| **ITEM** | **Page Number** |
| [**<u>PART I. Financial Information</u>**](#part_i_financial_information) | [<u>F-</u><u>1</u>](#part_i_financial_information) |
| <u>Item 1. Financial Statements (Unaudited)</u> |  |
| &nbsp;&nbsp;[<u>Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024</u>](#consol_bs) | [<u>F-</u>](#consol_bs)<u>3</u> |
| &nbsp;&nbsp;[<u>Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024</u>](#consolidated_statements_of_operations) | [<u>F-</u>](#consolidated_statements_of_operations)<u>4</u> |
| &nbsp;&nbsp;[<u>Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 2024</u>](#consol_stmt_of_oci) | [<u>F-</u>](#consol_stmt_of_oci)<u>5</u> |
| &nbsp;&nbsp;[<u>Condensed Consolidated Statements of Changes in Stockholders' Equity for the periods ended September 30, 2025 and 2024</u>](#consol_stmt_of_eqty) | [<u>F-</u>](#consol_stmt_of_eqty)<u>6</u> |
| &nbsp;&nbsp;[<u>Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024</u>](#cf) | [<u>F-</u>](#cf)<u>8</u> |
| &nbsp;&nbsp;[<u>Notes to Condensed Consolidated Financial Statements</u>](#financial_fns) | [<u>F-</u>](#financial_fns)<u>9</u> |
| [<u>Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item2_managements_discussion_and_analys) | [<u>47</u>](#item2_managements_discussion_and_analys) |
| [<u>Item 3. Quantitative and Qualitative Disclosures About Market Risk</u>](#item3_quantitative_and_qualitative) | [<u>68</u>](#item3_quantitative_and_qualitative) |
| [<u>Item 4. Controls and Procedures</u>](#item_4_controls_and_procedures) | [<u>68</u>](#item_4_controls_and_procedures) |
| [**<u>PART II. Other Information</u>**](#part_ii_other_information) | [<u>69</u>](#part_ii_other_information) |
| [<u>Item 1. Legal Proceedings</u>](#item_1_legal_proceedings) | [<u>69</u>](#item_1_legal_proceedings) |
| [<u>Item 1A. Risk Factors</u>](#item_1a_risk_factors) | [<u>69</u>](#item_1a_risk_factors) |
| [<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</u>](#item_2_unregistered_sales_of_equity) | [<u>72</u>](#item_2_unregistered_sales_of_equity) |
| [<u>Item 3. Defaults Upon Senior Securities</u>](#item_3_defaults_upon_senior_securities) | [<u>72</u>](#item_3_defaults_upon_senior_securities) |
| [<u>Item 4. Mine Safety Disclosures</u>](#item_4_mine_safety_disclosures) | [<u>72</u>](#item_4_mine_safety_disclosures) |
| [<u>Item 5. Other Information</u>](#item_5_other_information) | [<u>72</u>](#item_5_other_information) |
| [<u>Item 6. Exhibits, Financial Statement Schedules</u>](#item_6_exhibits_financial_statement) | [<u>73</u>](#item_6_exhibits_financial_statement) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Signatures</u>](#signatures) | [<u>75</u>](#signatures) |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>PART I. FINANC</u><u>IAL INFORMATION</u>**

**Forward-Looking Statements** 

Except for the historical information included and incorporated by reference in this Quarterly Report on Form 10-Q, the information included and incorporated by reference herein are "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements provide our current expectations or forecasts of future events and are not statements of historical fact. These forward-looking statements include information about possible or assumed future events, including, among other things, discussion and analysis of our future financial condition, results of operations, our strategic plans and objectives, government legislation and the Merger. When we use words such as "anticipate," "believe," "estimate," "expect," "intend," "seek," "may," "might," "plan," "project," "should," "target," "will," or similar expressions, we intend to identify forward-looking statements.

Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, many of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including, but not limited to, those described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, in this Quarterly Report on Form 10-Q and in our other public filings with the SEC.

The factors described herein are not necessarily all of the important factors that could cause actual results or developments to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors also could affect our forward-looking statements. Consequently, our actual performance could be materially different from the results described or anticipated by our forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by the applicable law, we undertake no obligation to update any forward-looking statements.

Among various events, risks, uncertainties or factors that could cause actual results to differ materially is the proposed Merger and the failure to consummate the Merger in a timely manner or at all; potential litigation relating to the proposed Merger, disruptions from the proposed Merger that may harm Tiptree's business, including current plans and operations and potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed Merger. See "Risk Factors" beginning on Part II. Item 1A for additional risk factors related to the Merger.

**Market and Industry Data**

Certain market data and industry data included in this Quarterly Report on Form 10-Q were obtained from reports of governmental agencies and industry publications and surveys. We believe the data from third-party sources to be reliable based upon our management's knowledge of the industry, but have not independently verified such data and as such, make no guarantees as to its accuracy, completeness or timeliness.

**Note to Reader**

In reading this Quarterly Report on Form 10-Q, references to:

"2017 Notes" means our insurance subsidiaries' 8.50% Fixed Rate Resetting Junior Subordinated Notes due in October 2057.

"2024 Notes" means our insurance subsidiaries' 9.25% Fixed Rate Resetting Junior Subordinated Notes due in November 2064.

"A.M. Best" means A.M. Best Company, Inc.

"E&S" means excess and surplus.

"EBITDA" means earnings before interest, taxes, depreciation and amortization.

"EBITDAR" means earnings before interest, taxes, depreciation and amortization, and restructuring or rent costs.

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Fannie Mae" means Federal National Mortgage Association.

"Fortegra" or "The Fortegra Group" means The Fortegra Group, Inc. and its subsidiaries.

"Fortegra Additional Warrants" means the additional warrants issued to Warburg and Tiptree Holdings to acquire Fortegra Common Stock.

"Fortegra Additional Warrants (Warburg)" means the Fortegra Additional Warrants issued to Warburg.

"Fortegra Common Stock" means the common stock of Fortegra.

"Fortegra Plan" means the 2022 Equity Incentive Plan of Fortegra.

"Fortegra Preferred Stock" means the 5,333,333 shares of Series A Preferred Stock of Fortegra issued to Warburg.

"Fortegra Warrants" means the warrants to purchase shares of Fortegra Common Stock.

"Fortress" means Fortress Credit Corp., as administrative agent, collateral agent and lead arranger, and affiliates of Fortress that are lenders under the Credit Agreement among the Company, Fortress and the lenders party thereto.

"Freddie Mac" means Federal Home Loan Mortgage Corporation.

"GAAP" means U.S. generally accepted accounting principles.

"Ginnie Mae" means Government National Mortgage Association.

F -1

------

[**<u>**Table of Contents**</u>**](#toc_page)

"GSE" means government-sponsored enterprise.

"Invesque" means Invesque Inc.

"Merger" means the series of transactions pursuant to the Merger Agreement whereby Purchaser will acquire Fortegra for a purchase price of $1.65 billion in cash (subject to certain adjustments set forth in the Merger Agreement) and Merger Sub will merge with and into Fortegra, with Fortegra being the surviving corporation, and as a result of which Purchaser shall be the sole stockholder of Fortegra.

"Merger Agreement" means that certain Agreement and Plan of Merger, dated September 26, 2025, by and among Tiptree, Fortegra, DB Insurance Co., Ltd. ("Purchaser") and a subsidiary of Purchaser ("Merger Sub") to be incorporated in Delaware following the date of the Merger Agreement and prior to the closing of the Merger.

"NAIC" means the National Association of Insurance Commissioners.

"Reliance" means Reliance First Capital, LLC.

"Securities Act" means the Securities Act of 1933, as amended.

"SOFR" means the Secured Overnight Financing Rate.

"Tiptree", the "Company", "we", "its", "us" and "our" means, unless otherwise indicated by the context, Tiptree Inc. and its consolidated subsidiaries.

"Tiptree Advisors" means collectively: Tiptree Advisors Holdings, L.P., Tiptree Advisors, LLC, Tiptree GP Holdings, LLC and Tiptree Holdings GP, LLC.

"Tiptree Holdings" means Tiptree Holdings LLC.

"Transition Services Agreement" means the Amended and Restated Transition Services Agreement between Tiptree Advisors and Tiptree Inc., effective as of January 1, 2019.

"Warburg" means WP Falcon Aggregator, L.P., a Delaware limited partnership affiliated with funds advised or managed by Warburg Pincus LLC.

"WP Transaction" means the $200 million strategic investment in Fortegra by Warburg.

F -2

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Condensed Consolidated Balance Sheets (Unaudited)

*(in thousands, except share data)*

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |
| **Assets:** |  |  |
| Investments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Available for sale securities, at fair value, net of allowance for credit losses | $1305403 | $1107929 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans, at fair value | 90422 | 81330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities | 171673 | 108620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments | 53501 | 53084 |
| Total investments | 1620999 | 1350963 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 366087 | 320067 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 113473 | 96197 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes and accounts receivable, net | 813622 | 799131 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance recoverable | 1345662 | 992883 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid reinsurance premiums | 1100965 | 1046253 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred acquisition costs | 572790 | 565872 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 207802 | 206706 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 93672 | 102859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 181197 | 213858 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $**6416269** | $**5694789** |
| **Liabilities and Stockholders' Equity** |  |  |
| **Liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt, net | $507560 | $427089 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unearned premiums | 1920104 | 1766068 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy liabilities and unpaid claims | 1615702 | 1298081 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 654504 | 695772 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance payable | 470505 | 443083 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities and accrued expenses | 506476 | 407925 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | $**5674851** | $**5038018** |
| **Stockholders' Equity:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock: $0.001 par value, 100,000,000 shares authorized, none issued or outstanding | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock: $0.001 par value, 200,000,000 shares authorized, 37,820,120 and 37,255,838 shares issued and outstanding, respectively | 38 | 37 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 392947 | 389693 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss), net of tax | (7756) | (27750) |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 119945 | 95718 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Tiptree Inc. stockholders' equity | 505174 | 457698 |
| Non-controlling interests: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fortegra preferred interests | 77679 | 77679 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common interests | 158565 | 121394 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-controlling interests | 236244 | 199073 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total stockholders' equity** | **741418** | **656771** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities and stockholders' equity** | $**6416269** | $**5694789** |

---

See accompanying notes to condensed consolidated financial statements.

F -3

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Operations (Unaudited)

*(in thousands, except share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **<u>Revenues:</u>** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $383881 | $359496 | $1129259 | $1105273 |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 95821 | 95362 | 289966 | 311696 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 3483 | 3716 | 10658 | 11525 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 7397 | 9111 | 29631 | 22250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 34879 | 8316 | 62354 | 36518 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 14841 | 18361 | 44610 | 51994 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total revenues** | **540302** | **494362** | **1566478** | **1539256** |
| **<u>Expenses:</u>** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy and contract benefits | 217330 | 203442 | 653115 | 645081 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 144919 | 154005 | 437005 | 484232 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 62094 | 52335 | 171701 | 151438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 10690 | 7614 | 31912 | 23919 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5259 | 5395 | 15064 | 16254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 61734 | 34790 | 141343 | 111206 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total expenses** | **502026** | **457581** | **1450140** | **1432130** |
| Income (loss) before taxes | 38276 | 36781 | 116338 | 107126 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: provision (benefit) for income taxes | 22666 | 16308 | 56656 | 48799 |
| **Net income (loss)** | **15610** | **20473** | **59682** | **58327** |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to non-controlling interests | 9189 | 8558 | 28666 | 24511 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net income (loss) attributable to common stockholders** | $**6421** | $**11915** | $**31016** | $**33816** |
| **<u>Net income (loss) per common share:</u>** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic earnings per share | $0.17 | $0.32 | $0.82 | $0.91 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings per share | $0.13 | $0.29 | $0.68 | $0.83 |
| **<u>Weighted average number of common shares:</u>** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 37565019 | 36789571 | 37470832 | 36781408 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 38583747 | 37818491 | 38550969 | 37784637 |
| Dividends declared per common share | $0.06 | $0.06 | $0.18 | $0.18 |

---

See accompanying notes to condensed consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

*(in thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Net income (loss)** | $15610 | $20473 | $59682 | $58327 |
| **<u>Other comprehensive income (loss), net of tax:</u>** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in unrealized gains (losses) on available for sale securities | 10749 | 21682 | 25803 | 16065 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in unrealized currency translation adjustments | (2022) | 6332 | 13051 | 5241 |
| &nbsp;&nbsp;&nbsp;&nbsp;Related (provision) benefit for income taxes | (3534) | (8990) | (11604) | (6640) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | 5193 | 19024 | 27250 | 14666 |
| Comprehensive income (loss) | 20803 | 39497 | 86932 | 72993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: comprehensive income (loss) attributable to non-controlling interests | 10515 | 13537 | 35922 | 28275 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Comprehensive income (loss) attributable to common stockholders** | $**10288** | $**25960** | $**51010** | $**44718** |

---

See accompanying notes to condensed consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

*(in thousands, except shares)*

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** |  |  |  |  | **Non-controlling interests** | **Non-controlling interests** |  |
|  | **Number<br>of shares** | **Par<br>value** | **Additional<br>paid-in<br>capital** | **Accumulated<br>other<br>comprehensive<br>income (loss)** | **Retained<br>earnings** | **Total<br>Tiptree Inc.<br>stockholders'<br>equity** | **Fortegra<br>preferred<br>interests** | **Common<br>interests** | **Total<br>stockholders'<br>equity** |
| **Balance at December 31, 2024** | **37255838** | $**37** | $**389693** | $**(27750)** | $**95718** | $**457698** | $**77679** | $**121394** | $**656771** |
| Amortization of share-based incentive compensation |  |  | 9637 |  |  | 9637 |  | 3021 | 12658 |
| Vesting of share-based incentive compensation | 564282 | 1 | (6383) |  |  | (6382) |  | 3015 | (3367) |
| Common stock dividends declared |  |  |  |  | (6789) | (6789) |  |  | (6789) |
| Other comprehensive income (loss), net of tax |  |  |  | 19994 |  | 19994 |  | 7256 | 27250 |
| Subsidiary preferred dividends declared |  |  |  |  | (4787) | (4787) |  |  | (4787) |
| Net income (loss) |  |  |  |  | 35803 | 35803 |  | 23879 | 59682 |
| **Balance at September 30, 2025** | **37820120** | $**38** | $**392947** | $**(7756)** | $**119945** | $**505174** | $**77679** | $**158565** | $**741418** |
| **Balance at June 30, 2025** | **37496977** | $**37** | $**395637** | $**(11623)** | $**115787** | $**499838** | $**77679** | $**145851** | $**723368** |
| Amortization of share-based incentive compensation |  |  | 1417 |  |  | 1417 |  | 486 | 1903 |
| Vesting of share-based incentive compensation | 323143 | 1 | (4107) |  |  | (4106) |  | 3326 | (780) |
| Common stock dividends declared |  |  |  |  | (2263) | (2263) |  |  | (2263) |
| Other comprehensive income (loss), net of tax |  |  |  | 3867 |  | 3867 |  | 1326 | 5193 |
| Subsidiary preferred dividends declared |  |  |  |  | (1613) | (1613) |  |  | (1613) |
| Net income (loss) |  |  |  |  | 8034 | 8034 |  | 7576 | 15610 |
| **Balance at September 30, 2025** | **37820120** | $**38** | $**392947** | $**(7756)** | $**119945** | $**505174** | $**77679** | $**158565** | $**741418** |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

*(in thousands, except shares)*

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** |  |  |  |  | **Non-controlling interests** | **Non-controlling interests** |  |
|  | **Number<br>of shares** | **Par<br>value** | **Additional<br>paid-in<br>capital** | **Accumulated<br>other<br>comprehensive<br>income (loss)** | **Retained<br>earnings** | **Total<br>Tiptree Inc.<br>stockholders'<br>equity** | **Fortegra<br>preferred<br>interests** | **Common<br>interests** | **Total<br>stockholders'<br>equity** |
| **Balance at December 31, 2023** | **36756187** | $**37** | $**382239** | $**(26073)** | $**60663** | $**416866** | $**77679** | $**82020** | $**576565** |
| Amortization of share-based incentive compensation |  |  | 6983 |  |  | 6983 |  | 2524 | 9507 |
| Vesting of share-based incentive compensation | 33384 |  | 53 |  |  | 53 |  | (752) | (699) |
| Non-controlling interest contributions |  |  |  |  |  |  |  | 9956 | 9956 |
| Non-controlling interest distributions |  |  |  |  |  |  |  | (644) | (644) |
| Common stock dividends declared |  |  |  |  | (6674) | (6674) |  |  | (6674) |
| Other comprehensive income (loss), net of tax |  |  |  | 10902 |  | 10902 |  | 3764 | 14666 |
| Subsidiary preferred dividends declared |  |  |  |  | (4804) | (4804) |  |  | (4804) |
| Net income (loss) |  |  |  |  | 38620 | 38620 |  | 19707 | 58327 |
| **Balance at September 30, 2024** | **36789571** | $**37** | $**389275** | $**(15171)** | $**87805** | $**461946** | $**77679** | $**116575** | $**656200** |
| **Balance at June 30, 2024** | **36785305** | $**37** | $**387513** | $**(29216)** | $**78115** | $**436449** | $**77679** | $**103941** | $**618069** |
| Amortization of share-based incentive compensation |  |  | 1693 |  |  | 1693 |  | 839 | 2532 |
| Vesting of share-based incentive compensation | 4266 |  | 69 |  |  | 69 |  | (130) | (61) |
| Common stock dividends declared |  |  |  |  | (2225) | (2225) |  |  | (2225) |
| Other comprehensive income (loss), net of tax |  |  |  | 14045 |  | 14045 |  | 4979 | 19024 |
| Subsidiary preferred dividends declared |  |  |  |  | (1612) | (1612) |  |  | (1612) |
| Net income (loss) |  |  |  |  | 13527 | 13527 |  | 6946 | 20473 |
| **Balance at September 30, 2024** | **36789571** | $**37** | $**389275** | $**(15171)** | $**87805** | $**461946** | $**77679** | $**116575** | $**656200** |

---

See accompanying notes to condensed consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Cash Flows (Unaudited)

*(in thousands)*

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** |
| **Operating Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common stockholders | $**31016** | $**33816** |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to non-controlling interests | 28666 | 24511 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 59682 | 58327 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjustments to reconcile net income to net cash provided by (used in) operating activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized (gains) losses | (62354) | (36518) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash compensation expense | 17080 | 13220 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization/accretion of premiums and discounts | (3740) | (4416) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 15064 | 16254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expense | 5319 | 5875 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred provision (benefit) for income taxes | 37919 | 41695 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 1399 | 907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of liability classified warrants | 17560 | 6018 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (556) | 453 |
| **Changes in operating assets and liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans originated for sale | (705702) | (693056) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from the sale of mortgage loans originated for sale | 727470 | 710605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in notes and accounts receivable | (41374) | (101126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in reinsurance recoverable | (352779) | 21230 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in prepaid reinsurance premiums | (54712) | (77625) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in deferred acquisition costs | (6918) | (5177) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in other assets | (2904) | (1971) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in unearned premiums | 154036 | 14908 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in policy liabilities and unpaid claims | 317621 | 348009 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in deferred revenue | (41268) | 19304 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in reinsurance payable | 27422 | (84992) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in other liabilities and accrued expenses | 15101 | (81125) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 123366 | 170799 |
| **Investing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (906432) | (614279) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and maturities of investments | 760570 | 477843 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (4358) | (2229) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from notes receivable | 100033 | 74867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of notes receivable | (72704) | (82400) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | (122891) | (146198) |
| **Financing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | (11576) | (11566) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interest (redemptions) contributions |  | 9312 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash (paid) received in connection with vested or exercised stock awards | (9285) | (931) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of debt issuance costs | (2346) | (144) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from borrowings and mortgage notes payable | 970807 | 773990 |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal paydowns of borrowings and mortgage notes payable | (889549) | (788641) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 58051 | (17980) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash | 4770 | 5188 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in cash, cash equivalents and restricted cash | 63296 | 11809 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash – beginning of period | 416264 | 492561 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash – end of period | $479560 | $504370 |
| **<u>Supplemental Schedule of Non-Cash Investing and Financing Activities:</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Right of use asset obtained in exchange for lease liability | $4364 | $1923 |

---

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
| **<u>Reconciliation of cash, cash equivalents and restricted cash</u>** | **September 30,<br>2025** | **December 31,<br>2024** |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $366087 | $320067 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 113473 | 96197 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash shown in the statements of cash flows | $479560 | $416264 |

---

See accompanying notes to condensed consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

**<u>(1) Organization</u>** 

Tiptree Inc. (together with its consolidated subsidiaries, collectively, Tiptree, the Company, or we) is a Maryland Corporation that was incorporated on March 19, 2007. Tiptree's common stock trades on the Nasdaq Capital Market under the symbol "TIPT." Tiptree is a holding company that allocates capital across a broad spectrum of businesses, assets and other investments. We classify our business into two reportable segments: Insurance and Mortgage. We refer to our non-insurance operations, assets and other investments, which is comprised of our Mortgage reportable segment and our non-reportable segments and other business activities, as Tiptree Capital.

As of September 30, 2025, Fortegra was owned approximately 78.9% by Tiptree Holdings, 17.6% by Warburg and 3.5% by management and directors of Fortegra, before giving effect to the exercise of outstanding warrants and management options, and the conversion of outstanding preferred stock. See Note (15) Stockholders' Equity for additional information.

On September 26, 2025, Tiptree entered into an Agreement and Plan of Merger (the "<u>Merger Agreement</u>") with DB Insurance Co., Ltd., incorporated and existing under the laws of the Republic of Korea ("<u>Purchaser</u>"), and Fortegra, a Delaware corporation and subsidiary of Tiptree. A subsidiary of Purchaser ("<u>Merger Sub</u>") to be incorporated in Delaware following the date of the Merger Agreement and prior to the closing of the merger (the "<u>Closing</u>") will, upon its formation, execute a joinder to the Merger Agreement and thereby become a party thereto.

Pursuant to the Merger Agreement, Purchaser will acquire Fortegra for a purchase price of $1.65 billion in cash (subject to certain adjustments set forth in the Merger Agreement) and Merger Sub will merge with and into Fortegra, with Fortegra being the surviving corporation (the "<u>Merger</u>"), and as a result of which Purchaser shall be the sole stockholder of Fortegra. The purchase price will be reduced by certain categories of payments made by Fortegra after June 30, 2025 and at or prior to the Closing ("<u>Leakage</u>"), except for certain categories of agreed permitted Leakage ("<u>Permitted Leakage</u>"). Leakage includes payments for, among other categories, specified transaction expenses, certain dividends or distributions to related parties, payments to related parties for equity or securities redemptions, returns of capital, and other specified categories of payments or liabilities. Permitted Leakage includes payments reserved for in the financial statements of Fortegra, requested or consented to by Purchaser, and other specified categories of payments or liabilities. Purchaser's recovery for Leakage that is not adjusted for at the Closing is limited to a leakage reserve holdback account. If the Closing has not occurred on or before June 1, 2026, the $1.65 billion purchase price will be increased by a profit sharing fee which shall accrue on such price from June 1, 2026 through the Closing at a rate of 10% per annum.

The Merger Agreement contains customary representations and warranties made by each of the parties. The parties have also agreed to various covenants in the Merger Agreement, including agreements by Fortegra to conduct its business in the ordinary course of business in all material respects and in compliance with applicable law and to use commercially reasonable efforts to maintain and preserve substantially intact its present business organization and significant business relationships and goodwill.

Tiptree is also subject to customary "no-shop" restrictions on its ability to solicit acquisition proposals from third parties (including acquisition proposals relating to the sale of all or a significant portion of Fortegra or its assets) and to provide information to, and participate in discussions and engage in negotiations with, third parties regarding any acquisition proposals. Tiptree may, under certain specified circumstances, provide information to, and participate in discussions and engage in negotiations with, third parties with respect to an acquisition proposal if the board of directors of Tiptree has determined in good faith (after consultation with its outside legal counsel and financial advisors) that such alternative acquisition proposal constitutes or would reasonably be expected to lead to or result in a Superior Proposal (as defined in the Merger Agreement). If the board of directors of Tiptree has determined in good faith (after consultation with its outside legal counsel and financial advisors) that an acquisition proposal constitutes a Superior Proposal, then Tiptree may terminate the Merger Agreement to enter into an agreement with respect to such Superior Proposal, subject to compliance with the procedures specified in the Merger Agreement and payment of a termination fee of $49,500. The Merger Agreement also provides that Tiptree will call a special stockholder meeting and take customary steps, including mailing a proxy statement to Tiptree's stockholders, in order to obtain stockholder approval of the Merger.

The Merger is anticipated to close in mid-2026. The Closing is subject to certain conditions, including (i) Tiptree stockholder approval, (ii) Fortegra stockholder approval, (iii) regulatory approval, including certain Form A filings and other insurance regulatory approvals in certain foreign jurisdictions, clearance by the Committee on Foreign Investment in the United States and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (iv) the continued accuracy of the representations and warranties of the parties (subject to specified materiality standards), (v) performance of each party's obligations under the Merger Agreement in all material respects and (vi) the absence of a material adverse effect with respect to Fortegra.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

**<u>(2) Summary of Significant Accounting Policies</u>**

***Basis of Presentation and Principles of Consolidation***

The accompanying unaudited condensed consolidated financial statements of Tiptree have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and include the accounts of the Company and its subsidiaries. The condensed consolidated financial statements are presented in U.S. dollars, the main operating currency of the Company. The unaudited condensed consolidated financial statements presented herein should be read in conjunction with the annual audited financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. In the opinion of management, the accompanying unaudited interim financial information reflects all adjustments, including normal recurring adjustments necessary to present fairly the Company's financial position, results of operations, comprehensive income and cash flows for each of the interim periods presented. The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of the results that may be expected for the full year ending on December 31, 2025.

Non-controlling interests (NCI) on the condensed consolidated balance sheets represent the ownership interests in certain consolidated subsidiaries held by entities or persons other than Tiptree. Accounts and transactions between consolidated entities have been eliminated.

***Recent Accounting Standards***

*Recently Adopted Accounting Pronouncements*

During the nine months ended September 30, 2025, there were no accounting standards adopted by the Company.

*Recently Issued Accounting Pronouncements, Not Yet Adopted*

---

| | | | |
|:---|:---|:---|:---|
| **Accounting**<br>**Standard Update** | **Description** | **Adoption Date** | **Impact on Financial Statements** |
| 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures | The amendments in this update enhance the transparency and decision usefulness of income tax disclosures. Investors, lenders, creditors, and other allocators of capital (collectively, "investors") indicated that the existing income tax disclosures should be enhanced to provide information to better assess how an entity's operations and related tax risks and tax planning and operational opportunities affect its tax rate and prospects for future cash flows. Investors currently rely on the rate reconciliation table and other disclosures, including total income taxes paid, to evaluate income tax risks and opportunities. While investors find these disclosures helpful, they suggested possible enhancements to better (1) understand an entity's exposure to potential changes in jurisdictional tax legislation and the ensuing risks and opportunities, (2) assess income tax information that affects cash flow forecasts and capital allocation decisions, and (3) identify potential opportunities to increase future cash flows. | The amendments in this update are effective for annual periods beginning after December 15, 2024. | The Company expects to adopt this guidance when required, which will enhance our income tax disclosures. |
| 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses<br>| The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The amendments require that at each interim and annual reporting period an entity:<br> 1. Disclose the amounts of relevant expense and within which expense caption the relevant expense is presented on the face of the income statement within continuing operations.<br> 2. Include certain amounts that are already required to be disclosed under current generally accepted accounting principles (GAAP) in the same disclosure as the other disaggregation requirements.<br> 3. Disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively.<br> 4. Disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. | The amendments in this update are effective for annual reporting periods beginning after December 15, 2026.<br>| The Company expects to adopt this guidance when required, with minimal impact to our financials and disclosures.<br>|
| 2025-05, Financial Instruments — Credit Losses (Topic 326) | The amendments in this update provide all entities with a practical expedient when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. In developing reasonable and supportable forecasts as part of estimating expected credit losses, all entities may elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. | The amendments in this update are effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within  | The Company expects to adopt this guidance when required, with minimal impact to our financials and disclosures. |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

---

| | | | |
|:---|:---|:---|:---|
|  |  | those annual reporting periods. |  |
| 2025-06, Intangibles Goodwill and Other Internal-Use Software (Subtopic 350-40) | The amendments in this update remove all references to prescriptive and sequential software development stages (referred to as "project stages") throughout Subtopic 350-40. Therefore, an entity is required to start capitalizing software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended (referred to as the "probable-to-complete recognition threshold").<br>| The amendments in this update are effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods. | The Company expects to adopt this guidance when required, with minimal impact to our financials and disclosures. |

---

**<u>(3)</u>** Operating Segment Data

Tiptree is a holding company that allocates capital across a broad spectrum of businesses, assets and other investments. Tiptree's principal operating subsidiary, Fortegra, is a provider of specialty insurance, service contract products and related service solutions. Based on the quantitative analysis performed related to Accounting Standard Codification (ASC) 280, Segment Reporting, our reportable segments are Insurance and Mortgage. We refer to our non-insurance operations, assets and other investments, comprised of our Mortgage reportable segment and our non-reportable operating segments and other business activities, as Tiptree Capital. Corporate activities include holding company interest expense, employee compensation and benefits, and other expenses.

For the nine months ended September 30, 2025 and 2024, the Chief Operating Decision Maker (CODM) was the Executive Committee of the Company, comprised of the Executive Chairman and Chief Executive Officer. The CODM uses Income (loss) before taxes and other information provided in tables below to allocate resources and assess performance. Our reportable segments' income or loss is reported before income taxes and non-controlling interests. Segment results incorporate the revenues and expenses of these subsidiaries since they commenced operations or were acquired. Intercompany transactions are eliminated.

Descriptions of our Insurance reportable segment and Tiptree Capital, including our Mortgage reportable segment, are as follows:

***Insurance*** operations are conducted through Fortegra, which is a leading provider of specialty insurance products and related services. Fortegra designs, markets and underwrites specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. Fortegra's products and services include niche commercial and personal lines, service contracts, and other insurance services.

***Tiptree Capital:***

***Mortgage*** operations are conducted through Reliance. The Company's mortgage business originates loans for sale to institutional investors, including GSEs and FHA/VA and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

***Other*** includes our asset manager, Tiptree Advisors, other investments, and our maritime shipping operations for prior year periods.

The tables below present the components of total assets, revenue, expense and income (loss) before taxes for our reportable segments and other business activities for the following periods:

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Insurance** | **Mortgage** | **Segments subtotal** | **Other** | **Corporate** | **Total** |
| **<u>Total assets</u>** | $6114642 | $212864 | $6327506 | $69509 | $19254 | $6416269 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|  | **Insurance** | **Mortgage** | **Segments subtotal** | **Other** | **Corporate** | **Total** |
| **<u>Revenues:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $383881 | $— | $383881 | $— | $— | $383881 |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 95821 |  | 95821 |  |  | 95821 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 3483 |  | 3483 |  |  | 3483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 7397 |  | 7397 |  |  | 7397 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 24761 | 9843 | 34604 | 275 |  | 34879 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 7273 | 6327 | 13600 | 1241 |  | 14841 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 522616 | 16170 | 538786 | 1516 |  | 540302 |
| **<u>Expenses:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy and contract benefits | 217330 |  | 217330 |  |  | 217330 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 144919 |  | 144919 |  |  | 144919 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 41736 | 9922 | 51658 | 141 | 10295 | 62094 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 8261 | 346 | 8607 |  | 2083 | 10690 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 4824 | 70 | 4894 |  | 365 | 5259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 50323 | 5630 | 55953 | 9 | 5772 | 61734 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 467393 | 15968 | 483361 | 150 | 18515 | 502026 |
| Income (loss) before taxes | 55223 | 202 | 55425 | 1366 | (18515) | 38276 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: provision (benefit) for income taxes |  |  |  |  |  | 22666 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | 15610 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to non-controlling interests |  |  |  |  |  | 9189 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common stockholders |  |  |  |  |  | $6421 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **Insurance** | **Mortgage** | **Segments subtotal** | **Other** | **Corporate** | **Total** |
| **<u>Revenues:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $1129259 | $— | $1129259 | $— | $— | $1129259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 289966 |  | 289966 |  |  | 289966 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 10658 |  | 10658 |  |  | 10658 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 29631 |  | 29631 |  |  | 29631 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 33310 | 29485 | 62795 | (441) |  | 62354 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 23390 | 18096 | 41486 | 3124 |  | 44610 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 1516214 | 47581 | 1563795 | 2683 |  | 1566478 |
| **<u>Expenses:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy and contract benefits | 653115 |  | 653115 |  |  | 653115 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 437005 |  | 437005 |  |  | 437005 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 115882 | 29065 | 144947 | 362 | 26392 | 171701 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 25553 | 1040 | 26593 |  | 5319 | 31912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13758 | 223 | 13981 |  | 1083 | 15064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 110480 | 17023 | 127503 | 4076 | 9764 | 141343 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 1355793 | 47351 | 1403144 | 4438 | 42558 | 1450140 |
| Income (loss) before taxes | 160421 | 230 | 160651 | (1755) | (42558) | 116338 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: provision (benefit) for income taxes |  |  |  |  |  | 56656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | 59682 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to non-controlling interests |  |  |  |  |  | 28666 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common stockholders |  |  |  |  |  | $31016 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Insurance** | **Mortgage** | **Segments subtotal** | **Other** | **Corporate** | **Total** |
| **<u>Total assets</u>** | $5432987 | $202664 | $5635651 | $36818 | $22320 | $5694789 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|  | **Insurance** | **Mortgage** | **Segments subtotal** | **Other** | **Corporate** | **Total** |
| **<u>Revenues:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $359496 | $— | $359496 | $— | $— | $359496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 95362 |  | 95362 |  |  | 95362 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 3716 |  | 3716 |  |  | 3716 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 9111 |  | 9111 |  |  | 9111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 2218 | 8862 | 11080 | (2764) |  | 8316 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 11110 | 6030 | 17140 | 1221 |  | 18361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 481013 | 14892 | 495905 | (1543) |  | 494362 |
| **<u>Expenses:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy and contract benefits | 203442 |  | 203442 |  |  | 203442 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 154005 |  | 154005 |  |  | 154005 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 37876 | 9129 | 47005 | 117 | 5213 | 52335 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 7173 | 441 | 7614 |  |  | 7614 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 4970 | 61 | 5031 |  | 364 | 5395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 26338 | 5350 | 31688 | 943 | 2159 | 34790 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 433804 | 14981 | 448785 | 1060 | 7736 | 457581 |
| Income (loss) before taxes | 47209 | (89) | 47120 | (2603) | (7736) | 36781 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: provision (benefit) for income taxes |  |  |  |  |  | 16308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | 20473 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to non-controlling interests |  |  |  |  |  | 8558 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common stockholders |  |  |  |  |  | $11915 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|  | **Insurance** | **Mortgage** | **Segments subtotal** | **Other** | **Corporate** | **Total** |
| **<u>Revenues:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $1105273 | $— | $1105273 | $— | $— | $1105273 |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 311696 |  | 311696 |  |  | 311696 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 11525 |  | 11525 |  |  | 11525 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 22250 |  | 22250 |  |  | 22250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 7582 | 29662 | 37244 | (726) |  | 36518 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 31385 | 17004 | 48389 | 3605 |  | 51994 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 1489711 | 46666 | 1536377 | 2879 |  | 1539256 |
| **<u>Expenses:</u>** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy and contract benefits | 645081 |  | 645081 |  |  | 645081 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 484232 |  | 484232 |  |  | 484232 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 100884 | 27746 | 128630 | 360 | 22448 | 151438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 22300 | 1619 | 23919 |  |  | 23919 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 14886 | 283 | 15169 |  | 1085 | 16254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 87058 | 15826 | 102884 | 1917 | 6405 | 111206 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expense | 1354441 | 45474 | 1399915 | 2277 | 29938 | 1432130 |
| Income (loss) before taxes | 135270 | 1192 | 136462 | 602 | (29938) | 107126 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: provision (benefit) for income taxes |  |  |  |  |  | 48799 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  |  |  |  | 58327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to non-controlling interests |  |  |  |  |  | 24511 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common stockholders |  |  |  |  |  | $33816 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The Company conducts its operations primarily in the U.S. with 5.6 % and 4.4 % of total revenues generated overseas for the three months ended September 30, 2025 and 2024, respectively, and 5.0 % and 4.6 % of total revenues generated overseas for the nine months ended September 30, 2025 and 2024, respectively.

**<u>(4) Investments</u>**

The following table presents the Company's investments related to insurance operations and other Tiptree investing activities, measured at fair value as of the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  |  | **Tiptree Capital** | **Tiptree Capital** |  |
|  | **Insurance** | **Mortgage** | **Other** | **Total** |
| Available for sale securities, at fair value, net of allowance for credit losses | $1265621 | $— | $39782 | $1305403 |
| Loans, at fair value | 8209 | 82213 |  | 90422 |
| Equity securities | 165965 |  | 5708 | 171673 |
| Other investments | 49454 | 3586 | 461 | 53501 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | $1489249 | $85799 | $45951 | $1620999 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  |  | **Tiptree Capital** | **Tiptree Capital** |  |
|  | **Insurance** | **Mortgage** | **Other** | **Total** |
| Available for sale securities, at fair value, net of allowance for credit losses | $1097057 | $— | $10872 | $1107929 |
| Loans, at fair value | 10272 | 71058 |  | 81330 |
| Equity securities | 104468 |  | 4152 | 108620 |
| Other investments | 49983 | 3101 |  | 53084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | $1261780 | $74159 | $15024 | $1350963 |

---

***Available for Sale Securities, at fair value***

A majority of the Company's investments in Available for Sale Securities, at fair value, net of allowance for credit losses (AFS securities) as of September 30, 2025 and December 31, 2024 are held by subsidiaries in the insurance segment. The following tables present the Company's investments in AFS securities:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Amortized cost** | **Allowance for credit losses**<sup>(1)</sup> | **Gross<br>unrealized gains** | **Gross<br>unrealized losses** | **Fair value** |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $329195 | $— | $874 | $(21222) | $308847 |
| Obligations of state and political subdivisions | 17481 | (1) | 33 | (1833) | 15680 |
| Corporate securities | 818685 | (713) | 10230 | (1731) | 826471 |
| Asset backed securities | 91956 | (74) | 215 | (1338) | 90759 |
| Certificates of deposit | 1151 |  |  |  | 1151 |
| Obligations of foreign governments | 62092 |  | 529 | (126) | 62495 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1320560 | $(788) | $11881 | $(26250) | $1305403 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Amortized cost** | **Allowance for credit losses**<sup>(1)</sup> | **Gross<br>unrealized gains** | **Gross<br>unrealized losses** | **Fair value** |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $426002 | $— | $611 | $(30970) | $395643 |
| Obligations of state and political subdivisions | 41593 | (1) |  | (2917) | 38675 |
| Corporate securities | 605517 | (3157) | 3177 | (7403) | 598134 |
| Asset backed securities | 25455 | (68) | 4 | (2531) | 22860 |
| Certificates of deposit | 1145 |  |  |  | 1145 |
| Obligations of foreign governments | 51857 | (1) |  | (384) | 51472 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1151569 | $(3227) | $3792 | $(44205) | $1107929 |

---

<sup>(1)</sup> Represents the amount of impairment that has resulted from credit-related factors, and therefore was recognized in net realized and unrealized gains (losses) as a credit loss on AFS securities. Amount excludes unrealized losses relating to non-credit factors.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The amortized cost and fair values of AFS securities, by contractual maturity date, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of** | **As of** | **As of** | **As of** |
|  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Amortized cost** | **Fair value** | **Amortized cost** | **Fair value** |
| Due in one year or less | $187121 | $188158 | $250036 | $249392 |
| Due after one year through five years | 532945 | 535899 | 438322 | 430597 |
| Due after five years through ten years | 306925 | 308184 | 223969 | 201948 |
| Due after ten years | 201613 | 182403 | 213787 | 203132 |
| Asset backed securities | 91956 | 90759 | 25455 | 22860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1320560 | $1305403 | $1151569 | $1107929 |

---

The following tables present the gross unrealized losses on AFS securities by length of time that individual AFS securities have been in a continuous unrealized loss position for less than twelve months, and twelve months or greater and do not have an allowance for credit losses:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Less Than or Equal to One Year** | **Less Than or Equal to One Year** | **Less Than or Equal to One Year** | **More Than One Year** | **More Than One Year** | **More Than One Year** |
|  | **Fair value** | **Gross<br>unrealized losses** | **# of Securities**<sup>(1)</sup> | **Fair value** | **Gross unrealized losses** | **# of Securities**<sup>(1)</sup> |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $37639 | $(277) | 43 | $171813 | $(20945) | 469 |
| Obligations of state and political subdivisions |  |  |  | 14326 | (1833) | 30 |
| Corporate securities | 226482 | (902) | 365 | 18524 | (829) | 51 |
| Asset backed securities | 47205 | (153) | 113 | 11394 | (1185) | 92 |
| Obligations of foreign governments | 17328 | (57) | 2 | 1314 | (69) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $328654 | $(1389) | 523 | $217371 | $(24861) | 647 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Less Than or Equal to One Year** | **Less Than or Equal to One Year** | **Less Than or Equal to One Year** | **More Than One Year** | **More Than One Year** | **More Than One Year** |
|  | **Fair value** | **Gross<br>unrealized losses** | **# of Securities**<sup>(1)</sup> | **Fair value** | **Gross unrealized losses** | **# of Securities**<sup>(1)</sup> |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $118269 | $(4359) | 612 | $176083 | $(26611) | 570 |
| Obligations of state and political subdivisions | 5856 | (77) | 147 | 31769 | (2840) | 96 |
| Corporate securities | 293224 | (2156) | 958 | 103002 | (5247) | 385 |
| Asset backed securities |  |  |  | 21756 | (2531) | 130 |
| Obligations of foreign governments | 48346 | (266) | 15 | 1273 | (118) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $465695 | $(6858) | 1732 | $333883 | $(37347) | 1187 |

---

<sup>(1)</sup> Presented in whole numbers.

Management believes that it is more likely than not that the Company will be able to hold the fixed maturity AFS securities that were in an unrealized loss position as of September 30, 2025 until full recovery of their amortized cost basis.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The table below presents a roll-forward of the activity in the allowance for credit losses on AFS securities by type for the following periods:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Obligations of state and political subdivisions** | **Corporate securities** | **Asset backed securities** | **Obligations of foreign governments** | **Total** |
| **Balance at December 31, 2023** | $(1) | $(73) | $(10) | $— | $(84) |
| (Increase) in allowance for credit losses |  | (47) | (122) |  | (169) |
| Additions for AFS securities purchased with credit deterioration during the year |  | (380) |  |  | (380) |
| Reduction in credit losses due to AFS securities sold during the year |  | 2 |  |  | 2 |
| Gains from recoveries of amounts previously written off |  | 20 | 1 |  | 21 |
| **Balance at September 30, 2024** | $(1) | $(478) | $(131) | $— | $(610) |
| **Balance at December 31, 2024** | $(1) | $(3157) | $(68) | $(1) | $(3227) |
| (Increase) in allowance for credit losses |  | (87) |  |  | (87) |
| Additions for AFS securities purchased with credit deterioration during the year |  | (315) | (67) |  | (382) |
| Reduction in credit losses due to AFS securities sold during the year |  | 581 | 54 | 1 | 636 |
| Gains from recoveries of amounts previously written off |  | 2265 | 7 |  | 2272 |
| **Balance at September 30, 2025** | $(1) | $(713) | $(74) | $— | $(788) |

---

The Company applies a discounted cash flow model, based on assumptions and model outputs provided by an investment management company, in determining its lifetime expected credit losses on AFS securities. This includes determining the present value of expected future cash flows discounted at the book yield of the security.

The table below presents the amount of gains from recoveries (credit losses, including Current Expected Credit Losses (CECL)) on AFS securities recorded by the Company for the following period:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net gains from recoveries (credit losses) on AFS securities | $(64) | $316 | $2439 | $(526) |

---

Pursuant to certain statutory licensing requirements, the Company has deposited $18,682 of invested assets in insurance department safekeeping accounts as of September 30, 2025. The Company also has deposited invested assets in custody accounts pursuant to certain reinsurance agreements. The Company cannot remove or replace investments in such safekeeping and custody accounts without prior approval of the regulatory authority or contractual party, as applicable. The following table presents the Company's restricted investments included in the Company's AFS securities:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |
| Fair value of restricted investments | $34634 | $45483 |

---

The following table presents additional information on the Company's AFS securities for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Purchases of AFS securities | $472080 | $182430 | $759584 | $471202 |
| Proceeds from maturities, calls and prepayments of AFS securities | $192236 | $21911 | $327520 | $263990 |
| Gross proceeds from sales of AFS securities | $149278 | $4425 | $278307 | $24264 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the gross realized gains and gross realized losses from sales and redemptions of AFS securities:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Gross realized gains | $1978 | $220 | $4221 | $360 |
| Gross realized (losses) | (1913) | (277) | (4744) | (510) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net realized gains (losses) from investment sales and redemptions | $65 | $(57) | $(523) | $(150) |

---

***Loans, at fair value***

The following table presents the Company's investments in loans measured at fair value and the Company's investments in loans measured at fair value pledged as collateral:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Fair value** | **Unpaid principal balance (UPB)** | **Fair value exceeds / (below) UPB** | **Pledged as collateral** | **Fair value** | **Unpaid principal balance (UPB)** | **Fair value exceeds / (below) UPB** | **Pledged as collateral** |
| <u>Insurance:</u> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate loans <sup>(1)</sup> | $8209 | $12927 | $(4718) | $— | $10272 | $12927 | $(2655) | $— |
| <u>Mortgage:</u> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans held for sale <sup>(2)</sup> | 82213 | 79906 | 2307 | 81930 | 71058 | 70074 | 984 | 70361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans, at fair value | $90422 | $92833 | $(2411) | $81930 | $81330 | $83001 | $(1671) | $70361 |

---

<sup>(1)</sup> The cost basis of Corporate loans was approximately $12,927 at September 30, 2025 and December 31, 2024.

<sup>(2)</sup> As of September 30, 2025, there was one mortgage loan held for sale that was 90 days or more past due. As of December 31, 2024, there were three mortgage loans held for sale that were 90 days or more past due.

***Equity Securities***

Equity securities consist mainly of publicly traded common and preferred stocks and exchange traded funds. The following table presents information on the cost and fair value of the Company's equity securities related to Insurance and Tiptree Capital as of the following periods:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Insurance** | **Insurance** | **Tiptree Capital - Other** | **Tiptree Capital - Other** | **Total** | **Total** |
|  | **Cost** | **Fair Value** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| Exchange traded funds | $40 | $42 | $— | $— | $40 | $42 |
| Other equity securities | 145729 | 165923 | 7464 | 5708 | 153193 | 171631 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity securities | $145769 | $165965 | $7464 | $5708 | $153233 | $171673 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Insurance** | **Insurance** | **Tiptree Capital - Other** | **Tiptree Capital - Other** | **Total** | **Total** |
|  | **Cost** | **Fair Value** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| Exchange traded funds | $4997 | $5075 | $— | $— | $4997 | $5075 |
| Other equity securities | 100738 | 99393 | 4967 | 4152 | 105705 | 103545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity securities | $105735 | $104468 | $4967 | $4152 | $110702 | $108620 |

---

***Other Investments***

The following table contains information regarding the Company's other investments, measured at fair value, as of the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  |  | **Tiptree Capital** | **Tiptree Capital** |  |
|  | **Insurance** | **Mortgage** | **Other** | **Total** |
| Debentures | $21291 | $— | $— | $21291 |
| Investment in credit fund | 22547 |  |  | 22547 |
| Other | 5616 | 3586 | 461 | 9663 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other investments | $49454 | $3586 | $461 | $53501 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  |  | **Tiptree Capital** | **Tiptree Capital** |  |
|  | **Insurance** | **Mortgage** | **Other** | **Total** |
| Corporate bonds <sup>(1)</sup> | $3331 | $— | $— | $3331 |
| Debentures | 25320 |  |  | 25320 |
| Investment in credit fund | 21332 |  |  | 21332 |
| Other |  | 3101 |  | 3101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other investments | $49983 | $3101 | $— | $53084 |

---

<sup>(1)</sup> As of September 30, 2025, there were no corporate bonds held. The cost basis of corporate bonds was $3,139 as of December 31, 2024.

***Net Investment Income - Insurance***

Net investment income represents investment income and expense from investments related to insurance operations as disclosed within net investment income on the condensed consolidated statements of operations. The following table presents the components of net investment income by source of income:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Interest: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AFS securities | $11819 | $8431 | $35634 | $21894 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans, at fair value | 16 | 22 | 47 | 77 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments | 1167 | 2035 | 3329 | 5157 |
| Dividends from equity securities | 2609 | 412 | 3338 | 684 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 15611 | 10900 | 42348 | 27812 |
| Less: investment expenses | 8214 | 1789 | 12717 | 5562 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net investment income | $7397 | $9111 | $29631 | $22250 |

---

***Other Investment Income - Tiptree Capital***

Other investment income represents revenue from non-insurance activities as disclosed within other revenue on the condensed consolidated statements of operations, see Note (14) Other Revenue and Other Expenses. The following tables present the components of other investment income by type:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Interest income from Loans, at fair value | $1096 | $1061 | $3004 | $2819 |
| Dividends from equity securities | 20 |  | 59 |  |
| Loan fee income | 5176 | 4877 | 14914 | 14017 |
| Other | 657 | 947 | 2093 | 2553 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investment income | $6949 | $6885 | $20070 | $19389 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

***Net Realized and Unrealized Gains (Losses)***

The following table presents the components of net realized and unrealized gains (losses) recorded on the condensed consolidated statements of operations. Net unrealized gains (losses) on AFS securities are included within other comprehensive income (loss) (OCI), net of tax, and, as such, are not included in this table. Net realized and unrealized gains (losses) on non-investment related financial assets and liabilities are included below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Net realized gains (losses)** |  |  |  |  |
| <u>Insurance:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclass of unrealized gains (losses) on AFS securities from OCI | $65 | $(58) | $(523) | $(151) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized gains (losses) on loans |  |  |  | 58 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized gains (losses) on equity securities <sup>(1)</sup> | 12152 | 20 | 11251 | (22023) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized gains (losses) on corporate bonds | (20) | 70 | (20) | 2870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other |  | 89 | 73 | (872) |
| <u>Tiptree Capital</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>Mortgage:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized gains (losses) on loans | 13083 | 13553 | 35581 | 35305 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (1513) | (1048) | (1794) | (1294) |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>Other:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized gains on vessel sales |  |  | 50 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized gains (losses) on equity securities <sup>(1)</sup> |  |  |  | (98529) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net realized gains (losses) | $23767 | $12626 | $44618 | $(84636) |
| **Net unrealized gains (losses)** |  |  |  |  |
| <u>Insurance:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized gains (losses) on loans | $(150) | $(123) | $(2063) | $(247) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gains from recoveries (credit losses) on AFS securities | (64) | 316 | 2439 | (526) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on equity securities held at period end | 17781 | 1287 | 16996 | 7436 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclass of unrealized (gains) losses from prior periods for equity securities sold <sup>(1)</sup> | (5548) |  | 4462 | 22567 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 545 | 617 | 695 | (1530) |
| <u>Tiptree Capital</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>Mortgage:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in unrealized gains (losses) on loans | 361 | 332 | 1324 | (103) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (2088) | (3975) | (5626) | (4246) |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>Other:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on equity securities held at period end | 274 | (965) | (942) | (687) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclass of unrealized (gains) losses from prior periods for equity securities sold <sup>(1)</sup> |  |  |  | 100289 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 1 | (1799) | 451 | (1799) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net unrealized gains (losses) | 11112 | (4310) | 17736 | 121154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net realized and unrealized gains (losses) | $34879 | $8316 | $62354 | $36518 |

---

<sup>(1)</sup> On April 15, 2024, the Company sold its 16.98 million shares of Invesque for $625 of proceeds resulting in a realized loss of $134,204.

**<u>(5) Notes and Accounts Receivable, net</u>**

The following table presents the total notes and accounts receivable, net:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |
| Accounts and premiums receivable, net | $337740 | $341613 |
| Retrospective commissions receivable | 348717 | 286314 |
| Notes receivable, net | 109504 | 138162 |
| Other receivables | 17661 | 33042 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total notes and accounts receivable, net | $813622 | $799131 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the total valuation allowance and bad debt expense for the following periods:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Valuation allowance** | **Valuation allowance** | **Bad Debt Expense** | **Bad Debt Expense** | **Bad Debt Expense** | **Bad Debt Expense** |
|  | **As of** | **As of** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **September 30,<br>2025** | **December 31,<br>2024** | **2025** | **2024** | **2025** | **2024** |
| Notes receivable, net - premium financing program <sup>(1)</sup> | $28 | $26 | $6 | $33 | $24 | $118 |
| Accounts and premiums receivable, net | $290 | $294 | $31 | $8 | $66 | $333 |

---

<sup>(1)</sup> As of September 30, 2025 and December 31, 2024, there were $25 and $37 in balances classified as 90 days plus past due, respectively.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

**<u>(6) Reinsurance Recoverable and Prepaid Reinsurance Premiums</u>**

The following table presents the effect of reinsurance on premiums written and earned by our insurance business for the following periods:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Direct<br>Amount** | **Ceded to<br>Other<br>Companies** | **Assumed<br>from Other<br>Companies** | **Net Amount** | **Percentage of<br>Amount -<br>Assumed to<br>Net** |
| **Three Months Ended September 30, 2025** |  |  |  |  |  |
| *<u>Premiums written:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $22032 | $13857 | $(5) | $8170 | (0.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 34196 | 25125 | 4 | 9075 | 0.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 611210 | 361474 | 129692 | 379428 | 34.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums written | $667438 | $400456 | $129691 | $396673 | 32.7% |
| *<u>Premiums earned:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $19295 | $11455 | $17 | $7857 | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 31443 | 22368 | 9 | 9084 | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 541202 | 309990 | 135728 | 366940 | 37.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums earned | $591940 | $343813 | $135754 | $383881 | 35.4% |
| **Three Months Ended September 30, 2024** |  |  |  |  |  |
| *<u>Premiums written:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $19149 | $9621 | $16 | $9544 | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 34333 | 22344 | 84 | 12073 | 0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 519565 | 259803 | 107894 | 367656 | 29.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums written | $573047 | $291768 | $107994 | $389273 | 27.7% |
| *<u>Premiums earned:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $20056 | $10176 | $55 | $9935 | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 33974 | 21850 | 55 | 12179 | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 454793 | 246820 | 129409 | 337382 | 38.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums earned | $508823 | $278846 | $129519 | $359496 | 36.0% |
| **Nine Months Ended September 30, 2025** |  |  |  |  |  |
| *<u>Premiums written:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $56609 | $33379 | $27 | $23257 | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 87533 | 62027 | 6796 | 32302 | 21.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 1751496 | 1026887 | 403000 | 1127609 | 35.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums written | $1895638 | $1122293 | $409823 | $1183168 | 34.6% |
| *<u>Premiums earned:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $57488 | $30823 | $121 | $26786 | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 93237 | 63693 | 6813 | 36357 | 18.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 1559987 | 920034 | 426163 | 1066116 | 40.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums earned | $1710712 | $1014550 | $433097 | $1129259 | 38.4% |
| **Nine Months Ended September 30, 2024** |  |  |  |  |  |
| *<u>Premiums written:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $55579 | $27902 | $260 | $27937 | 0.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 93004 | 62093 | 10192 | 41103 | 24.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 1455323 | 769268 | 318226 | 1004281 | 31.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums written | $1603906 | $859263 | $328678 | $1073321 | 30.6% |
| *<u>Premiums earned:</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $60623 | $30751 | $322 | $30194 | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 100331 | 66142 | 10152 | 44341 | 22.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 1305534 | 694946 | 420150 | 1030738 | 40.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total premiums earned | $1466488 | $791839 | $430624 | $1105273 | 39.0% |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the components of policy and contract benefits, including the effect of reinsurance on losses and loss adjustment expenses (LAE) incurred:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Direct<br>Amount** | **Ceded to<br>Other<br>Companies** | **Assumed from<br>Other<br>Companies** | **Net Amount** | **Percentage of<br>Amount -<br>Assumed to<br>Net** |
| **Three Months Ended September 30, 2025** |  |  |  |  |  |
| *<u>Losses and LAE Incurred</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $10368 | $6060 | $(3) | $4305 | (0.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 6688 | 5110 | 18 | 1596 | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 278628 | 173796 | 81669 | 186501 | 43.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total losses and LAE incurred | $295684 | $184966 | $81684 | $192402 | 42.5% |
|  | Member benefit claims <sup>(1)</sup> | Member benefit claims <sup>(1)</sup> |  | 24928 |  |
|  | Total policy and contract benefits | Total policy and contract benefits |  | $217330 |  |
| **Three Months Ended September 30, 2024** |  |  |  |  |  |
| *<u>Losses and LAE Incurred</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $10251 | $6078 | $5 | $4178 | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 6463 | 5060 | 550 | 1953 | 28.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 218525 | 134038 | 85314 | 169801 | 50.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total losses and LAE incurred | $235239 | $145176 | $85869 | $175932 | 48.8% |
|  | Member benefit claims <sup>(1)</sup> | Member benefit claims <sup>(1)</sup> |  | 27510 |  |
|  | Total policy and contract benefits | Total policy and contract benefits |  | $203442 |  |
| **Nine Months Ended September 30, 2025** |  |  |  |  |  |
| *<u>Losses and LAE Incurred</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $30121 | $17960 | $(1) | $12160 | (0.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 16497 | 12891 | 6434 | 10040 | 64.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 791494 | 527354 | 283781 | 547921 | 51.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total losses and LAE incurred | $838112 | $558205 | $290214 | $570121 | 50.9% |
|  | Member benefit claims <sup>(1)</sup> | Member benefit claims <sup>(1)</sup> |  | 82994 |  |
|  | Total policy and contract benefits | Total policy and contract benefits |  | $653115 |  |
| **Nine Months Ended September 30, 2024** |  |  |  |  |  |
| *<u>Losses and LAE Incurred</u>* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $32746 | $18308 | $(16) | $14422 | (0.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 17355 | 12027 | 11035 | 16363 | 67.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 648751 | 376720 | 253755 | 525786 | 48.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total losses and LAE incurred | $698852 | $407055 | $264774 | $556571 | 47.6% |
|  | Member benefit claims <sup>(1)</sup> | Member benefit claims <sup>(1)</sup> |  | 88510 |  |
|  | Total policy and contract benefits | Total policy and contract benefits |  | $645081 |  |

---

<sup>(1)</sup> Member benefit claims are not covered by reinsurance.

The following table presents the components of the reinsurance recoverable:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |
| Ceded claim reserves: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance | $4638 | $4621 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance | 27422 | 24836 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 781780 | 607250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total ceded claim reserves recoverable | 813840 | 636707 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other reinsurance settlements recoverable | 531822 | 356176 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total reinsurance recoverable | $1345662 | $992883 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the components of prepaid reinsurance premiums:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |
| Prepaid reinsurance premiums: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life insurance <sup>(1)</sup> | $74864 | $71427 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health insurance <sup>(1)</sup> | 70878 | 72840 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and liability insurance | 955223 | 901986 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total prepaid reinsurance premiums | $1100965 | $1046253 |

---

<sup>(1)</sup> Including policyholder account balances ceded.

The following table presents the aggregate amount included in reinsurance receivables that is comprised of the three largest receivable balances from non-affiliated reinsurers:

---

| | |
|:---|:---|
|  | **As of** |
|  | **September 30,<br>2025** |
| Total of the three largest receivable balances from non-affiliated reinsurers | $340084 |

---

As of September 30, 2025, the non-affiliated reinsurers from whom our insurance business has the largest receivable balances were: Accident Fund Insurance Company of America (AM Best Rating: A rated), Allianz Reinsurance America, Inc. (AM Best Rating: A+ rated), and Ferian Re, LTD (AM Best Rating: Not Rated). Receivable balances from authorized reinsurers, such as the Allianz companies noted above, do not require collateral based on the authorized status of the parties. Receivable balances from unauthorized reinsurers are collateralized by assets on hand, assets held in trust accounts, and/or letters of credit. The Company monitors collateral values, authorization status, financial statements and A.M. Best ratings of its reinsurers periodically. As of September 30, 2025, the Company does not believe there is a risk of loss due to the concentration of credit risk in the reinsurance program given the related collateralization or reinsurer A.M. Best rating.

**<u>(7) Goodwill and Intangible Assets, net</u>**

The following table presents identifiable finite and indefinite-lived intangible assets, accumulated amortization, and goodwill by operating segment and/or reporting unit, as appropriate:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Insurance** | **Other** | **Total** | **Insurance** | **Other** | **Total** |
| **Finite-Lived Intangible Assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer relationships | $164034 | $— | $164034 | $162520 | $— | $162520 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated amortization | (96211) |  | (96211) | (87610) |  | (87610) |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade names | 16317 | 800 | 17117 | 16202 | 800 | 17002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated amortization | (10785) | (800) | (11585) | (9869) | (760) | (10629) |
| &nbsp;&nbsp;&nbsp;&nbsp;Software licensing | 17864 | 640 | 18504 | 17238 | 640 | 17878 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated amortization | (11394) | (640) | (12034) | (10705) | (640) | (11345) |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance policies and contracts acquired | 36500 |  | 36500 | 36500 |  | 36500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated amortization | (36500) |  | (36500) | (36500) |  | (36500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 1115 |  | 1115 | 1081 |  | 1081 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated amortization | (1029) |  | (1029) | (799) |  | (799) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total finite-lived intangible assets | 79911 |  | 79911 | 88058 | 40 | 88098 |
| **Indefinite-Lived Intangible Assets:** <sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance licensing agreements | 13761 |  | 13761 | 13761 |  | 13761 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  |  |  |  | 1000 | 1000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total indefinite-lived intangible assets | 13761 |  | 13761 | 13761 | 1000 | 14761 |
| Total intangible assets, net | $93672 | $— | $93672 | $101819 | $1040 | $102859 |
| Goodwill | 206094 | 1708 | 207802 | 204998 | 1708 | 206706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total goodwill and intangible assets, net | $299766 | $1708 | $301474 | $306817 | $2748 | $309565 |

---

<sup>(1)</sup> Impairment tests are performed at least annually on indefinite-lived intangible assets.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

***Goodwill***

The following table presents the activity in goodwill, by operating segment and/or reporting unit, as appropriate, and includes the adjustments made to the balance of goodwill to reflect the effect of the final valuation adjustments made for acquisitions, as well as the reduction to any goodwill attributable to impairment related charges:

---

| | | | |
|:---|:---|:---|:---|
|  | **Insurance** | **Other** | **Total** |
| Balance at December 31, 2024 | $204998 | $1708 | $206706 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation and other | 1096 |  | 1096 |
| Balance at September 30, 2025 | $206094 | $1708 | $207802 |

---

The Company conducts annual impairment tests of its goodwill as of October 1. For the three and nine months ended September 30, 2025 and 2024, no impairments were recorded on the Company's goodwill.

***Intangible Assets, net***

The following table presents the activity, by operating segment and/or reporting unit, as appropriate, in finite and indefinite-lived other intangible assets and includes the adjustments made to the balance to reflect the effect of any final valuation adjustments made for acquisitions, as well as any reduction attributable to impairment-related charges:

---

| | | | |
|:---|:---|:---|:---|
|  | **Insurance** | **Other** | **Total** |
| Balance at December 31, 2024 | $101819 | $1040 | $102859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | (10047) | (40) | (10087) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation and other | 1900 |  | 1900 |
| &nbsp;&nbsp;&nbsp;&nbsp;Disposal of intangible assets |  | (1000) | (1000) |
| Balance at September 30, 2025 | $93672 | $— | $93672 |

---

The following table presents the amortization expense on finite-lived intangible assets for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Amortization expense on intangible assets | $3362 | $3879 | $10087 | $11617 |

---

For the nine months ended September 30, 2025 and 2024, no impairments were recorded on the Company's intangible assets.

The following table presents the amortization expense on finite-lived intangible assets for the next five years and thereafter by operating segment and/or reporting unit, as appropriate:

---

| | | |
|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Insurance** <sup>(1)</sup> | **Total** |
| Remainder of 2025 | $3273 | $3273 |
| 2026 | 10894 | 10894 |
| 2027 | 9543 | 9543 |
| 2028 | 8341 | 8341 |
| 2029 | 7291 | 7291 |
| 2030 and thereafter | 38811 | 38811 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $78153 | $78153 |

---

<sup>(1)</sup> Does not include foreign currency translation adjustment of $1,758 as of September 30, 2025.

**<u>(8)</u>** Derivative Financial Instruments and Hedging

The Company selectively utilizes derivative financial instruments as part of its overall investment and hedging activities. Derivative contracts are subject to additional risk that can result in a loss of all or part of an investment. The Company's derivative activities are primarily to manage underlying credit risk, market risk, interest rate risk and currency exchange rate risk. In addition, the Company is also subject to counterparty risk should its counterparties fail to meet the contract terms. Derivative assets are reported in other

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

investments. Derivative liabilities are reported within other liabilities and accrued expenses. Derivatives for our mortgage business are primarily comprised of interest rate lock commitments (IRLCs), forward delivery contracts, and TBA mortgage-backed securities.

*Interest Rate Lock Commitments*

The fair value of these instruments is based upon valuation pricing models, which represent the amount the Company would expect to receive or pay at the balance sheet date to exit the position. Our mortgage origination subsidiary issues IRLCs to their customers, which are carried at estimated fair value on the Company's condensed consolidated balance sheets. The estimated fair values of these commitments are generally calculated by reference to the value of the underlying loan associated with the IRLC net of costs to produce and an expected pull through assumption. The fair values of these commitments generally fall under Level 3 in the fair value hierarchy.

*Forward Delivery Contracts and TBA Mortgage-Backed Securities*

Our mortgage origination subsidiary manages their exposure by entering into forward delivery commitments with loan investors. For loans not locked with investors under a forward delivery commitment, the Company enters into hedge instruments, primarily TBAs, to protect against movements in interest rates. The fair values of TBA mortgage-backed securities and forward delivery contracts generally fall under Level 2 in the fair value hierarchy.

The remaining derivatives are generally comprised of a combination of swaps, currency forwards and options, which are generally classified as Level 2 in the fair value hierarchy. In addition, the Fortegra Additional Warrant (Warburg) is a derivative liability and classified as Level 3 in the fair value hierarchy. See Note (15) Stockholders' Equity for additional information regarding the Fortegra Additional Warrant.

The following table presents the gross notional and fair value amounts of derivatives (on a gross basis) categorized by underlying risk:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Notional<br>values** | **Asset <br>derivatives** | **Liability<br>derivatives** | **Notional<br>values** | **Asset <br>derivatives** | **Liability<br>derivatives** |
| Interest rate lock commitments | $117415 | $3189 | $— | $105898 | $2257 | $— |
| Forward delivery contracts | 47900 | 149 | 70 | 26090 | 33 | 54 |
| TBA mortgage-backed securities | 233050 | 248 | 215 | 133200 | 811 | 115 |
| Fortegra Additional Warrants (Warburg)<sup>(1)</sup> |  |  | 28518 |  |  | 10958 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $398365 | $3586 | $28803 | $265188 | $3101 | $11127 |

---

<sup>(1)</sup> See Note (15) Stockholders' Equity for additional information.

**<u>(9) Debt, net</u>**

The following table presents the balance of the Company's debt obligations, net of discounts and deferred financing costs for our corporate and asset based debt. Asset based debt is generally recourse only to specific assets and related cash flows.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
| **Corporate debt** | **Insurance** | **Mortgage** | **Corporate** | **Total** |
| Secured revolving credit agreements <sup>(1)</sup> | $55000 | $— | $— | $55000 |
| Secured term credit agreement (SOFR + 5.25%)<sup>(2)</sup> |  |  | 74438 | 74438 |
| 8.50% Junior subordinated notes | 125000 |  |  | 125000 |
| 9.25% Junior subordinated notes | 150000 |  |  | 150000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total corporate debt | 330000 |  | 74438 | 404438 |
| **Asset based debt** |  |  |  |  |
| Asset based revolving financing (SOFR + 2.75%) | 41287 |  |  | 41287 |
| Residential mortgage warehouse borrowings (1.75% to 3.30% over SOFR)<sup>(4)(5)</sup> |  | 78377 |  | 78377 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total asset based debt | 41287 | 78377 |  | 119664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt, face value | 371287 | 78377 | 74438 | 524102 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unamortized discount, net |  |  | (590) | (590) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unamortized deferred financing costs | (14136) | (15) | (1801) | (15952) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt, net | $357151 | $78362 | $72047 | $507560 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
| **Corporate debt** | **Insurance** | **Mortgage** | **Corporate** | **Total** |
| Secured revolving credit agreements <sup>(1)</sup> | $— | $— | $— | $— |
| Preferred trust securities (SOFR + 4.10% + spread adjustment)<sup>(3)</sup> | 35000 |  |  | 35000 |
| 8.50% Junior subordinated notes | 125000 |  |  | 125000 |
| 9.25% Junior subordinated notes | 150000 |  |  | 150000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total corporate debt | 310000 |  |  | 310000 |
| **Asset based debt** |  |  |  |  |
| Asset based revolving financing (SOFR + 2.75%) | 63699 |  |  | 63699 |
| Residential mortgage warehouse borrowings (1.75% to 3.30% over SOFR)<sup>(4)(5)</sup> |  | 68394 |  | 68394 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total asset based debt | 63699 | 68394 |  | 132093 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt, face value | 373699 | 68394 |  | 442093 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unamortized deferred financing costs | (14957) | (47) |  | (15004) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt, net | $358742 | $68347 | $— | $427089 |

---

<sup>(1)</sup> The secured credit agreements include separate tranches with multiple rate structures that are adjustable based on Fortegra's senior leverage ratio, which as of September 30, 2025 and December 31, 2024 was SOFR + 1.50%.

<sup>(2)</sup> The $75,000 Corporate debt is a secured term credit agreement at 5.25% over the one month SOFR rate, with a floor of 1.00%.

<sup>(3)</sup> Previously based on 3-month LIBOR, moved to SOFR plus the tenor spread adjustment of 0.26%, in accordance with the Adjustable Interest Rate (LIBOR) Act of 2021.

<sup>(4)</sup> As of September 30, 2025, included (i) a $50,000 line of credit at 1.75%, 2.00% and 2.50% over the one month SOFR rate, (ii) a $25,000 line of credit at 1.75% over the one month SOFR rate, with a floor of 2.75%, (iii) a $30,000 line of credit at 1.875% over the one month SOFR rate and (iv) a $10,000 line of credit at 3.30% over the one month SOFR rate. As of December 31, 2024, included (i) a $50,000 line of credit at 1.75%, 2.00% and 2.50% over the one month SOFR rate, and (ii) a $25,000 line of credit at 1.75% over the one month SOFR rate, with a floor of 2.75%. (iii) a $30,000 line of credit at 1.875% over the one month SOFR rate and (iv) a $10,000 line of credit at 3.30% over the one month SOFR rate.

<sup>(5)</sup> The weighted average coupon rate for residential mortgage warehouse borrowings was 6.02% and 6.25% at September 30, 2025 and December 31, 2024, respectively.

The following table presents the amount of interest expense the Company incurred on its debt for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Interest expense - corporate debt | $9334 | $5602 | $27518 | $17491 |
| Interest expense - asset based debt | 1356 | 2012 | 4394 | 6428 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest expense on debt | $10690 | $7614 | $31912 | $23919 |

---

The following table presents the contractual principal payments and future maturities of the unpaid principal balance on the Company's debt for the following periods:

---

| | |
|:---|:---|
|  | **As of<br>September 30, 2025** |
| Remainder of 2025 | $— |
| 2026 | 119664 |
| 2027 | 55000 |
| 2028 | 74438 |
| 2029 |  |
| 2030 and thereafter | 275000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $524102 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following narrative is a summary of certain terms of our debt agreements for the nine months ended September 30, 2025:

***Corporate Debt***

*Secured Revolving Credit Agreements*

As of September 30, 2025 and December 31, 2024, a total of $55,000 and $0, respectively, was outstanding under the revolving line of credit. The maximum borrowing capacity under the agreements as of September 30, 2025 was $200,000.

*Secured Term Credit Agreement*

On February 7, 2025, Tiptree Holdings, a subsidiary of Tiptree Inc., entered into a $75,000 senior secured credit facility due February 7, 2028. Interest is paid monthly, at an interest rate of SOFR plus 5.25%, with quarterly principal payments at an amount equal to 0.25% of the aggregate original principal.

*Preferred Trust Securities*

On June 20, 2007, a subsidiary of Fortegra issued $35,000 of preferred trust securities due June 15, 2037. Interest is payable quarterly at an interest rate of SOFR plus 4.10% plus a spread adjustment (previously, LIBOR plus 4.10%). The Company redeemed the preferred trust securities, at the full outstanding principal amount, $35,000, and unpaid interest, $771, on March 17, 2025.

*Junior Subordinated Notes*

On October 16, 2017, a subsidiary of Fortegra issued $125,000 of 8.50% Fixed Rate Resetting Junior Subordinated Notes due October 2057 (the "2017 Notes"). Substantially all of the net proceeds were used to repay the existing secured credit agreement at that time, which was terminated thereafter. Beginning on October 15, 2027, the Company may redeem the 2017 Notes at par plus accrued and unpaid interest.

On November 7, 2024, Fortegra issued $150,000 of 9.25% Fixed Rate Resetting Junior Subordinated Notes due November 2064 (the "2024 Notes"). The proceeds of the 2024 Notes were used to repay outstanding indebtedness under the Company's credit agreement, for insurance company growth capital and general corporate purposes. Beginning on November 15, 2029, the Company may redeem the 2024 Notes at par plus accrued and unpaid interest.

***Asset Based Debt***

*Asset Based Revolving Financing*

As of September 30, 2025 and December 31, 2024, a total of $41,287 and $63,699, respectively, was outstanding under the borrowing related to our premium finance offerings in our insurance business.

*Residential Mortgage Warehouse Borrowings*

As of September 30, 2025, our mortgage business had three warehouse lines of credit with three separate lending partners totaling $105,000 of borrowing capacity. The $50,000 line of credit matures in August 2026, the $25,000 line of credit matures in June 2026, and the $30,000 line of credit matures in February 2026.

As of September 30, 2025 and December 31, 2024, a total of $78,377 and $68,394, respectively, was outstanding under such financing agreements.

*Mortgage Servicing Rights (MSR) Line of Credit*

As of September 30, 2025, our mortgage business had a MSR line of credit with borrowing capacity of $9,205 at 3.30% over SOFR, with no borrowings outstanding at the end of the period.

**<u>(10)</u>** Fair Value of Financial Instruments

The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs to the extent possible to measure a financial instrument's fair value. Observable inputs reflect the assumptions market participants would use in pricing an asset or liability, and are affected by the type of product, whether the product is traded on an active exchange or in the secondary market, as well as current market conditions. To the extent that valuation is based on models or inputs that are less observable or unobservable in the

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Fair value is estimated by applying the hierarchy discussed in Note (2) Summary of Significant Accounting Policies of our Annual Report on Form 10-K which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized within Level 3 of the fair value hierarchy.

The Company's fair value measurements are based primarily on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable financial instruments. Sources of inputs to the market approach include third-party pricing services, independent broker quotations and pricing matrices. Management analyzes the third-party valuation methodologies and its related inputs to perform assessments to determine the appropriate level within the fair value hierarchy and to assess reliability of values. Further, management has a process in place to review all changes in fair value that occurred during each measurement period. Any discrepancies or unusual observations are followed through to resolution through the source of the pricing as well as utilizing comparisons, if applicable, to alternate pricing sources.

The Company utilizes observable and unobservable inputs within its valuation methodologies. Observable inputs may include: benchmark yields, reported trades, broker-dealer quotes, issuer spreads, benchmark securities, bids, offers and reference data. In addition, specific issuer information and other market data is used. Broker quotes are obtained from sources recognized to be market participants. Unobservable inputs may include: expected cash flow streams, default rates, supply and demand considerations and market volatility.

***Available for Sale Securities, at fair value***

The fair values of AFS securities are based on prices provided by an independent pricing service and a third-party investment manager. The Company obtains an understanding of the methods, models and inputs used by the independent pricing service and the third-party investment manager by analyzing the investment manager-provided pricing report.

The following details the methods and assumptions used to estimate the fair value of each class of AFS securities and the applicable level each security falls within the fair value hierarchy:

*U.S. Treasury Securities, Obligations of U.S. Government Authorities and Agencies, Obligations of State and Political Subdivisions, Corporate Securities, Asset Backed Securities, and Obligations of Foreign Governments:* Fair values were obtained from an independent pricing service and a third-party investment manager. The prices provided by the independent pricing service and third-party investment manager are based on quoted market prices, when available, non-binding broker quotes, or matrix pricing and fall under Level 2 or Level 3 in the fair value hierarchy.

*Certificates of Deposit:* The estimated fair value of certificates of deposit approximate carrying value and fall under Level 1 of the fair value hierarchy.

***Equity Securities***

The fair values of publicly traded common and preferred equity securities and exchange traded funds ("ETFs") are obtained from market value quotations provided by an independent pricing service and fall under Level 1 in the fair value hierarchy. The fair values of non-publicly traded common and preferred stocks are based on prices derived from multiples of comparable public companies and fall under Level 3 in the fair value hierarchy.

***Loans, at fair value***

*Corporate Loans*: These loans are comprised of middle market loans and bank loans and are generally classified under either Level 2 or Level 3 in the fair value hierarchy. To determine fair value, the Company uses quoted prices, including those provided from pricing vendors, which provide coverage of secondary market participants, where available. The values represent a composite of mark-to-market bid/offer prices. In certain circumstances, the Company will make its own determination of fair value of loans based on internal models and other unobservable inputs.

*Mortgage Loans Held for Sale*: Mortgage loans held for sale are generally classified under Level 2 in the fair value hierarchy and fair value is based upon forward sales contracts with third-party investors, including estimated loan costs.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

***Derivative Assets and Liabilities***

Derivatives for our mortgage business are primarily comprised of IRLCs, forward delivery contracts and TBA mortgage-backed securities. The fair value of these instruments is based upon valuation pricing models, which represent the amount the Company would expect to receive or pay at the balance sheet date to exit the position. Our mortgage origination subsidiaries issue IRLCs to their customers, which are carried at estimated fair value on the Company's condensed consolidated balance sheets. The estimated fair values of these commitments are generally calculated by reference to the value of the underlying loan associated with the IRLC net of costs to produce and an expected pull through assumption. The fair values of these commitments generally fall under Level 3 in the fair value hierarchy. Our mortgage origination subsidiaries manage their exposure by entering into forward delivery commitments with loan investors. For loans not locked with investors under a forward delivery commitment, the Company enters into hedge instruments, primarily TBAs, to protect against movements in interest rates. The fair values of TBA mortgage-backed securities and forward delivery contracts generally fall under Level 2 in the fair value hierarchy.

The remaining derivatives are generally comprised of a combination of swaps, currency forwards and options, which are generally classified as Level 2 in the fair value hierarchy. In addition, the Fortegra Additional Warrants (Warburg) are a derivative liability and classified as Level 3 in the fair value hierarchy. See Note (15) Stockholders' Equity for additional information regarding the Fortegra Additional Warrants.

***Corporate Bonds***

Corporate bonds are generally classified under Level 2 in the fair value hierarchy and fair value is based on quoted market prices. We perform internal price verification procedures to ensure that the prices provided are reasonable.

***Securities Sold, Not Yet Purchased***

Securities sold, not yet purchased are generally classified under Level 1 or Level 2 in the fair value hierarchy, based on the leveling of the securities sold short, and fair value is provided by a third-party investment manager, based on quoted market prices. We perform internal price verification procedures monthly to ensure that the prices provided are reasonable.

***Mortgage Servicing Rights***

Mortgage servicing rights are classified under Level 3 in the fair value hierarchy and fair value is provided by a third-party valuation service. Various observable and unobservable inputs are used to determine fair value, including discount rate, cost to service and weighted average prepayment speed.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following tables present the Company's fair value hierarchies for financial assets and liabilities, measured on a recurring basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Quoted<br>prices in<br>active<br>markets <br>Level 1** | **Other<br>significant<br>observable<br>inputs<br>Level 2** | **Significant<br>unobservable<br>inputs<br>Level 3** | **Fair value** |
| **<u>Assets:</u>** |  |  |  |  |
| Available for sale securities, at fair value: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities and obligations of U.S. government authorities and agencies | $— | $308847 | $— | $308847 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of state and political subdivisions |  | 15680 |  | 15680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of foreign governments |  | 62495 |  | 62495 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certificates of deposit | 1151 |  |  | 1151 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset backed securities |  | 90759 |  | 90759 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate securities |  | 826471 |  | 826471 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total available for sale securities, at fair value | 1151 | 1304252 |  | 1305403 |
| Loans, at fair value: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate loans |  |  | 8209 | 8209 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans held for sale |  | 82213 |  | 82213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans, at fair value |  | 82213 | 8209 | 90422 |
| Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exchange traded funds | 42 |  |  | 42 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other equity securities | 162333 |  | 9298 | 171631 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity securities | 162375 |  | 9298 | 171673 |
| Other investments, at fair value: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative assets |  | 397 | 3189 | 3586 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  | 22547 | 5616 | 28163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other investments, at fair value |  | 22944 | 8805 | 31749 |
| Mortgage servicing rights <sup>(1)</sup> |  |  | 40597 | 40597 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $163526 | $1409409 | $66909 | $1639844 |
| **<u>Liabilities:</u>** <sup>(2)</sup> |  |  |  |  |
| Derivative liabilities | $— | $269 | $16 | $285 |
| Fortegra Additional Warrants (Warburg) |  |  | 28518 | 28518 |
| Contingent consideration payable |  |  | 1896 | 1896 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $269 | $30430 | $30699 |

---

<sup>(1)</sup> Included in other assets. See Note (13) Other Assets and Other Liabilities and Accrued Expenses.

<sup>(2)</sup> Included in other liabilities and accrued expenses. See Note (13) Other Assets and Other Liabilities and Accrued Expenses.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Quoted<br>prices in<br>active<br>markets <br>Level 1** | **Other<br>significant<br>observable<br>inputs <br>Level 2** | **Significant<br>unobservable<br>inputs<br>Level 3** | **Fair value** |
| **<u>Assets:</u>** |  |  |  |  |
| Available for sale securities, at fair value: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities and obligations of U.S. government authorities and agencies | $— | $395643 | $— | $395643 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of state and political subdivisions |  | 38675 |  | 38675 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of foreign governments |  | 51472 |  | 51472 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certificates of deposit | 1145 |  |  | 1145 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset backed securities |  | 22860 |  | 22860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate securities |  | 598134 |  | 598134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total available for sale securities, at fair value | 1145 | 1106784 |  | 1107929 |
| Loans, at fair value: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate loans |  |  | 10272 | 10272 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans held for sale |  | 71058 |  | 71058 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total loans, at fair value |  | 71058 | 10272 | 81330 |
| Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exchange traded funds | 5075 |  |  | 5075 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other equity securities | 95360 |  | 8185 | 103545 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity securities | 100435 |  | 8185 | 108620 |
| Other investments, at fair value: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds |  | 3331 |  | 3331 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative assets |  | 834 | 2267 | 3101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  | 21332 |  | 21332 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other investments, at fair value |  | 25497 | 2267 | 27764 |
| Mortgage servicing rights <sup>(1)</sup> |  |  | 42611 | 42611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $101580 | $1203339 | $63335 | $1368254 |
| **<u>Liabilities:</u>** <sup>(2)</sup> |  |  |  |  |
| Derivative liabilities | $— | $143 | $26 | $169 |
| Fortegra Additional Warrants (Warburg) |  |  | 10958 | 10958 |
| Contingent consideration payable |  |  | 1779 | 1779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $143 | $12763 | $12906 |

---

<sup>(1)</sup> Included in other assets. See Note (13) Other Assets and Other Liabilities and Accrued Expenses.

<sup>(2)</sup> Included in other liabilities and accrued expenses. See Note (13) Other Assets and Other Liabilities and Accrued Expenses.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

Transfers between Level 2 and 3 were a result of subjecting third-party pricing on assets to various liquidity, depth, bid-ask spread and benchmarking criteria as well as assessing the availability of observable inputs affecting their fair valuation.

The following table presents additional information about assets that are measured at fair value on a recurring basis for which the Company has utilized Level 3 inputs to determine fair value for the following periods:

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** |
| Balance at January 1, | $63335 | $61565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains or losses included in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings | (2651) | 1333 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OCI |  | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;Origination of IRLCs | 34098 | 31100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases | 5435 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions | (142) | (1910) |
| &nbsp;&nbsp;&nbsp;&nbsp;Conversions to mortgage loans held for sale | (33166) | (31435) |
| Balance at September 30, | $66909 | $60728 |
| Changes in unrealized gains (losses) included in earnings related to assets still held at period end | $(2982) | $1333 |
| Changes in unrealized gains (losses) included in OCI related to assets still held at period end | $— | $75 |

---

The following table presents the range and weighted average (WA) used to develop significant unobservable inputs for the fair value measurements of Level 3 assets and liabilities:

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of** | **As of** |  |  | **As of** | **As of** | **As of** | **As of** | **As of** | **As of** | **As of** | **As of** |
|  | **September 30,<br>2025** | **December 31,<br>2024** |  |  | **September 30,<br>2025** | **September 30,<br>2025** | **September 30,<br>2025** | **September 30,<br>2025** | **December 31,<br>2024** | **December 31,<br>2024** | **December 31,<br>2024** | **December 31,<br>2024** |
| **<u>Assets</u>** | **Fair value** | **Fair value** | **Valuation<br>technique** | **Unobservable<br>input(s)** | **Range** | **Range** | **Range** | **WA** <sup>(1)</sup> | **Range** | **Range** | **Range** | **WA** <sup>(1)</sup> |
| IRLCs | $3189 | $2257 | Internal model | Pull through rate | 45% | to | 95% | 63% | 45% | to | 95% | 60% |
| Mortgage |  |  |  | Discount rate | 9% | to | 14% | 10% | 10% | to | 15% | 11% |
| servicing | 40597 | 42611 | External | Cost to service | $65 | to | $3000 | $129 | $65 | to | $3000 | $133 |
| rights |  |  | model | Prepayment<br>speed | 3% | to | 82% | 11% | 3% | to | 87% | 9% |
| Equity securities | 9298 | 8185 | Internal model | Forecast EBITDAR | $1422000 | to | $1604000 | N/A | $1422000 | to | $1604000 | N/A |
| Corporate loans | 8209 | 10272 | External model | Bid marks | $63 | to | $65 | $64 | $78 | to | $81 | $80 |
| Commercial real<br>estate loan | 5616 |  | Cash Flow<br>model | Forecast cash<br>flow | $20000 | to | $25000 | $23640 | $— | to | $— | $— |
| Total | $66909 | $63325 |  |  |  |  |  |  |  |  |  |  |
| **<u>Liabilities</u>** |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Equity value | N/A | to | N/A | $1623000 | N/A | to | N/A | $1172000 |
| Fortegra Additional |  |  |  | Time until liquidation | N/A | to | N/A | 0.6 years | N/A | to | N/A | 3.5 years |
| Warrants (Warburg) | $28518 | $10958 | External<br>Model | Discount rate | 3% | to | 5% | 4.2% | 3% | to | 5% | 3.4% |
|  |  |  |  | Implied Equity<br>Volatility | N/A | to | N/A | N/A | 40% | to | 50% | 45% |
| Contingent consideration | 1896 | 1779 | Cash Flow model | Forecast Cash EBITDA | $2500 | to | $4000 | N/A | $2500 | to | $4000 | N/A |
| payable |  |  |  | Forecast Underwriting EBITDA | $— | to | $2000 | N/A | $— | to | $2000 | N/A |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $30414 | $12737 |  |  |  |  |  |  |  |  |  |  |

---

<sup>(1)</sup> Unobservable inputs were weighted by the relative fair value of the instruments.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the carrying amounts and estimated fair values of financial assets and liabilities that are not recorded at fair value and their respective levels within the fair value hierarchy:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Level within<br>fair value<br>hierarchy** | **Fair value** | **Carrying<br>value** | **Level within<br>fair value<br>hierarchy** | **Fair value** | **Carrying<br>value** |
| <u>Assets:</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debentures | 2 | $21291 | $21291 | 2 | $25320 | $25320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes receivable, net | 2 | 109504 | 109504 | 2 | 138162 | 138162 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets |  | $130795 | $130795 |  | $163482 | $163482 |
| <u>Liabilities:</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt | 3 | $521012 | $523512 | 3 | $439906 | $442093 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities |  | $521012 | $523512 |  | $439906 | $442093 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

*Debentures:* Since interest rates on debentures are at current market rates for similar credit risks, the carrying amount approximates fair value. These values are net of allowance for doubtful accounts. See Note (4) Investments.

*Notes Receivable, net:* To the extent that carrying amounts differ from fair value, fair value is determined based on contractual cash flows discounted at market rates for similar credits. Categorized under Level 2 in the fair value hierarchy. See Note (5) Notes and Accounts Receivable, net.

*Debt:* The carrying value, which approximates fair value of floating rate debt, represents the total debt balance at face value excluding the unamortized discount. The fair value of the Junior subordinated notes is determined based on dealer quotes. Categorized under Level 3 in the fair value hierarchy.

Additionally, the following financial assets and liabilities on the condensed consolidated balance sheets are not carried at fair value, but whose carrying amounts approximate their fair value:

*Cash and Cash Equivalents:* The carrying amounts of cash and cash equivalents are carried at cost which approximates fair value. Categorized under Level 1 in the fair value hierarchy.

*Accounts and Premiums Receivable, net, Retrospective Commissions Receivable and Other Receivables:* The carrying amounts approximate fair value since no interest rate is charged on these short duration assets. Categorized under Level 2 in the fair value hierarchy. See Note (5) Notes and Accounts Receivable, net.

*Due from Brokers, Dealers, and Trustees and Due to Brokers, Dealers and Trustees:* The carrying amounts are included in other assets and other liabilities and accrued expenses and approximate their fair value due to their short term nature. Categorized under Level 2 in the fair value hierarchy.

**<u>(11) Liability for Unpaid Claims and Claim Adjustment Expenses</u>**

***Roll forward of Claim Liability***

The following table presents the activity in the net liability for unpaid losses and allocated loss adjustment expenses of short duration contracts for the following periods:

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** |
| Policy liabilities and unpaid claims balance as of January 1, | $1298081 | $844848 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: liabilities of policy-holder account balances, gross | (304) | (878) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: non-insurance warranty benefit claim liabilities | (2837) | (2103) |
| Gross liabilities for unpaid losses and loss adjustment expenses | 1294940 | 841867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: reinsurance recoverable on unpaid losses - short duration | (636300) | (448117) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: other lines, gross | (430) | (295) |
| Net balance as of January 1, short duration | 658210 | 393455 |
| <u>Incurred (short duration) related to:</u> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current year | 573832 | 555034 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior years | (7106) | 646 |
| Total incurred | 566726 | 555680 |
| <u>Paid (short duration) related to:</u> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current year | 253734 | 242422 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior years | 172522 | 99174 |
| Total paid | $426256 | $341596 |
| Net balance as of September 30, short duration | $798680 | $607539 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: reinsurance recoverable on unpaid losses - short duration | 813498 | 581685 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: other lines, gross | 366 | 241 |
| Gross liabilities for unpaid losses and loss adjustment expenses | 1612544 | 1189465 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus : liabilities of policy-holder accounts balances, gross |  | 600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: non-insurance warranty benefit claim liabilities | 3158 | 2792 |
| Policy liabilities and unpaid claims balance as of September 30, | $1615702 | $1192857 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following schedule reconciles the total amount of losses incurred on short duration contracts per the table above to the amount of total losses incurred as presented in the condensed consolidated statements of operations, excluding the amount for member benefit claims:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Short duration incurred | $191463 | $175845 | $566726 | $555680 |
| Other lines incurred | (5) | (83) | (83) | (26) |
| Unallocated loss adjustment expenses | 944 | 170 | 3478 | 917 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total losses incurred | $192402 | $175932 | $570121 | $556571 |

---

During the nine months ended September 30, 2025, the Company experienced favorable prior year development of $7,106, primarily driven by lower-than-expected losses in its commercial and personal property lines of business.

During the nine months ended September 30, 2024, the Company experienced unfavorable prior year development of $646, primarily driven by higher-than expected claims paid development in our commercial lines of business.

Management considers the prior year development for each of these years to be insignificant when considered in the context of our annual earned premiums, net as well as our net losses and loss adjustment expenses and member benefit claims expenses. We analyze our development on a quarterly basis and given the short duration nature of our products, favorable or adverse development emerges quickly and allows for timely reserve strengthening, if necessary, or modifications to our product pricing or offerings.

The favorable prior year development of $7,106 in the nine months ended September 30, 2025 represented 4.4% of our insurance business income before taxes of $160,421 and 1.1% of the opening net liability for losses and loss adjustment expenses of $658,210, as of January 1, 2025.

The unfavorable prior year development of $646 in the nine months ended September 30, 2024 represented 0.5% of our insurance business income before taxes of $135,270 and 0.2% of the opening net liability for losses and loss adjustment expenses of $393,455, as of January 1, 2024.

Based upon our internal analysis and our review of the statement of actuarial opinions provided by our actuarial consultants, we believe that the amounts recorded for policy liabilities and unpaid claims reasonably represent the amount necessary to pay all claims and related expenses which may arise from incidents that have occurred as of the balance sheet date.

**<u>(12) Revenue from Contracts with Customers</u>**

The Company's revenues from insurance and contractual and liability insurance operations are primarily accounted for under Financial Services-Insurance (ASC 944) that are not within the scope of Revenue for Contracts with Customers (ASC 606). The Company's remaining revenues that are within the scope of ASC 606 are primarily comprised of revenues from contracts with customers for monthly membership dues for motor clubs, monthly administration fees for services provided for premiums, claims and reinsurance processing revenues, vehicle service contracts, vessel related revenue and revenues for household goods and appliances service contracts (collectively, remaining contracts).

The following table presents the disaggregated amounts of revenue from contracts with customers by product type for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;Service and Administrative Fees: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Service contract revenue | $69479 | $70882 | $212598 | $227884 |
| &nbsp;&nbsp;&nbsp;&nbsp;Motor club revenue | 9112 | 10565 | 28093 | 33202 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 667 | 1341 | 2700 | 3128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue from contracts with customers | $79258 | $82788 | $243391 | $264214 |

---

<u>Service and Administrative Fees</u>

Service and administrative fees are generated from non-insurance programs including warranty service contracts, motor clubs and other services. Service and administrative fees are recognized consistent with the earnings recognition pattern of the underlying policies, debt cancellation contracts and motor club memberships being administered, using pro rata, Rule of 78's, modified Rule of 78's, or other

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

methods as appropriate for the contract. Management selects the appropriate method based on available information, and periodically reviews the selections as additional information becomes available.

Management reviews the financial results under each significant contract on a monthly basis. Any losses that may occur due to a specific contract would be recognized in the period in which the loss is determined to be probable.

We do not disclose information about remaining performance obligations pertaining to contracts that have an original expected duration of one year or less. The transaction price allocated to remaining unsatisfied or partially unsatisfied performance obligations with an original expected duration exceeding one year was not material as of September 30, 2025.

The timing of our revenue recognition may differ from the timing of payment by our customers. We record a receivable when revenue is recognized prior to payment and we have an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, we record deferred revenue until the performance obligations are satisfied.

The following table presents the activity in the deferred assets and liabilities related to revenue from contracts with customers for the following period:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **January 1, 2025** |  |  | **September 30, 2025** |
|  | **Beginning balance** | **Additions** | **Amortization** | **Ending balance** |
| **Deferred acquisition costs** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and Administrative Fees: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Service contract revenue | $211406 | $65276 | $69330 | $207352 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Motor club revenue | 12904 | 21199 | 21998 | 12105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $224310 | $86475 | $91328 | $219457 |
| **Deferred revenue** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and Administrative Fees: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Service contract revenue | $617633 | $185373 | $212598 | $590408 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Motor club revenue | 16746 | 27031 | 28093 | 15684 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other |  | 2692 | 2692 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $634379 | $215096 | $243383 | $606092 |

---

For the periods presented, no write-offs for unrecoverable deferred acquisition costs and deferred revenue were recognized.

**<u>(13) Other Assets and Other Liabilities and Accrued Expenses</u>**

***Other Assets***

The following table presents the components of other assets as reported in the condensed consolidated balance sheets:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30, 2025** | **December 31, 2024** |
| Accrued investment income | $13919 | $12415 |
| Loans eligible for repurchase | 54370 | 56279 |
| Mortgage servicing rights | 40597 | 42611 |
| Right of use assets - operating leases <sup>(1)</sup> | 27549 | 27816 |
| Income tax receivable | 2340 | 1976 |
| Furniture, fixtures and equipment, net | 26722 | 27321 |
| Due from broker/trustee | 100 | 28327 |
| Prepaid expenses | 12241 | 12481 |
| Other | 3359 | 4632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets | $181197 | $213858 |

---

<sup>(1)</sup> See Note (19) Commitments and Contingencies for additional information.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the depreciation expense related to furniture, fixtures and equipment for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Depreciation expense related to furniture, fixtures and equipment | $1897 | $1516 | $4977 | $4637 |

---

***Other Liabilities and Accrued Expenses***

The following table presents the components of other liabilities and accrued expenses as reported in the condensed consolidated balance sheets:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30, 2025** | **December 31, 2024** |
| Accounts payable and accrued expenses | $114808 | $83287 |
| Loans eligible for repurchase liability | 54370 | 56279 |
| Deferred tax liabilities, net | 220449 | 170802 |
| Operating lease liabilities <sup>(1)</sup> | 35220 | 36588 |
| Commissions payable | 3401 | 7066 |
| Derivative liabilities | 28803 | 11127 |
| Due to broker/trustee | 11061 | 2693 |
| Other | 38364 | 40083 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other liabilities and accrued expenses | $506476 | $407925 |

---

<sup>(1)</sup> See Note (19) Commitments and Contingencies for additional information.

**<u>(14) Other Revenue and Other Expenses</u>**

***Other Revenue***

The following table presents the components of other revenue as reported in the condensed consolidated statement of operations.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Other investment income <sup>(1)</sup> | $6949 | $6885 | $20070 | $19389 |
| Financing interest income | 3977 | 4967 | 12214 | 13978 |
| Other <sup>(2)</sup> | 3915 | 6509 | 12326 | 18627 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other revenue | $14841 | $18361 | $44610 | $51994 |

---

<sup>(1)</sup> See Note (4) Investments for the components of Other investment income.

<sup>(2)</sup> Includes $3,300 and $6,150 for the three months ended September 30, 2025 and 2024, respectively, and $11,192 and $17,439 for the nine months ended September 30, 2025 and 2024, respectively, related to Insurance.

***Other Expenses***

The following table presents the components of other expenses as reported in the condensed consolidated statement of operations:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| General and administrative | $11547 | $11026 | $34698 | $31877 |
| Professional fees | 11617 | 7106 | 31582 | 22402 |
| Premium taxes | 6083 | 3662 | 16783 | 14781 |
| Mortgage origination expenses | 3573 | 3337 | 10946 | 9817 |
| Rent and related | 3967 | 3988 | 11933 | 12252 |
| Fortegra Additional Warrants (Warburg) | 16967 | 946 | 17560 | 6018 |
| Other | 7980 | 4725 | 17841 | 14059 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other expenses | $61734 | $34790 | $141343 | $111206 |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

**<u>(15) Stockholders' Equity</u>**

***Stock Repurchases***

The Board of Directors authorized the Company to make repurchases of up to $20,000 of shares of the Company's outstanding common stock in the aggregate, at the discretion of the Company's Executive Committee. There were no shares repurchased during the nine months ended September 30, 2025. As of September 30, 2025, the remaining repurchase authorization was $11,945.

***Dividends***

The Company declared cash dividends per share for the following periods presented below:

---

| | | |
|:---|:---|:---|
|  | **Dividends per share for the** | **Dividends per share for the** |
|  | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** |
| First quarter | $0.06 | $0.06 |
| Second quarter | 0.06 | 0.06 |
| Third quarter | 0.06 | 0.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash dividends declared | $0.18 | $0.18 |

---

***Fortegra Non-Controlling Interests***

On June 21, 2022, the Company closed the WP Transaction. On that date, Fortegra converted to a Delaware corporation and Warburg made a $200,000 investment in Fortegra in exchange for Fortegra Common Stock, Fortegra Preferred Stock, Fortegra Warrants and Fortegra Additional Warrants. Also, in connection with the closing of the WP Transaction, Tiptree was issued Fortegra Additional Warrants, and management's interests in LOTS Intermediate were exchanged for interests in Fortegra.

In March and April 2024, Tiptree, Warburg and Fortegra independent directors contributed $30,044, $9,889 and $67, respectively, to Fortegra in exchange for Fortegra Common Stock. As of September 30, 2025, Fortegra was owned approximately 78.9% by Tiptree Holdings, 17.6% by Warburg and 3.5% by management and directors of Fortegra before giving effect to the exercise of outstanding warrants and management options and the conversion of outstanding preferred stock.

*Fortegra Preferred Stock*

The face amount of the Fortegra Preferred Stock is $80,000. Dividends are cumulative and accrue at a rate of 8% per annum, compounding quarterly. Any quarterly dividend may be paid in cash, at Fortegra's option. For the nine months ended September 30, 2025 and 2024, cash dividends declared were $4,787 and $4,804, respectively.

Warburg has the option to convert, at any time, its shares of Fortegra Preferred Stock into shares of Fortegra Common Stock at an initial conversion premium of 33% to Warburg's initial investment valuation (the "Fortegra Preferred Stock Conversion Price"). The Fortegra Preferred Stock Conversion Price is adjusted for any Fortegra Common Stock splits, dividends, extraordinary dividends and similar transactions. All of the Fortegra Preferred Stock will automatically convert into shares of Fortegra Common Stock at the Fortegra Preferred Stock Conversion Price upon the closing of a qualifying initial public offering, subject to a five year make-whole provision. Upon conversion, the Fortegra Preferred Stock would result in Warburg owning an additional 6.3% interest in Fortegra, for a total as converted ownership of 24.0% (including its ownership of Fortegra Common Stock).

*Fortegra Warrants*

The Fortegra Warrants have a seven-year term and an exercise premium of 33% to Warburg's initial investment valuation (the "Fortegra Warrant Exercise Price"). The Fortegra Warrant Exercise Price will be reduced by any Fortegra Common Stock cash dividends made by Fortegra and adjusted for stock splits, common stock dividends, extraordinary dividends and similar transactions. The Fortegra Warrants, if exercised with cash, would result in Warburg owning an additional 3.7% interest in Fortegra.

*Fortegra Additional Warrants*

The Fortegra Additional Warrants issued to both Warburg and Tiptree have a seven-year term and an exercise price of $0.01 per share of Fortegra Common Stock. The Fortegra Additional Warrants issued to Warburg will be forfeited based on Warburg achieving an all-in return on its investment in excess of 23%, as measured primarily by Fortegra's Common Stock price. The Fortegra Additional Warrants issued to Warburg are classified as liabilities, at fair value. The Fortegra Additional Warrants issued to Tiptree will vest based on Warburg achieving an all-in return on its investment in excess of 30%, as measured primarily by Fortegra's Common Stock price.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The number of shares of Fortegra Common Stock issuable to Warburg or Tiptree with respect to the Fortegra Additional Warrants is subject to adjustment for Fortegra Common Stock splits, stock or cash dividends and similar transactions. The Fortegra Additional Warrants are exercisable from the earlier of a transaction that results in Warburg having sold 50% of its Fortegra Common Stock or the fifth anniversary of the closing date. The maximum number of shares issued to Warburg or Tiptree, if exercised with cash, would be an additional 1.7% interest in Fortegra on an as converted basis (including its ownership of Fortegra Common and Preferred Stock). As of September 30, 2025, the estimated fair value of the Fortegra Additional Warrants (WP) was $28,518 based on the expected Merger proceeds and estimated closing date in 2026.

The following table presents the components of non-controlling interests as reported in the condensed consolidated balance sheets:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30, 2025** | **December 31, 2024** |
| Fortegra preferred interests | $77679 | $77679 |
| Fortegra common interests | 158565 | 121394 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total non-controlling interests | $236244 | $199073 |

---

***Statutory Reporting and Insurance Company Subsidiaries Dividend Restrictions***

The Company's U.S. insurance subsidiaries prepare financial statements in accordance with Statutory Accounting Principles (SAP) prescribed or permitted by the insurance departments of their states of domicile. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules.

*Statutory Capital and Surplus*

The Company's insurance company subsidiaries must maintain minimum amounts of statutory capital and surplus as required by regulatory authorities, including the NAIC; their capital and surplus levels exceeded respective minimum requirements as of September 30, 2025 and December 31, 2024.

Under the NAIC Risk-Based Capital Act of 1995, a company's Risk-Based Capital (RBC) is calculated by applying certain risk factors to various asset, claim and reserve items. If a company's adjusted surplus falls below calculated RBC thresholds, regulatory intervention or oversight is required. The Company's U.S. domiciled insurance company subsidiaries' RBC levels, as calculated in accordance with the NAIC's RBC instructions, exceeded all RBC thresholds as of September 30, 2025 and December 31, 2024.

The Company also has a foreign insurance subsidiary that is not subject to SAP. The statutory capital and surplus amounts and statutory net income presented above do not include the foreign insurance subsidiary in accordance with SAP.

*Statutory Dividends*

The Company's U.S. domiciled insurance company subsidiaries may pay dividends to the Company, subject to statutory restrictions. Payments in excess of statutory restrictions (extraordinary dividends) to the Company are permitted only with prior approval of the insurance department of the applicable state of domicile. The Company eliminates all dividends from its subsidiaries in the condensed consolidated financial statements.

There were no dividends paid to the Company by its U.S. domiciled insurance company subsidiaries for the nine months ended September 30, 2025 and 2024. The combined amount available for ordinary dividends of the Company's U.S. domiciled insurance company subsidiaries for the following periods:

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **September 30, 2025** | **December 31, 2024** |
| Amount available for ordinary dividends of the Company's insurance company subsidiaries | $71030 | $78614 |

---

The following table presents the dividends paid to the Company by its insurance company subsidiaries for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Ordinary dividends | $— | $— | $7000 | $— |
| Extraordinary dividends |  |  | 3000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total dividends | $— | $— | $10000 | $— |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

At September 30, 2025, the maximum amount of dividends that our U.S. domiciled insurance company subsidiaries could pay under applicable laws and regulations without regulatory approval was approximately $71,030. The Company may seek regulatory approval to pay dividends in excess of this permitted amount, but there can be no assurance that the Company would receive regulatory approval if sought.

**<u>(16) Accumulated Other Comprehensive Income (Loss) (AOCI)</u>**

The following table presents the activity of AFS securities in AOCI, net of tax, for the following periods:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Unrealized gains (losses) on available for sale securities** | **Foreign currency translation adjustment** | **Total AOCI** | **Amount attributable to non-controlling interests** | **Total AOCI to Tiptree Inc.** |
| Balance at December 31, 2023 | $(32145) | $(98) | $(32243) | $6170 | $(26073) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (losses) before reclassifications | 9308 | 5241 | 14549 | (3764) | 10785 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI | 117 |  | 117 |  | 117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OCI | 9425 | 5241 | 14666 | (3764) | 10902 |
| Balance at September 30, 2024 | $(22720) | $5143 | $(17577) | $2406 | $(15171) |
| Balance at December 31, 2024 | $(32266) | $(2529) | $(34795) | $7045 | $(27750) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (losses) before reclassifications | 13795 | 13051 | 26846 | (7256) | 19590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI | 404 |  | 404 |  | 404 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OCI | 14199 | 13051 | 27250 | (7256) | 19994 |
| Balance at September 30, 2025 | $(18067) | $10522 | $(7545) | $(211) | $(7756) |

---

The following table presents the reclassification adjustments out of AOCI included in net income and the impacted line items on the condensed consolidated statement of operations for the following periods:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Affected line item in consolidated statements** |
| **Components of AOCI** | **2025** | **2024** | **2025** | **2024** | **of operations** |
| Unrealized gains (losses) on available for sale securities | $65 | $(57) | $(523) | $(150) | Net realized and unrealized gains (losses) |
| Related tax (expense) benefit | (15) | 9 | 119 | 33 | Provision for income tax |
| &nbsp;&nbsp;&nbsp;&nbsp;Net of tax | $50 | $(48) | $(404) | $(117) |  |

---

**<u>(17) Stock Based Compensation</u>**

***Tiptree Equity Plans***

The table below summarizes changes to the issuances under the Company's 2017 Omnibus Incentive Equity Plan for the periods indicated, excluding awards granted under the Company's subsidiary incentive plans that are exchangeable for Tiptree common stock:

---

| | |
|:---|:---|
| **<u>2017 Equity Plan</u>** | **Number of shares** |
| Available for issuance as of December 31, 2024 | 756984 |
| &nbsp;&nbsp;&nbsp;&nbsp;RSU, stock and option awards granted | (292428) |
| Available for issuance as of September 30, 2025 | 464556 |

---

*Restricted Stock Units (RSUs) and Stock Awards*

The Company values RSUs at their grant-date fair value as measured by Tiptree's common stock price. Generally, the Tiptree RSUs vest and become non-forfeitable either (i) after the third anniversary, or (ii) with respect to one-third of Tiptree shares granted on each of the first, second and third year anniversaries of the grant date. RSU awards are expensed using the straight-line method over the

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

requisite service period. The RSUs include a retirement provision and are amortized over the lesser of the service condition or expected retirement date.

Stock awards issued as director compensation are deemed to be granted and immediately vested upon issuance. On February 25, 2025, the Company issued Messrs. Barnes and Ilany 60,813 and 151,778 shares of the Company's common stock, respectively, as part of their compensation for 2024 performance.

The following table presents changes to the issuances of RSUs under the 2017 Omnibus Incentive Equity Plan for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Number of<br>shares issuable** | **Weighted average<br>grant date<br>fair value** |
| Unvested units as of December 31, 2024 | 287684 | $15.22 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 292428 | 21.43 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested | (362094) | 18.39 |
| Unvested units as of September 30, 2025 <sup>(1)</sup> | 218018 | $18.64 |

---

<sup>(1)</sup> Includes 76,930, 70,866 and 70,222 shares that vest in 2026, 2027 and 2028, respectively.

The following tables present the detail of the granted and vested RSUs and Stock Awards for the periods indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **<u>Granted</u>** | **2025** | **2024** | **<u>Vested</u>** | **2025** | **2024** |
| Directors | 9615 | 13309 | Directors | 9615 | 13309 |
| Employees | 282813 | 78360 | Employees | 352479 | 31470 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Granted | 292428 | 91669 | &nbsp;&nbsp;&nbsp;&nbsp;Total Vested | 362094 | 44779 |
|  |  |  | Taxes | (117764) | (11395) |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;Net Vested | 244330 | 33384 |

---

*Tiptree Senior Management Incentive Plan*

On August 4, 2021, a total of 3,500,000 Performance Restricted Stock Units (PRSUs) were awarded to members of the Company's senior management. An additional 350,000 PRSUs were awarded on October 14, 2022. The PRSUs have a 10-year term and are subject to the recipient's continuous service and a market requirement. A portion of the PRSUs will generally vest upon the achievement of each of five Tiptree share price target milestones ranging from $15 to $60, adjusted for dividends paid, within five pre-established determination periods (subject to a catch-up vesting mechanism) occurring on the second, fourth, sixth, eighth and tenth anniversaries of the grant date. In November 2021 and October 2024, the first and second tranches of the PRSUs vested, resulting in a net issuance of 215,583 and 462,766 shares, respectively, of Tiptree common stock.

On January 1, 2024, Tiptree granted 1,420,833 PRSUs to members of the Company's senior management. The PRSUs will generally vest upon achievement of a $70 Tiptree share price target (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Grantee's continued employment with Tiptree.

As of September 30, 2025, 4,520,833 PRSUs were unvested. The below table illustrates the aggregate number of PRSUs that will vest upon the achievement of each Tiptree share price target. Such price targets are adjusted down for cumulative dividends paid by the Company since grant (e.g., the next share price target is $28.89 as adjusted for cumulative dividends paid to date).

---

| | |
|:---|:---|
| **Original Tiptree Share Price Target** | **Number of PRSUs that Vest** |
| $30 | 775000 |
| $45 | 1033333 |
| $60 | 1291667 |
| $70 | 1420833 |

---

Upon vesting, the Company will issue shares, or if shares are not available under the 2017 Equity Plan, then the Company may in its sole discretion instead deliver cash equal to the fair market value of the underlying shares. The fair value of the PRSUs was estimated using a Black-Scholes-Merton option pricing formula embedded within a Monte Carlo model used to simulate the future stock prices of the Company, which assumes that the market requirement is achieved. The historical volatility was computed based on historical daily returns of the Company's stock price simulated over the performance period using a lookback period of 10 years. The valuation was done under a risk-neutral framework using the 10-year zero-coupon risk-free interest rate derived from the Treasury Constant Maturities yield curve on the reporting date. The quarterly dividend rates in effect as of the reporting date are used to calculate a spot dividend yield for use in the model.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

The following table presents the assumptions used to measure the fair value of the PRSUs as of the respective grant date, or June 7, 2022, when the original tranches were converted to equity awards.

---

| | | | |
|:---|:---|:---|:---|
| **<u>Valuation Input</u>** | **June 2022** | **October 2022** | **January 2024** |
| Historical volatility | 38.75% | 39.23% | 39.10% |
| Risk-free rate | 3.04% | 3.95% | 3.80% |
| Dividend yield | 1.45% | 1.44% | 1.05% |
| Cost of equity | 11.72% | 14.19% | 13.65% |
| Expected term (years) | 6.0 | 5.9 | 5.5 |

---

*Stock Option Awards*

Between 2016 and 2020, option awards were granted to the Executive Committee with an exercise price equal to the fair market value of our common stock on the date of grant. The option awards have a 10-year term and are subject to the recipient's continuous service, a market requirement, and vest one third on each of the three, four, and five-year anniversaries of the grant date. As of September 30, 2025, the market requirement for all outstanding options has been achieved. There were no stock option awards granted from 2021 to September 30, 2025.

The following table presents the Company's stock option activity for the current period:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Options<br>outstanding** | **Weighted average<br>exercise price<br>(in dollars per<br>stock option)** | **Weighted<br>average grant<br>date value (in<br>dollars per<br>stock option)** | **Options<br>exercisable** |
| Balance, December 31, 2024 | 1583873 | $6.51 | $2.25 | 1442114 |
| Balance, September 30, 2025 | 910130 | $6.61 | $2.25 | 910130 |
| Weighted average remaining contractual term at September 30, 2025 (in years) | 3.6 |  |  |  |

---

***Subsidiary Equity Plans***

Certain of the Company's subsidiaries have established incentive plans under which they are authorized to issue equity of those subsidiaries to certain of their employees. Such awards are accounted for as equity unless otherwise noted. These awards are subject to performance-vesting criteria based on the performance of the subsidiary (performance vesting awards) and time-vesting subject to continued employment (time vesting awards). The Company has the option, but not the obligation to settle the exchange right in cash.

*Fortegra Equity Incentive Plan*

Fortegra adopted the 2022 Equity Incentive Plan ("Fortegra Plan") on June 21, 2022, and further amended on January 18, 2024, which permits the grant of RSUs, stock based awards and options up to 11.0% of Fortegra Common Stock (assuming conversion of the Fortegra Preferred Stock), of which the substantial majority is expected to be delivered in options. The general purpose of the Fortegra Plan is to attract, motivate and retain selected employees of Fortegra, to provide them with incentives and rewards for performance and to better align their interests with those of Fortegra's stockholders. Unless otherwise extended, the Fortegra Plan terminates automatically on June 21, 2032. The awards under the Fortegra Plan are not exchangeable for Tiptree common stock.

As of September 30, 2025, unvested time vesting RSUs represented 0.2% and unvested time and performance vesting options represented 3.5% of Fortegra Common Stock (in each case, assuming conversion of the Fortegra Preferred Stock). The RSUs include a retirement provision and are amortized over the lesser of the service condition or expected retirement date. The time vested options vest in equal parts over five years with the first tranche vested and exercised in 2024. The performance vested options vest based on specific internal rate of return targets determined at the time of a change of control of Fortegra or sale by Warburg of more than 50% of its Fortegra securities (on an as converted basis) acquired in 2022. A majority of these time and performance options must be exercised in the calendar year they vest and shall be deemed automatically exercised if not otherwise done so by December 31 of the calendar year in which they vest. The fair value option grants were estimated on the date of grant using a Black-Scholes Merton option pricing formula embedded within a Monte Carlo model used to simulate the future value of Fortegra Common Stock, which assumes the market requirement is achieved. Key assumptions used in the model were a historical volatility of 45.0%, a risk free rate of 3.7%, no dividend yield and an expected term of 4.2 years.

In 2023, Fortegra granted performance based restricted stock units (Fortegra PRSUs) that vest based on the achievement of specified gross written premium volume targets and underwriting ratios for selected specialty insurance lines written in 2024. Upon vesting, the

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

Fortegra PRSUs entitle recipients to participate in an aggregate pool of between $5,000 and $20,000 payable in shares of Fortegra. The Fortegra PRSUs are accounted for as liability awards with one-third of the award pool vested and issued in September 2025 and two-thirds of the pool remain unvested as of September 30, 2025.

The following table presents changes to the issuances of subsidiary awards under the subsidiary incentive plans for the periods indicated:

---

| | |
|:---|:---|
|  | **Grant date fair value of<br>equity shares issuable** |
| Unvested balance as of December 31, 2024 | $19112 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 6915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested | (8307) |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (831) |
| Unvested balance as of September 30, 2025 | $16889 |

---

***Stock Based Compensation Expense***

The following table presents total stock based compensation expense and the related income tax benefit recognized on the condensed consolidated statements of operations:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Employee compensation and benefits | $5554 | $5898 | $16892 | $13012 |
| Director compensation | 75 | 70 | 222 | 208 |
| Income tax benefit | (1722) | (1253) | (3125) | (2776) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net stock based compensation expense | $3907 | $4715 | $13988 | $10444 |

---

Additional information on total non-vested stock based compensation is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
|  | **Subsidiary<br>Stock options** | **Restricted stock<br>awards and RSUs** | **Performance Restricted<br>Stock Units** |
| Unrecognized compensation cost related to non-vested awards <sup>(1)</sup> | $13319 | $930 | $10601 |
| Weighted - average recognition period (in years) | 1.4 | 1.0 | 1.0 |

---

<sup>(1)</sup> Includes unrecognized compensation cost of $13,319 related to stock options and $2,985 related to PRSUs at The Fortegra Group.

**<u>(18) Income Taxes</u>**

The following table presents the Company's provision (benefit) for income taxes reflected as a component of income (loss):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Total income tax expense (benefit) | $22666 | $16308 | $56656 | $48799 |
| Effective tax rate (ETR) | 59.2%<sup>(1)</sup> | 44.4%<sup>(1)</sup> | 48.7%<sup>(1)</sup> | 45.6%<sup>(1)</sup> |

---

<sup>(1)</sup> Higher than the U.S. federal statutory income tax rate of 21% primarily due to the impact of outside basis deferred taxes on Tiptree's investment in Fortegra and other discrete items.

Tiptree owns less than 80% of Fortegra and is required to record deferred taxes on the outside basis on its investment in Fortegra. This deferred tax liability represents the tax that would be due, before consideration of loss carryforwards, if Tiptree were to sell all of its Fortegra stock at its carrying value on Tiptree's balance sheet.

For the three months ended September 30, 2025, the deferred tax liability relating to Fortegra increased by $7,258, of which $1,101 of expense was recorded in OCI, and $6,157 of expense was recorded as a provision for income taxes. For the three months ended September 30, 2024, the deferred tax liability relating to Fortegra increased by $9,913, of which $4,006 of expense was recorded in OCI, and $5,907 of expense was recorded as a provision for income taxes. Excluding the impact of these deferred taxes, the effective tax rates for the three months ended September 30, 2025 and 2024 were 43.1% and 28.2%, respectively.

For the nine months ended September 30, 2025, the deferred tax liability relating to Fortegra increased by $24,538, of which $5,721 of expense was recorded in OCI, and $18,817 of expense was recorded as a provision for income taxes. For the nine months ended

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

September 30, 2024, the deferred tax liability relating to Fortegra increased by $19,844, of which $3,115 of expense was recorded in OCI, and $16,729 of expense was recorded as a provision for income taxes. Excluding the impact of these deferred taxes, the effective tax rates for the nine months ended September 30, 2025 and 2024 were 32.5% and 29.9%, respectively.

The Organization for Economic Cooperation and Development ("OECD") has introduced a framework to implement a global minimum corporate tax rate of 15%, commonly referred to as Pillar Two. Many aspects of Pillar Two were effective in 2024 and other aspects will be effective in 2025. While it is uncertain whether the U.S. will adopt Pillar Two, certain countries in which the Company operates have adopted legislation and other countries are in the process of introducing legislation to implement Pillar Two. While we do not expect Pillar Two to have a material impact on the Company, our analysis is ongoing as the OECD releases additional guidance and countries implement additional legislation.

"An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14," commonly referred to as the One Big Beautiful Bill Act ("OBBBA"), was enacted into law in the U.S on July 4, 2025. The OBBBA permanently extended parts of the Tax Cuts and Jobs Act, updated international tax rules, and restored certain business tax benefits. Its provisions take effect between 2025 and 2027. We do not expect these provisions to have a material impact on our financial statements.

**<u>(19) Commitments and Contingencies</u>**

The following table presents rent expense for the Company's office leases recorded in other expenses on the condensed consolidated statements of operations for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Rent expense for office leases | $1796 | $1918 | $5376 | $5875 |

---

The Company entered into a sublease of its former corporate office space in December 2022. As a result of the sublease, future lease payments will be offset by $1,842 annually from July 2023 through August 2029.

***Litigation***

The Company is a defendant in Mullins v. Southern Financial Life Insurance Co., a class action filed in February 2006, in Pike County Circuit Court in the Commonwealth of Kentucky on behalf of Kentucky consumers that purchased certain credit life and disability insurance coverage between 1997-2007. The action alleges violations of the Kentucky Consumer Protection Act ("KCPA") and certain insurance statutes, common law fraud and breach of contract and the covenant of good faith and fair dealing. The plaintiffs seek compensatory and punitive damages, attorneys' fees and interest.

Two classes were certified in June 2010: Subclass A includes class members who suffered a disability during the coverage period but allegedly received less than full disability benefits; Subclass B includes all class members whose loan termination date extended beyond the termination date of the credit disability coverage period.

In a series of orders issued in October 2022 on competing motions for partial summary judgment, the court found in favor of the plaintiffs as to the Subclass A breach of contract claim (the "Subclass A Order") and, as to Subclass B, found that the Company was unjustly enriched to the extent the premium it collected exceeded the proportion of the premium for which the Company provided benefits coverage (the "Subclass B Order"). The court found in favor of the Company as to the plaintiffs' claims for common law fraud and violation of Kentucky's insurance statutes and ordered the plaintiffs' Motion for Sanctions for Spoliation of Evidence held in abeyance. The Company has appealed the Subclass A Order and Subclass B Order and all interlocutory orders made final by entry of the Subclass A Order and Subclass B Order.

In December 2022, the court dismissed the plaintiffs' KCPA claims as to both Subclass A Order and Subclass B Order. The court also dismissed the plaintiffs' breach of covenant of good faith and fair dealing claim as to Subclass B Order but declined to dismiss such claim as to Subclass A Order pending resolution of the Company's appeal.

In May 2024, the Commonwealth of Kentucky Court of Appeals disagreed with the court's interpretation of the policies at issue and entered an order (the "Court of Appeals Order") affirming in part, reversing in part, and remanding the Subclass A Order and Subclass B Order. In June 2024, the Company filed a Motion for Discretionary Review of the Court of Appeals Order in the Supreme Court of the Commonwealth of Kentucky.

In February 2025, the Supreme Court of the Commonwealth of Kentucky denied the Company's Motion for Discretionary Review of the Court of Appeals' May 2024 Order and proceedings recommenced in the Pike County Circuit Court. In June 2025, the Pike County

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

Circuit Court issued orders amending the Subclass A Order and Subclass B Order consistent with its reading of the Court of Appeals Order and declined to find at this time that members of Subclass B did not sustain any damages as a matter of law. A trial date has not been set.

The Company considers such litigation customary in the insurance industry. In management's opinion, based on information available at this time, the ultimate resolution of such litigation, which it is vigorously defending, should not be materially adverse to the financial position of the Company. It should be noted that large punitive damage awards, bearing little relation to actual damages sustained by plaintiffs, have been awarded in certain states against other companies in the credit insurance business. At this time, the Company cannot estimate a range of loss that is reasonably possible.

The Company and its subsidiaries are parties to other legal proceedings in the ordinary course of business. Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, the Company does not believe that these proceedings, either individually or in the aggregate, are likely to have a material adverse effect on the Company's financial position.

**<u>(20) Earnings Per Share</u>**

The Company calculates basic net income per share of common stock (common share) based on the weighted average number of common shares outstanding, which includes vested corporate RSUs. Unvested corporate RSUs have a non-forfeitable right to participate in dividends declared and paid on the Company's common stock on an as vested basis and are therefore considered a participating security. The Company calculates basic earnings per share using the "two-class" method under which the income available to common stockholders is allocated to the unvested corporate RSUs.

Diluted net income attributable to common stockholders includes the effect of unvested subsidiaries' RSUs, when dilutive. The assumed exercise of all potentially dilutive instruments is included in the diluted net income per common share calculation, if dilutive.

The following table presents a reconciliation of basic and diluted net income per common share for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net income (loss) | $15610 | $20473 | $59682 | $58327 |
| <u>Less:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to non-controlling interests | 9189 | 8558 | 28666 | 24511 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income allocated to participating securities | 37 | 92 | 181 | 270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Tiptree Inc. common shares - basic | 6384 | 11823 | 30835 | 33546 |
| <u>Effect of Dilutive Securities:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities of subsidiaries | (1548) | (956) | (4766) | (2374) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to income relating to exchangeable interests and contingent considerations, net of tax | 1 | 2 | 4 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Tiptree Inc. common shares - diluted | $4837 | $10869 | $26073 | $31179 |
| Weighted average number of shares of common stock outstanding - basic | 37565019 | 36789571 | 37470832 | 36781408 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average number of incremental shares of common stock issuable from exchangeable interests and contingent considerations | 1018728 | 1028920 | 1080137 | 1003229 |
| Weighted average number of shares of common stock outstanding - diluted | 38583747 | 37818491 | 38550969 | 37784637 |
| Basic net income (loss) attributable to common shares | $0.17 | $0.32 | $0.82 | $0.91 |
| Diluted net income (loss) attributable to common shares | $0.13 | $0.29 | $0.68 | $0.83 |

---

**<u>(21) Related Party Transactions</u>**

Tiptree Advisors is a related party of the Company because Tiptree Advisors is deemed to be controlled by Michael Barnes, the Company's Executive Chairman. Tiptree Advisors manages investment portfolio accounts of Fortegra and certain of its subsidiaries under an investment advisory agreement (the IAA). The Company is invested in funds managed by Tiptree Advisors. The Company incurred $8,045 and $1,594 of management and incentive fees for the three months ended September 30, 2025 and 2024, respectively. The Company incurred $12,063 and $4,760 of management and incentive fees for the nine months ended September 30, 2025 and 2024, respectively.

For the nine months ended September 30, 2025, the Company's percentage of profits interest in Tiptree Advisors was 52.0%.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**TIPTREE INC. AND SUBSIDIARIES**

Notes to Condensed Consolidated Financial Statements

September 30, 2025

*(in thousands, except share data)*

Pursuant to the Transition Services Agreement, the Company and Tiptree Advisors have mutually agreed to provide certain services to one another. Payments under the Transition Services Agreement in the nine months ended September 30, 2025 and 2024 were not material.

Pursuant to a Partner Emeritus Agreement, the Company agreed to provide Mr. Inayatullah, a greater than 5% stockholder of the Company, support services and reimburse Mr. Inayatullah for a portion of benefit expenses in exchange for advice and other consulting services as requested by the Company's Executive Committee. Transactions related to the Partner Emeritus Agreement in the nine months ended September 30, 2025 and 2024 were not material.

**<u>(22) Subsequent Events</u>**

On October 28, 2025, the Company's board of directors declared a quarterly cash dividend of $0.06 per share to holders of common stock with a record date of November 17, 2025, and a payment date of November 24, 2025.

On October 31, 2025, Tiptree entered into a Purchase Agreement, dated as of October 31, 2025 (the "Purchase Agreement") by and among Carrington Holding Company, LLC, as buyer (the "Reliance Buyer"), Tiptree and Reliance Holdings LLC ("Holdings"), a wholly owned subsidiary of Tiptree, as sellers (the "Reliance Sellers") and Reliance First Capital, LLC, a wholly owned subsidiary of Holdings ("Reliance").

Pursuant to the Purchase Agreement, the Reliance Buyer will acquire from the Reliance Sellers, pursuant to the terms of the Purchase Agreement, all of the issued and outstanding membership interests of Reliance for an amount equal, in U.S. dollars, to the sum of (a) the product of (i) the Tangible Book Value (as defined in the Purchase Agreement) of Reliance as of the closing of the Reliance Transaction and (ii) 93.50%; less (b) Transaction Expenses (as defined in the Purchase Agreement); less (c) Unpaid Taxes (as defined in the Purchase Agreement) (the "Reliance Transaction"). At the closing of the Reliance Transaction, the Reliance Buyer will pay, or cause to be paid, to the Reliance Sellers the Estimated Cash Payment (as defined in the Purchase Agreement), less an amount equal to the Purchase Price Adjustment Holdback Amount (as defined in the Purchase Agreement).

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>Item 2. Management's Discussion and Analysis of Financia</u><u>l Condition and Results of Operations</u>**

Our Management's Discussion and Analysis of Financial Condition and Results of Operations is presented in this section as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Overview

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Results of Operations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Non-GAAP Measures and Reconciliations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Liquidity and Capital Resources

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Critical Accounting Policies and Estimates

**<u>OVERVIEW</u>**

Tiptree allocates capital to select small and middle market companies with the mission of building long-term value. Established in 2007, we have a significant track record investing in the insurance sector and across a variety of other industries, including mortgage, specialty finance and shipping. Our largest operating subsidiary, Fortegra, is a leading provider of specialty insurance products and related services. We also generate earnings from a diverse group of select investments that we refer to as Tiptree Capital, which includes our Mortgage segment and other, non-insurance businesses and assets. We evaluate performance primarily by the comparison of stockholders' long-term total return on capital, as measured by growth in stock price plus dividends paid, in addition to Adjusted Net Income.

Our year-to-date 2025 highlights include:

<u>Overall:</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•On September 26, 2025, Tiptree entered into the Merger Agreement with Purchaser and Fortegra, pursuant to which and subject to the conditions set forth therein, Tiptree and Warburg will sell all of the issued and outstanding shares of common stock of Fortegra to Purchaser for aggregate consideration of $1.65 billion in cash (subject to certain adjustments set forth in the Merger Agreement). A subsidiary of Purchaser, Merger Sub, to be incorporated in Delaware following the date of the Merger Agreement and prior to the Closing will, upon its formation, execute a joinder to the Merger Agreement and at the Closing, Merger Sub will merge with and into Fortegra, with Fortegra being the surviving corporation. As of September 30, 2025, Tiptree owns approximately 69.1% of Fortegra on a fully diluted basis. The terms of the Merger, as contemplated by the Merger Agreement, provide that, at the Closing, Purchaser will acquire complete common equity ownership of Fortegra and all of its subsidiaries. This pending transaction has had no impact on Tiptree's financial statements at September 30, 2025, other than incurred transaction expenses of approximately $8.1 million and $11.7 million, respectively, for the three and nine months ended September 30, 2025. If the transaction had been completed as of September 30, 2025, Tiptree would have reflected the below:

---

| | |
|:---|:---|
|  | **As of** |
|  | **September 30, 2025** |
| Consideration | $1650000 |
| Less: transaction expenses | 27000 |
| Net consideration | 1623000 |
| Tiptree diluted ownership of Fortegra | 69.10% |
| Fair value of consideration received | $1121490 |
| Estimated gain on disposal | $448679 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Tiptree reported net income of $31.0 million for the nine months ended September 30, 2025, compared to $33.8 million in the prior year period, with the decrease driven by deal-related expenses, increase in the Fortegra Additional Warrant liability, and incremental interest expense on $74.4 million of outstanding borrowings at the holding company level, partially offset by growth in Fortegra's underwriting and fee income, and investment gains on equities. Return on average equity was 8.6% for the nine months ended September 30, 2025 as compared to 10.3% for the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted net income of $79.2 million increased from $72.8 million in the nine months ended September 30, 2024, driven by growth in insurance operations. Adjusted return on average equity was 21.9%, as compared to 22.1% in 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•On October 31, 2025, Tiptree entered into the Purchase Agreement with Reliance Buyer and Reliance, pursuant to which and subject to the conditions set forth therein, Tiptree will sell all of the issued and outstanding shares of common stock of Reliance to Reliance Buyer for aggregate consideration of 93.5% of tangible book value, or an estimated $51 million of gross proceeds as of September 30, 2025 (subject to certain adjustments set forth in the Purchase Agreement).

------

[**<u>**Table of Contents**</u>**](#toc_page)

<u>Insurance:</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Gross written premiums and premium equivalents were $2.5 billion for the nine months ended September 30, 2025, an increase of $304.2 million, or 13.7%, from the prior year period as a result of growth in E&S insurance lines in the U.S. and Europe.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Net written premiums were $1.2 billion for the nine months ended September 30, 2025, an increase of 10.2% from the nine months ended September 30, 2024, driven by growth in gross written premiums and stable premium retention levels.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Total revenues were $1.5 billion, an increase of $26.5 million, or 1.8%, from the nine months ended September 30, 2024, driven by growth in earned premiums, net, net investment income, and net realized and unrealized gains, partially offset by decreases in service and administrative fees and other revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Combined ratio of 88.5%, an improvement of 1.7 percentage points, driven by improvement in the underwriting ratio, partially offset by an increased expense ratio as we continue to invest in U.S. and European E&S markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Income before taxes of $160.4 million as compared to $135.3 million in the nine months ended September 30, 2024, with the increase driven by improved insurance operations and higher investment gains. Return on average equity was 22.2% in 2025 as compared to 25.1% in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted net income (before NCI) was $135.2 million, an increase of $20.7 million, or 18.1%, from the nine months ended September 30, 2024. Adjusted return on average equity was 25.7%, as compared to 28.8% in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Fortegra's total stockholders' equity was $776.2 million as of September 30, 2025, compared to $625.5 million as of December 31, 2024, an increase of 24.1%, driven by growth in retained earnings and a decrease in the accumulated other comprehensive loss position.

<u>Tiptree Capital:</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Mortgage income before taxes was $0.2 million for the nine months ended September 30, 2025, as compared to income of $1.2 million in the nine months ended September 30, 2024, with the decrease primarily driven by negative fair value adjustments in mortgage servicing rights, partially offset by higher loan servicing fees.

<u>Key Trends:</u>

Our results of operations are affected by a variety of factors including, but not limited to, general economic conditions and GDP growth, market liquidity and volatility, consumer confidence, U.S. demographics, employment and wage growth, business confidence and investment, inflation, interest rates and spreads, the impact of the regulatory environment, and the other factors set forth in Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Generally, our businesses are positively affected by a healthy U.S. consumer, stable to gradually rising interest rates, stable markets and business conditions, and global growth and trade flows. Conversely, rising unemployment, volatile markets, rapidly rising interest rates, inflation, changing regulatory requirements, economic uncertainty arising from the imposition of tariffs, and slowing business conditions can have a material adverse effect on our results of operations or financial condition.

Insurance results primarily depend on pricing, underwriting, risk retention and the accuracy of reserves, reinsurance arrangements, returns on invested assets, and policy and contract renewals and run-off. Factors affecting these items, including conditions in financial markets, the global economy and the markets in which we operate, fluctuations in exchange rates, interest rates and inflation, including the current period of inflationary pressures, may have a material adverse effect on our results of operations or financial condition. Fortegra designs, markets and underwrites specialty property and casualty insurance products for select target markets or niches. The business has historically generated significant fee-based revenues by incorporating value-add coverages and services. Underwriting risk is mitigated through a combination of reinsurance and sliding scale commission structures with agents, distribution partners and/or third-party reinsurers. To mitigate counterparty risk, Fortegra ensures its reinsurance receivables are placed with highly rated and appropriately capitalized counterparties or with our distribution partners' captive insurance vehicles which are collateralized with highly liquid investments, cash or letters of credit. While Fortegra's insurance operations have historically maintained a relatively stable combined ratio, initiatives to change the business mix along with these economic factors could generate different results than the business has historically experienced. In particular, inflation can have an impact on replacement costs associated with claims from our customers to the extent we are unable to pass the higher costs of claims through higher premiums. In addition, fluctuations of the U.S. dollar relative to other currencies, including the British pound and Euro, would have an impact on book value between periods.

Fortegra's investment portfolio includes fixed maturity securities, loans, credit investment funds, and equity securities. Many of those investments are held at fair value. From 2021 to 2024, the U.S. fixed income markets experienced a significant rise in interest rates. Rising interest rates have and could continue to impact the value of Fortegra's fixed maturity securities, with any unrealized losses recorded in equity, and if realized, could impact our results of operations. Offsetting the impact of a rising interest rate environment, new investments in fixed rate instruments from both maturities and portfolio growth have and could continue to result in higher net interest income on investments. The weighted average duration of our fixed income available for sale securities is less than three years. While our asset and liability mix is relatively matched, should we need to liquidate any of these investments before maturity to pay claims, any realized losses could materially negatively impact our results of operations. Changes in fair value for loans, credit investment funds, and equity securities in Fortegra's investment portfolio are reported as unrealized gains or losses in revenues and can be impacted by changes in interest rates, credit risk, currency risk, or market risk, including specific company or industry factors. In addition, our

------

[**<u>**Table of Contents**</u>**](#toc_page)

equity holdings are relatively concentrated. General equity market trends, along with company and industry specific factors, can impact the fair value which can result in unrealized gains and losses affecting our results.

Elevated 10-year treasury yields, and the tapering of the Federal Reserve's purchases of mortgage-backed securities, has resulted in substantial increases in mortgage interest rates. Low mortgage interest rates driven by the Federal Reserve intervention in mortgage markets, and rising home prices in certain markets, provided tailwinds to the mortgage markets in 2020 and 2021, which benefited our mortgage operations and margins. The substantial rise in rates resulted in a sharp reversal of those trends, with volumes and margins declining significantly. Only partially offsetting the declines in mortgage originations is an increase in the fair value of our mortgage servicing portfolio as rising rates slow prepayment speeds, with a resulting increase in servicing income. Continued elevated mortgage rates could have a negative impact on our mortgage operations, and is likely to be only partially mitigated by the improvement in mortgage servicing revenues. A sustained period of negative profitability in the mortgage industry could also impact the availability of funding sources for our mortgage business.

Rising interest rates can also impact the cost of floating interest rate debt obligations, while declining rates can decrease the cost of debt. Our secured revolving and term credit agreements, preferred trust securities and asset based revolving financing are all floating rate obligations.

**<u>RESULTS OF OPERATIONS</u>**

The following is a summary of our condensed consolidated financial results for the three and nine months ended September 30, 2025 and 2024. In addition to GAAP results, management uses the Non-GAAP measures Adjusted net income, Adjusted return on average equity and book value per share as measurements of operating performance. Management believes these measures provide supplemental information useful to investors as they are frequently used by the financial community to analyze financial performance and comparison among companies.

Adjusted net income and adjusted return on average equity are not measurements of financial performance or liquidity under GAAP and should not be considered as an alternative or substitute for GAAP net income. See "Non-GAAP Reconciliations" for a reconciliation of these measures to their GAAP equivalents.

**Selected Key Metrics**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands, except per share information)* | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| <u>GAAP:</u> | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $540302 | $494362 | $1566478 | $1539256 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to common stockholders | $6421 | $11915 | $31016 | $33816 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings per share | $0.13 | $0.29 | $0.68 | $0.83 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash dividends paid per common share | $0.06 | $0.06 | $0.18 | $0.18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Return on average equity | 5.1% | 10.6% | 8.6% | 10.3% |
| <u>Non-GAAP:</u> <sup>(1)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $28764 | $27872 | $79223 | $72827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity | 22.9% | 24.8% | 21.9% | 22.1% |

---

<sup>(1)</sup> See "—Non-GAAP Reconciliations" for a discussion of non-GAAP financial measures.

*Revenues*

For the three months ended September 30, 2025, revenues were $540.3 million, which increased $45.9 million, or 9.3%, compared to the prior year period. For the nine months ended September 30, 2025, revenues were $1.6 billion, which increased $27.2 million, or 1.8%, compared to the prior year period. The increase for the three month period was primarily driven by growth in earned premiums, net, and net realized and unrealized gains, partially offset by a decline in other revenue. The increase for the nine month period was

------

[**<u>**Table of Contents**</u>**](#toc_page)

primarily driven by growth in earned premiums, net, higher net investment income and net realized and unrealized gains, partially offset by declines in service and administrative fees and other revenue.

The table below provides a break down between net realized and unrealized gains and losses from Invesque and other securities which impacted our consolidated results on a pre-tax basis. Many investments are carried at fair value and marked to market through unrealized gains and losses. As a result, we expect earnings related to these investments to be relatively volatile between periods. Fixed income securities are primarily marked to market through AOCI in stockholders' equity and do not impact net realized and unrealized gains and losses until they are sold.

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net realized and unrealized gains (losses) - Invesque<sup>(1)</sup> | $— | $— | $— | $(3536) |
| Net realized and unrealized gains (losses)<sup>(2)</sup> | $24506 | $(2423) | $31542 | $9964 |

---

<sup>(1)</sup> On April 15, 2024, the Company sold its 16.98 million shares of Invesque for $0.6 million of proceeds resulting in a realized loss of $134.2 million.

<sup>(2)</sup> Excludes Invesque and Mortgage realized and unrealized gains and losses.

*Net Income (Loss) Attributable to common stockholders*

For the three months ended September 30, 2025, the net income attributable to common stockholders was $6.4 million, compared to $11.9 million in the prior year period. For the nine months ended September 30, 2025, the net income attributable to common stockholders was $31.0 million, compared to a net income of $33.8 million in the prior year period. Decreases in both periods were driven by deal-related expenses, an increase in the Fortegra Additional Warrant liability, and incremental interest expense on $74.4 million of outstanding borrowings at the holding company level, partially offset by growth in Fortegra's underwriting and fee income, and investment gains on equities.

*Adjusted net income & Adjusted return on average equity - Non-GAAP*

Adjusted net income for the three months ended September 30, 2025 was $28.8 million, an increase of $0.9 million, or 3.2%, from the three months ended September 30, 2024, driven by growth in Fortegra's operations. For the three months ended September 30, 2025, adjusted return on average equity was 22.9%, as compared to 24.8% for the three months ended September 30, 2024.

Adjusted net income for the nine months ended September 30, 2025 was $79.2 million, an increase of $6.4 million, or 8.8%, from the nine months ended September 30, 2024, driven by growth in Fortegra's operations. For the nine months ended September 30, 2025 and 2024, adjusted return on average equity was 21.9% as compared to 22.1% in the prior year period.

*Book Value per share - Non-GAAP*

Total stockholders' equity was $741.4 million as of September 30, 2025 compared to $656.2 million as of September 30, 2024, with the increase driven by comprehensive income over the trailing four quarters, partially offset by net changes in non-controlling interests, preferred dividends paid at Fortegra and common dividends paid by Tiptree. In the nine months ended September 30, 2025, Tiptree returned $6.8 million to stockholders through dividends paid.

Book value per share for the period ended September 30, 2025 was $13.36, a 6.4% increase from book value per share of $12.56 as of September 30, 2024, driven by comprehensive income per share, partially offset by dividends paid of $0.49 per share, net changes in non-controlling interests and preferred dividends paid at Fortegra.

**Results by Segment**

We classify our business into two reportable segments, Insurance and Mortgage, with the remainder of our operations aggregated into Tiptree Capital - Other. Corporate activities include holding company interest expense, corporate employee compensation and benefits, and other expenses, including public company expenses.

------

[**<u>**Table of Contents**</u>**](#toc_page)

The following tables present the components of Revenue, Income (loss) before taxes and Adjusted net income for the following periods:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| <u>Revenues:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance | $522616 | $481013 | $1516214 | $1489711 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage | 16170 | 14892 | 47581 | 46666 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tiptree Capital - other | 1516 | (1543) | 2683 | 2879 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $540302 | $494362 | $1566478 | $1539256 |
| <u>Income (loss) before taxes:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance | $55223 | $47209 | $160421 | $135270 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage | 202 | (89) | 230 | 1192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tiptree Capital - other | 1366 | (2603) | (1755) | 602 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate | (18515) | (7736) | (42558) | (29938) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total income (loss) before taxes | $38276 | $36781 | $116338 | $107126 |
| <u>Non-GAAP - Adjusted net income:</u> <sup>(1)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance | $39067 | $31728 | $106794 | $90744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage | 556 | 1359 | 1183 | 1231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tiptree Capital - other | 848 | 42 | (8) | 870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate | (11707) | (5257) | (28746) | (20018) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjusted net income | $28764 | $27872 | $79223 | $72827 |

---

<sup>(1)</sup> See "—Non-GAAP Reconciliations" for a discussion of non-GAAP financial measures.

**Insurance**

Fortegra is a specialty insurance underwriter and service provider, which focuses on niche lines and fee-oriented services. The combination of specialty insurance underwriting, service contract products, and related service solutions delivered through a vertically integrated business model creates a blend of traditional underwriting revenues, investment income and unregulated fee revenues. The business is an agent-driven model, distributing products through independent insurance agents, consumer finance companies, online retailers, auto dealers, and regional big box retailers to deliver products that complement the consumer transaction.

As of September 30, 2025, Fortegra was owned approximately 78.9% by Tiptree, 17.6% by Warburg and 3.5% by management and directors of Fortegra, before giving effect to the exercise of outstanding warrants and management options, and the conversion of outstanding preferred stock. The following tables and discussion present the Insurance segment results, including non-controlling interests, for the three months ended September 30, 2025 and 2024.

**Components of our Results of Operations**

**Revenues**

*Earned Premiums, net* represents the earned portion of gross written and assumed premiums, less the earned portion that is ceded to third-party reinsurers under reinsurance agreements. Fortegra's insurance policies generally have a term of six months to seven years depending on the underlying product and premiums are earned pro rata over the term of the policy. At the end of each reporting period, premiums written but not earned are classified as unearned premiums and are earned in subsequent periods over the remaining term of the policy.

*Service and Administrative Fees* represent the earned portion of gross written premiums and premium equivalents, which is generated from non-insurance products including warranty service contracts, motor club contracts and other services offered as part of Fortegra's vertically integrated product offerings. Such fees are typically positively correlated with transaction volume and are recognized as revenue when realized and earned. At the end of each reporting period, gross written premiums and premium equivalents written for service contracts not earned are classified as deferred revenue, which are earned in subsequent periods over the remaining term of the policy.

*Ceding Commissions and Other Revenue* consists of commissions earned on policies written on behalf of third-party insurance companies with no exposure to the insured risk and certain fees earned in conjunction with underwriting policies. Other revenue also includes the interest income earned on cash equivalents and premium finance product offerings.

*Net Investment Income* represents earned investment income on our portfolio of invested assets. Our invested assets are primarily comprised of fixed maturity securities, and may also include cash and cash equivalents and equity securities. The principal factors that

------

[**<u>**Table of Contents**</u>**](#toc_page)

influence net investment income are the size of our investment portfolio, the yield on that portfolio and expense due to external investment managers. The insurance investment portfolio includes investments held in statutory insurance companies and in unregulated entities. The portfolios held in statutory insurance companies are subject to different regulatory considerations, including with respect to types of assets, concentration limits, affiliate transactions and the use of leverage.

*Net Realized and Unrealized Gains (Losses)* on investments are a function of the difference between the amount received by us on the sale of a security and the security's cost-basis, as well as any "other-than-temporary" impairments and allowances for credit losses which are recognized in earnings. In addition, equity securities and certain other investments are carried at fair value with unrealized gains and losses included in this line. Fortegra's investment strategy is designed to achieve attractive risk-adjusted returns across select asset classes, sectors and geographies while maintaining adequate liquidity to meet claims payment obligations. As such, volatility from realized and unrealized gains and losses may impact period-over-period performance. Unrealized gains and losses on equity securities and loans held at fair value impact current period net income, while unrealized gains and losses on AFS securities impact AOCI.

**Expenses**

*Net Losses and Loss Adjustment Expenses* represent actual insurance claims paid, changes in unpaid claim reserves, net of amounts ceded and the costs of administering claims for insurance lines. Incurred claims are impacted by loss frequency, which is a measure of the number of claims per unit of insured exposure, and loss severity, which is based on the average size of claims. Factors affecting loss frequency and loss severity include the volume of underwritten contracts, changes in claims reporting patterns, claims settlement patterns, judicial decisions, economic conditions, morbidity patterns and the attitudes of claimants towards settlements, and original pricing of the product for purposes of the loss ratio in relation to loss emergence over time. Losses and loss adjustment expenses are based on an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods.

*Member Benefit Claims* represent the costs of services and replacement devices incurred in warranty and motor club service contracts. Member benefit claims represent claims paid on behalf of contract holders directly to third-party providers for roadside assistance and for the repair or replacement of covered products. Claims can also be paid directly to contract holders as a reimbursement payment, provided supporting documentation of loss is submitted to the Company. Claims are recognized as expense when incurred.

*Commission Expenses* reflect commissions paid to retail agents, third party administrators and managing general underwriters, net of ceding commissions received on business ceded under certain reinsurance contracts. Commission expenses are deferred and amortized to expense in proportion to the premium earned over the policy life. Commission expense is incurred on most product lines. The majority of commissions are retrospective commissions paid to agents, distributors and retailers selling the Company's products, including credit insurance policies, warranty service contracts and motor club memberships. When claims increase, in most cases distribution partners bear the risk through a reduction in their retrospective commissions. Commission rates are, in many cases, set by state regulators, such as in credit and collateral protection programs and are also impacted by market conditions and the retention levels of distribution partners.

*Operating and Other Expenses* represent the general and administrative expenses of insurance operations including employee compensation and benefits and other expenses, including, technology costs, office rent, and professional services fees, such as legal, accounting and actuarial services.

*Interest Expense* consists primarily of interest expense on corporate revolving debt, notes, preferred trust securities due June 15, 2037 and asset based debt for premium finance and warranty service contract financing, which is non-recourse to Fortegra.

*Depreciation Expense* is primarily associated with furniture, fixtures and equipment. *Amortization Expense* is primarily associated with purchase accounting amortization including values associated with acquired customer relationships, trade names and internally developed software and technology.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Key Performance Metrics**

We discuss certain key performance metrics, described below, which provide useful information about our business and the operational factors underlying its financial performance.

*Gross written premiums and premium equivalents* represent total gross written premiums from insurance policies and warranty service contracts issued, as well as premium finance volumes during a reporting period. They represent the volume of insurance policies written or assumed and warranty service contracts issued during a specific period of time without reduction for policy acquisition costs, reinsurance costs or other deductions. Gross written premiums is a volume measure commonly used in the insurance industry to compare sales performance by period. Premium equivalents are used to compare sales performance of warranty service and administrative contract volumes to gross written premiums. Similar to how management considers gross written premiums to be a relevant measure of volume, regardless of the impact of reinsurance on net earned premiums, management considers premium equivalents to be a relevant measure of contract volume, regardless of whether the Company retains the full obligation. Investors also use these measures to compare sales growth among comparable companies, while management uses these measures to evaluate the relative performance of various sales channels.

*Net written premiums* are gross written premiums less ceded written premiums. Gross written premiums are the amounts received, or to be received, for insurance policies written or assumed by us during a specific period of time without reduction for policy acquisition costs, reinsurance costs or other deductions. The volume of our gross written premiums in any given period is generally influenced by new business submissions, binding of new business submissions into policies, renewals of existing policies, and average size and premium rate of bound policies. Ceded written premiums are the amount of gross written premiums ceded to reinsurers. We enter into reinsurance contracts to limit our exposure to potential large losses. Ceded written premiums are earned over the reinsurance contract period in proportion to the period of risk covered. The volume of our ceded written premiums is impacted by the level of our gross written premiums and any decision we make to increase or decrease retention levels, policy limits and co-participations.

*Combined Ratio, Loss Ratio, Acquisition Ratio, Underwriting Ratio and Operating Expense Ratio*

Combined ratio is an operating measure, which equals the sum of the underwriting ratio and the operating expense ratio. Loss ratio is the ratio of the GAAP line items net losses and loss adjustment expenses and member benefit claims to earned premiums, net, service and administrative fees (excluding ceding fees), and other revenue (excluding cash and cash equivalent interest income). Acquisition ratio is the ratio of the GAAP line items commission expense (less ceding fees and ceding commissions) to earned premiums, net, service and administrative fees (excluding ceding fees), and other revenue (excluding cash and cash equivalent interest income). Underwriting ratio is the combination of the loss ratio and the acquisition ratio. Operating expense ratio is the ratio of the GAAP line items employee compensation and benefits and other expenses to earned premiums, net, service and administrative fees (excluding ceding fees) and other revenue (excluding cash and cash equivalent interest income).

A combined ratio under 100% generally indicates an underwriting profit. A combined ratio over 100% generally indicates an underwriting loss. These ratios are commonly used in the insurance industry as a measure of underwriting profitability, excluding earnings on the insurance portfolio. Investors commonly use these measures to compare underwriting performance among companies separate from the performance of the investment portfolio. Management uses these measures to compare the profitability of various products we underwrite as well as profitability among our various agents and sales channels.

*Return on average equity* is expressed as the ratio of net income to average stockholders' equity during the period. Management uses this ratio as a measure of the on-going performance of the totality of the Company's operations.

**Non-GAAP Financial Measures**

*Adjusted net income* represents income before taxes, less provision (benefit) for income taxes, and excluding the after-tax impact of various expenses that we consider to be unique and non-recurring in nature, including merger and acquisition related expenses, stock-based compensation, net realized and unrealized gains (losses), and intangibles amortization associated with purchase accounting.

*Adjusted return on average equity* represents adjusted net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period.

See "—Non-GAAP Reconciliations" for a reconciliation of adjusted net income and adjusted return on average equity to their GAAP equivalents.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Results of Operations - Three Months Ended September 30, 2025 compared to 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
|  | **2025** | **2024** | **Change** | **% Change** |
| **Revenues:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $383881 | $359496 | $24385 | 6.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 95821 | 95362 | 459 | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 3483 | 3716 | (233) | (6.3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 7397 | 9111 | (1714) | (18.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 24761 | 2218 | 22543 | 1016.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 7273 | 11110 | (3837) | (34.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $522616 | $481013 | $41603 | 8.6% |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses and loss adjustment expenses | $192402 | $175932 | $16470 | 9.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Member benefit claims | 24928 | 27510 | (2582) | (9.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 144919 | 154005 | (9086) | (5.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 41736 | 37876 | 3860 | 10.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 8261 | 7173 | 1088 | 15.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 4824 | 4970 | (146) | (2.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 50323 | 26338 | 23985 | 91.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $467393 | $433804 | $33589 | 7.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before taxes <sup>(1)</sup> | $55223 | $47209 | $8014 | 17.0% |
| **Key Performance Metrics:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross written premiums and premium equivalents | $859757 | $776847 | $82910 | 10.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net written premiums | $396672 | $389273 | $7399 | 1.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss ratio | 46.4% | 45.1% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition ratio | 26.9% | 31.1% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Underwriting ratio | 73.3% | 76.2% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expense ratio | 14.0% | 14.0% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Combined ratio | 87.3% | 90.2% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Return on average equity | 19.6% | 24.3% |  |  |
| **Non-GAAP Financial Measures** <sup>(2)</sup>**:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $49543 | $40042 | $9501 | 23.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity | 26.3% | 27.7% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $39067 | $31728 | $7339 | 23.1% |

---

<sup>(1)</sup> Net income was $36.6 million for the three months ended September 30, 2025 compared to $35.1 million for the three months ended September 30, 2024.

<sup>(2)</sup> See "—Non-GAAP Reconciliations" for a discussion of non-GAAP financial measures.

**Revenues - Three Months Ended September 30, 2025 compared to 2024**

For the three months ended September 30, 2025, total revenues increased 8.6%, to $522.6 million, as compared to $481.0 million for the three months ended September 30, 2024. Earned premiums, net of $383.9 million increased $24.4 million, or 6.8%, driven by growth in specialty E&S and admitted insurance lines. Earned premiums assumed from other insurance companies were $135.8 million, or 35.4% of the total, compared to $129.5 million, or 36.0% of the total, in the prior year period. As it expands to new geographies and expands product offerings, the Company works to obtain necessary licenses and intends to write this business directly upon obtaining necessary licenses. The Company views direct written and assumed business as having similar characteristics. Service and administrative fees of $95.8 increased by 0.5% driven primarily by an increase in ceding fee income, partially offset by a decline in service fee income in the U.S. and Europe. Ceding commissions of $3.5 million decreased by $0.2 million, or 6.3%. Other revenues decreased by $3.8 million, or 34.5%, driven by lower interest income on cash equivalents and premium finance product offerings.

For the three months ended September 30, 2025, net investment income was $7.4 million as compared to $9.1 million in the prior year period, a decrease of $1.7 million driven by $5.7 million of incentive fees related to realized and unrealized gains on equities and alternatives securities, partially offset by increased yields on investments and increased allocation to fixed income securities compared to cash equivalents. Net realized and unrealized gains were $24.8 million, an improvement of $22.5 million, as compared to net realized and unrealized gains of $2.2 million in the prior year period, primarily driven by the change in fair value of certain equity and other investments carried at fair value. Unrealized gains on AFS securities impacting OCI for the three months ended September 30, 2025 were $10.7 million, driven by positive fair value adjustments on U.S. Treasury securities and obligations of U.S. government authorities and agencies, corporate bonds and other investments.

**Expenses - Three Months Ended September 30, 2025 compared to 2024**

For the three months ended September 30, 2025, net losses and loss adjustment expenses were $192.4 million, member benefit claims were $24.9 million and commission expense was $144.9 million, as compared to $175.9 million, $27.5 million, and $154.0 million,

------

[**<u>**Table of Contents**</u>**](#toc_page)

respectively, for the three months ended September 30, 2024. The increase in net losses and loss adjustment expenses of $16.5 million, or 9.4%, was in line with the increase in earned premiums, net, driven by the U.S. insurance lines. During three months ended September 30, 2025 and 2024, the Company experienced unfavorable prior year development of $1.2 million, and $1.4 million, respectively, driven by higher-than-expected claims in our commercial lines of business. The decrease in member benefit claims of $2.6 million, or 9.4%, was driven by the decrease in service fee income, partially offset by higher replacement costs and labor rates on vehicle service contracts in the U.S. and Europe. Commission expenses decreased by $9.1 million, or 5.9%, driven by a decrease in service fee income, in addition to the impacts from sliding scale commissions on warranty contracts.

For the three months ended September 30, 2025, employee compensation and benefits were $41.7 million and other expenses were $50.3 million, as compared to $37.9 million and $26.3 million, respectively, for the three months ended September 30, 2024. Employee compensation and benefits increased by $3.9 million, or 10.2%, driven by investments in human capital associated with growth in E&S, admitted and services lines and increases in stock-based compensation. Other expenses increased by $24.0 million, or 91.1%, driven by an increase in fair value of the Fortegra Additional Warrant liability of $17.0 million. Included in other expenses were $3.7 million of deal-related expenses for the three months ended September 30, 2025, compared to $0.1 million of expenses in the prior year period.

For the three months ended September 30, 2025, interest expense was $8.3 million as compared to $7.2 million for the three months ended September 30, 2024. On November 7, 2024, Fortegra issued $150.0 million of 9.25% Fixed Rate Resetting Junior Subordinated Notes due November 2064. The proceeds of the 2024 Notes were used to repay outstanding indebtedness under Fortegra's credit agreement, for insurance company growth capital and general corporate purposes. The increase in interest expense of $1.1 million, or 15.2%, was primarily driven by the issuance of the new debt.

For the three months ended September 30, 2025, depreciation and amortization expense was $4.8 million, as compared to $5.0 million in 2024. Intangible amortization for the 2025 and 2024 periods is related to purchase accounting associated with acquisitions of Fortegra in 2014 and additional services businesses from 2019 to 2023.

**Gross Written Premiums and Premium Equivalents** <sup>(1)</sup>

The below table shows gross written premiums and premium equivalents by business mix for the three months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
|  | **2025** | **2024** |
| Property and short-tail | $273972 | $230538 |
| Contractual liability | 91359 | 84279 |
| General liability | 123698 | 86368 |
| Alternative risks | 98738 | 93352 |
| Professional liability | 64532 | 58312 |
| Europe | 56580 | 39993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial lines | $708879 | $592842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Personal lines | 88249 | 88198 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance | $797128 | $681040 |
| &nbsp;&nbsp;&nbsp;&nbsp;Auto and consumer goods warranty | 51883 | 83415 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other services | 10746 | 12392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Services | $62629 | $95807 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $859757 | $776847 |

---

<sup>(1)</sup> The total gross written premiums and premium equivalents of $859.8 million and $776.8 million for the three months ended September 30, 2025 and 2024, respectively, were comprised of gross written premiums of $667.4 million and $573.0 million, plus assumed premiums of $129.7 million and $108.0 million, plus gross service and administrative fee additions of $62.6 million and $95.8 million, respectively. See Note (6) Reinsurance Recoverable and Prepaid Reinsurance Premiums and Note (12) Revenue from Contracts with Customers within the respective periods for more information.

Total gross written premiums and premium equivalents for the three months ended September 30, 2025 were $859.8 million, representing an increase of $82.9 million, or 10.7%, as compared to the prior year period. The increase was driven by a combination of factors including expanding Fortegra's distribution partner network and growing E&S insurance lines. E&S premiums were $391.5 million for the three months ended September 30, 2025 compared to $312.1 million in the prior year period, a 25.5% increase.

For the three months ended September 30, 2025, Insurance increased by $116.1 million, or 17.0% as compared to the prior year period, driven by growth across all the product lines, most notably in property and short tail, general liability, and European lines. For the three months ended September 30, 2025, Services decreased by $33.2 million, or 34.6%, driven by lower volume in consumer goods and vehicle service contracts.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Net written premiums**

---

| | | |
|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
|  | **2025** | **2024** |
| Property and short-tail | $134702 | $152030 |
| Contractual liability | 22698 | 21884 |
| General liability | 62363 | 43505 |
| Alternative risks | 70962 | 73759 |
| Professional liability | 20528 | 14564 |
| Europe | 52305 | 39993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial lines | $363558 | $345735 |
| &nbsp;&nbsp;&nbsp;&nbsp;Personal lines | 33114 | 43538 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance | $396672 | $389273 |

---

Net written premiums for the three months ended September 30, 2025 were $396.7 million, representing an increase of $7.4 million, or 1.9% as compared to the prior year period. For the three months ended September 30, 2025, net written premiums from commercial lines increased by $17.8 million, or 5.2%, driven by growth in E&S lines. For the three months ended September 30, 2025, net written premiums from personal lines decreased by $10.4 million, or 23.9%, driven by declines in personal credit and auto insurance lines. Net written premiums from property and short-tail lines represented $134.7 million, or 34.0%, of the total net written premiums for the three months ended September 30, 2025 compared to $152.0 million, or 39.1%, for the prior year period. Property and short-tail net written premiums were diversified by geographic location, exposure and risk type with substantial reinsurance protection. As of September 30, 2025, the net loss to the Company in a 1-in-250 year catastrophe event represented approximately 3.7% of Fortegra's stockholders' equity. This reported loss includes the impact of incurred losses based on the estimated frequency and severity of potential events, reinstatements premiums, reinsurance recoveries and taxes.

**Combined Ratio**

The combined ratio was 87.3% and 90.2% for the three months ended September 30, 2025 and 2024, respectively, reflecting the consistent underwriting performance and scalability of the Company's operating platform. The underwriting ratio was 73.3%, a decrease of 2.9 percentage points from the prior year period, which consists of a loss ratio of 46.4%, compared to 45.1% in the prior year period, and an acquisition ratio of 26.9%, compared to 31.1% in the prior year period. The increase in loss ratio was driven by changes in business mix towards commercial lines and increases in repair and labor costs on vehicle service contracts compared to prior year period, which was more than offset by the decline in acquisition ratio as a result of changes in business mix and swing rate commission structures. The operating expense ratio remained consistent at 14.0%.

**Return on Average Equity**

Return on average equity was 19.6% for the three months ended September 30, 2025, as compared to 24.3% for the prior year period, with the decrease driven by the higher average stockholders' equity, partially offset by improved combined ratio and higher investment gains.

**Adjusted Net Income (before NCI) and Adjusted Return on Average Equity - Non-GAAP**

For the three months ended September 30, 2025, adjusted net income (before NCI) and adjusted return on average equity were $49.5 million and 26.3%, respectively, as compared to $40.0 million and 27.7%, respectively, for the three months ended September 30, 2024.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Results of Operations - Nine Months Ended September 30, 2025 compared to 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **Change** | **% Change** |
| **Revenues:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned premiums, net | $1129259 | $1105273 | $23986 | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Service and administrative fees | 289966 | 311696 | (21730) | (7.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commissions | 10658 | 11525 | (867) | (7.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 29631 | 22250 | 7381 | 33.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | 33310 | 7582 | 25728 | 339.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 23390 | 31385 | (7995) | (25.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 1516214 | 1489711 | 26503 | 1.8% |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses and loss adjustment expenses | $570121 | $556571 | $13550 | 2.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Member benefit claims | 82994 | 88510 | (5516) | (6.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Commission expense | 437005 | 484232 | (47227) | (9.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 115882 | 100884 | 14998 | 14.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 25553 | 22300 | 3253 | 14.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13758 | 14886 | (1128) | (7.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 110480 | 87058 | 23422 | 26.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | 1355793 | 1354441 | 1352 | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before taxes <sup>(1)</sup> | 160421 | 135270 | 25151 | 18.6% |
| **Key Performance Metrics:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross written premiums and premium equivalents | $2520556 | $2216323 | $304233 | 13.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net written premiums | $1183167 | $1073321 | $109846 | 10.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss ratio | 47.0% | 46.3% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition ratio | 27.5% | 31.1% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Underwriting ratio | 74.5% | 77.4% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expense ratio | 14.0% | 12.8% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Combined ratio | 88.5% | 90.2% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Return on average equity | 22.2% | 25.1% |  |  |
| **Non-GAAP Financial Measures** <sup>(2)</sup>**:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $135191 | $114491 | $20700 | 18.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity | 25.7% | 28.8% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $106794 | $90744 | $16050 | 17.7% |

---

<sup>(1)</sup> Net income was $115.9 million for the nine months ended September 30, 2025 compared to $99.6 million for the nine months ended September 30, 2024.

<sup>(2)</sup> See "—Non-GAAP Reconciliations" for a discussion of non-GAAP financial measures.

**Revenues - Nine Months Ended September 30, 2025 compared to 2024**

For the nine months ended September 30, 2025, total revenues increased 1.8%, to $1.5 billion, as compared to $1.5 billion for the nine months ended September 30, 2024. Earned premiums, net of $1.1 billion increased $24.0 million, or 2.2%, driven by growth in specialty E&S and admitted insurance lines. Earned premiums assumed from other insurance companies were $433.1 million, or 38.4% of the total, compared to $430.6 million, or 39.0% of the total, in the prior year period. As it expands to new geographies and expands product offerings, the Company works to obtain necessary licenses and intends to write this business directly upon obtaining necessary licenses. The Company views direct written and assumed business as having similar characteristics. For the presented periods, earned premiums, net, did not include any significant regional geographic concentrations. Service and administrative fees of $290.0 million decreased by 7.0% driven by decrease in warranty and consumer goods service contract revenues in U.S. and Europe. Ceding commissions of $10.7 million decreased by $0.9 million, or 7.5%. Other revenues decreased by $8.0 million, or 25.5%, driven by decreases in interest income on cash equivalents and premium finance product offerings.

For the nine months ended September 30, 2025, net investment income was $29.6 million as compared to $22.3 million in the prior year period, an increase of $7.4 million driven by increased yields on investments and increased allocation to fixed income securities compared to cash equivalents, partially offset by $5.7 million of incentive fees related to realized and unrealized gains on equities and alternatives securities. Net realized and unrealized gains were $33.3 million, compared to net realized and unrealized gains of $7.6 million in the prior year period, primarily driven by the change in fair value of equity securities and other investments carried at fair value. Unrealized gains on AFS securities impacting OCI for the nine months ended September 30, 2025 were $25.8 million, driven by positive fair value adjustments on U.S. Treasury securities and obligations of U.S. government authorities and agencies, corporate bonds and other investments.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Expenses - Nine Months Ended September 30, 2025 compared to 2024**

For the nine months ended September 30, 2025, net losses and loss adjustment expenses were $570.1 million, member benefit claims were $83.0 million and commission expense was $437.0 million, as compared to $556.6 million, $88.5 million, and $484.2 million, respectively, for the nine months ended September 30, 2024. The increase in net losses and loss adjustment expenses was $13.6 million, or 2.4%, was in line with the increase in earned premiums, net. During the nine months ended September 30, 2025 and 2024, the Company experienced favorable prior year development of $7.1 million and unfavorable prior year development of $0.6 million, respectively, primarily as a result of lower-than-expected claims in its commercial lines of business. The decrease in member benefit claims of $5.5 million, or 6.2%, was in line with decrease in service and administrative fees, partially offset by higher replacement costs and labor rates. Commission expense decreased by $47.2 million, or 9.8%, driven by impacts from sliding scale commission structures.

For the nine months ended September 30, 2025, employee compensation and benefits were $115.9 million and other expenses were $110.5 million, as compared to $100.9 million and $87.1 million, respectively, for the nine months ended September 30, 2024. Employee compensation and benefits increased by $15.0 million, or 14.9%, driven by investments in human capital associated with growth in E&S, admitted and services lines and increased stock-based compensation expense. Other expenses increased by $23.4 million, or 26.9%, driven by a change in fair value of the Fortegra Additional Warrant liability of $17.6 million, in comparison to $6.0 million in nine months ended September 30, 2024. Included in other expenses were $7.9 million of deal-related expenses in the 2025 period, compared to $3.5 million of expenses related to legal and other expenses associated with preparation of the registration statement for the withdrawn Fortegra initial public offering in February 2024.

For the nine months ended September 30, 2025, interest expense was $25.6 million as compared to $22.3 million for the nine months ended September 30, 2024. On November 7, 2024, Fortegra issued 150.0 million of 9.25% Fixed Rate Resetting Junior Subordinated Notes due November 2064. The proceeds of the 2024 Notes were used to repay outstanding indebtedness under Fortegra's credit agreement, for insurance company growth capital and general corporate purposes. The increase in interest expense of $3.3 million, or 14.6%, was primarily driven by the issuance of the new debt.

For the nine months ended September 30, 2025, depreciation and amortization expense was $13.8 million as compared to $14.9 million in 2024. Intangible amortization for the 2025 and 2024 periods is related to purchase accounting associated with acquisitions of Fortegra in 2014 and additional services businesses from 2019 to 2023.

**Gross Written Premiums and Premium Equivalents** <sup>(1)</sup>

The below table shows gross written premiums and premium equivalents by business mix for the nine months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| *($ in thousands)* | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Property and short-tail | $798488 | $601191 |
| Contractual liability | 281605 | 244491 |
| General liability | 367530 | 262804 |
| Alternative risks | 269757 | 256590 |
| Professional liability | 185751 | 196642 |
| Europe | 161667 | 119663 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial lines | $2064798 | $1681381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Personal lines | 240662 | 251202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance | $2305460 | $1932583 |
| &nbsp;&nbsp;&nbsp;&nbsp;Auto and consumer goods warranty | 181260 | 248710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other services | 33836 | 35030 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Services | $215096 | $283740 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $2520556 | $2216323 |

---

<sup>(1)</sup> The total gross written premiums and premium equivalents of $2,520.6 million and $2,216.3 million for the nine months ended September 30, 2025 and 2024, respectively, were comprised of gross written premiums of $1,895.6 million and $1,603.9 million, plus assumed premiums of $409.8 million and $328.7 million, plus gross service and administrative fee additions of $215.1 million and $283.7 million, respectively. See Note (6) Reinsurance Recoverable and Prepaid Reinsurance Premiums and Note (12) Revenue from Contracts with Customers within the respective periods for more information.

Total gross written premiums and premium equivalents for the nine months ended September 30, 2025 were $2.5 billion, representing an increase of $304.2 million, or 13.7%, as compared to the prior year period. The increase was driven by a combination of factors including expanding Fortegra's distribution partner network, and growing E&S insurance lines. E&S premiums were $1.1 billion for the nine months ended September 30, 2025 compared to $869.8 million in the prior year period, a 24.4% increase. For the nine months ended September 30, 2025, Insurance increased by $372.9 million, or 19.3%, driven primarily by growth in property and short-tail, general liability and contractual liability, and European lines, partially offset by decline in professional liability and personal lines. For the nine months ended September 30, 2025, Services decreased by $68.6 million, or 24.2%, driven by lower volume in consumer goods and vehicle service contracts.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Net written premiums**

---

| | | |
|:---|:---|:---|
| *($ in thousands)* | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Property and short-tail | $430672 | $368788 |
| Contractual liability | 69581 | 63400 |
| General liability | 174992 | 127466 |
| Alternative risks | 197237 | 193347 |
| Professional liability | 62955 | 78955 |
| Europe | 148233 | 119663 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial lines | $1083670 | $951619 |
| &nbsp;&nbsp;&nbsp;&nbsp;Personal lines | 99497 | 121702 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance | $1183167 | $1073321 |

---

Net written premiums for the nine months ended September 30, 2025 were $1.2 billion, representing an increase of $109.8 million, or 10.2%, as compared to the prior year period, consistent with growth in gross written premiums. For the nine months ended September 30, 2025, commercial lines increased by $132.1 million, or 13.9%, driven by growth in E&S and specialty admitted business. For the nine months ended September 30, 2025, personal lines decreased by $22.2 million, or 18.2%, driven by declines in personal credit and auto insurance lines. Property and short-tail lines represented $430.7 million, or 36.4%, of the total net written premiums for the nine months ended September 30, 2025 compared to $368.8 million, or 34.4%, for the prior year period. Property and short-tail net written premiums were diversified by geographic location, exposure and risk type with substantial reinsurance protection.

***Combined Ratio***

The combined ratio was 88.5% for the nine months ended September 30, 2025, compared to 90.2% for the prior year period, reflecting the consistent underwriting performance and scalability of the Company's operating platform. The underwriting ratio was 74.5%, a decrease of 2.9 percentage points from the prior year period, which consists of a loss ratio of 47.0%, compared to 46.3% in the prior year period, and an acquisition ratio of 27.5%, compared to 31.1% in the prior year period. The increase in loss ratio was driven by changes in business mix towards commercial lines and increases in repair and labor costs on vehicle service contracts compared to prior year period, which was offset by the decline in acquisition ratio as a result of changes in business mix and impacts from swing rate commission structures. The operating expense ratio increased 1.2 percentage points to 14.0%, as compared to 12.8% in the prior year period, driven by our continued investment in growing our E&S business.

***Return on Average Equity***

Return on average equity was 22.2% for the nine months ended September 30, 2025, as compared to 25.1% for the nine months ended September 30, 2024, with the decrease driven by slower revenue growth, partially offset by improvement of the combined ratio.

**Adjusted Net Income (before NCI) and Adjusted Return on Average Equity - Non-GAAP**

For the nine months ended September 30, 2025, adjusted net income (before NCI) and adjusted return on average equity were $135.2 million and 25.7%, respectively, as compared to $114.5 million and 28.8%, respectively, for the nine months ended September 30, 2024. The improvement of adjusted net income (before NCI) was driven by the improved combined ratio, in addition to improvements in net investment income.

**Tiptree Capital**

Tiptree Capital consists of our Mortgage segment, which includes the operating results of Reliance, our mortgage business, and Tiptree Capital - Other, which consists of our other non-insurance operating businesses and investments.

**Mortgage**

Through our Mortgage operating subsidiary, Reliance, we originate, sell, securitize and service one-to-four-family, residential mortgage loans, comprised of conforming mortgage loans, Federal Housing Administration ("FHA"), Veterans Administration ("VA"), United States Department of Agriculture ("USDA"), and to a lesser extent, non-agency jumbo prime.

We are an approved seller/servicer for Fannie Mae and Freddie Mac. We are also an approved issuer and servicer for Ginnie Mae. We originate residential mortgage loans through our retail distribution channel (directly to consumers) in 39 states and the District of Columbia as of September 30, 2025.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**Components of our Results of Operations**

**Revenues**

*Net Realized and Unrealized Gains (Losses)* include gains on sale of mortgage loans and the fair value adjustment in mortgage servicing rights. Gains on the sale of mortgage loans represent the difference between the selling price and carrying value of loans sold and are recognized upon settlement. Such gains also include the changes in fair value of loans held for sale and loan-related hedges and derivatives. We transfer the risk of loss or default to the loan purchaser, however, in some cases we are required to indemnify purchasers for losses related to non-compliance with borrowers' creditworthiness and collateral requirements. Because of this, we recognize gains on sale net of required indemnification and premium recapture reserves. The fair value adjustment on mortgage servicing rights represents fair value adjustments considering estimated prepayments and other factors associated with changes in interest rates, plus actual run-off in the servicing portfolio. We report these adjustments separate from servicing income and servicing expense.

*Other Revenue* includes loan origination fees, interest income, and mortgage servicing income. Loan origination fees are earned as mortgage loans are funded. Servicing fees are earned over the life of the loan. Interest income includes interest earned on loans held for sale and interest income on bank balances and short-term investments.

**Expenses**

*Employee Compensation and Benefits* includes salaries, commissions, benefits, bonuses, other incentive compensation and related taxes for employees. Commissions expense for sales staff generally varies with loan origination volumes.

*Interest Expense* represents borrowing costs under warehouse and other credit facilities used primarily to fund loan originations. Amortization of deferred financing costs, including commitment fees, is included in interest expense.

*Depreciation* is mainly associated with furniture, fixtures and equipment. *Amortization* is primarily associated with a trade name and internally developed software.

*Other Expenses* include loan origination expenses, namely, leads, appraisals, credit reporting and licensing fees, general and administrative expenses, including office rent, insurance, legal, consulting and payroll processing expenses, and servicing expense.

The following tables present the Mortgage segment results for the following periods:

**Results of Operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Revenues:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | $9843 | $8862 | $29485 | $29662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 6327 | 6030 | 18096 | 17004 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $16170 | $14892 | $47581 | $46666 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | $9922 | $9129 | $29065 | $27746 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 346 | 441 | 1040 | 1619 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 70 | 61 | 223 | 283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 5630 | 5350 | 17023 | 15826 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $15968 | $14981 | $47351 | $45474 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before taxes | $202 | $(89) | $230 | $1192 |
| **Key Performance Metrics:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Origination volumes | $252082 | $255783 | $705701 | $693056 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale margins | 4.8% | 4.8% | 4.7% | 4.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Return on average equity | (0.8)% | (0.4)% | (0.1)% | 2.4% |
| **Non-GAAP Financial Measures** <sup>(1)</sup>**:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $556 | $1359 | $1183 | $1231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity | 4.0% | 10.2% | 2.8% | 3.1% |

---

<sup>(1)</sup> See "—Non-GAAP Reconciliations" for a discussion of non-GAAP financial measures.

**Revenues - Three and Nine Months Ended September 30, 2025 compared to 2024**

For the three months ended September 30, 2025, $252.1 million of loans were funded, compared to $255.8 million for 2024, a decrease of $3.7 million, or 1.4%. Gain on sale margins remained consistent at 4.8% for the three months ended September 30, 2025 and 2024.

------

[**<u>**Table of Contents**</u>**](#toc_page)

For the nine months ended September 30, 2025, $705.7 million of loans were funded, compared to $693.1 million for the prior year period, an increase of $12.6 million, or 1.8%. Gain on sale margins decreased to 4.7% for the nine months ended September 30, 2025, as compared to 4.8% for the nine months ended September 30, 2024.

Net realized and unrealized gains for the three months ended September 30, 2025 were $9.8 million, compared to $8.9 million for 2024, an increase of $1.0 million, or 11.1%. Net realized and unrealized gains for the nine months ended September 30, 2025 were $29.5 million, compared to $29.7 million in the prior year period, a decrease of $0.2 million, or 0.6%. The primary driver of decreased gain on sale revenues for the nine months ended September 30, 2025 was the negative fair value adjustment in mortgage servicing rights of $1.3 million in 2025 compared to a negative fair value adjustment of $0.4 million in the prior year period.

Other revenue for the three months ended September 30, 2025 was $6.3 million, compared to $6.0 million in the prior year period, an increase of $0.3 million, or 4.9%. Other revenue for the nine months ended September 30, 2025 was $18.1 million, compared to $17.0 million in the prior year period, an increase of $1.1 million, or 6.4%. The increase was driven by higher loan servicing income and higher loan origination fees. As of September 30, 2025, the mortgage servicing asset was $40.6 million, a decrease from $42.6 million as of December 31, 2024.

**Expenses - Three and Nine Months Ended September 30, 2025 compared to 2024**

For the three months ended September 30, 2025, employee compensation and benefits were $9.9 million, compared to $9.1 million in 2024, an increase of $0.8 million, or 8.7%. For the nine months ended September 30, 2025, employee compensation and benefits were $29.1 million, compared to $27.7 million in the prior year period, an increase of $1.3 million, or 4.8%.

For the three months ended September 30, 2025, interest expense was $0.3 million, a decrease of $0.1 million, or 21.5%. For the nine months ended September 30, 2025, interest expense was at $1.0 million, compared to $1.6 million in prior year period. The decreases in both periods were driven by lower interest rates.

For the three months ended September 30, 2025, other expenses were $5.6 million, compared to $5.4 million in 2024, with the $0.3 million increase driven by increased loan origination expenses, including marketing costs. For the nine months ended September 30, 2025, other expenses $17.0 million, compared to $15.8 million in the prior year period, an increase of $1.2 million, with the increase driven by a higher mortgage operational expenses.

**Income (loss) before taxes - Three and Nine Months Ended September 30, 2025 compared to 2024** 

Income before taxes for the three months ended September 30, 2025 was $0.2 million, compared to loss before taxes of $0.1 million in 2024. The income before taxes for the nine months ended September 30, 2025 was $0.2 million, compared to income before taxes of $1.2 million in the prior year period. The decrease for the nine months ended September 30, 2025 was driven by negative fair value adjustment in mortgage servicing rights, partially offset by higher servicing fees.

**Tiptree Capital - Other**

The following tables present a summary of Tiptree Capital - Other results for the following periods:

**Results of Operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Revenues:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) | $275 | $(2764) | $(441) | $(726) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 1241 | 1221 | 3124 | 3605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue | $1516 | $(1543) | $2683 | $2879 |
| **Expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | $141 | $117 | $362 | $360 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 9 | 943 | 4076 | 1917 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $150 | $1060 | $4438 | $2277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before taxes | $1366 | $(2603) | $(1755) | $602 |
| **Non-GAAP Financial Measures** <sup>(1)</sup>**:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $848 | $42 | $(8) | $870 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity | 4.5% | 0.3% | (0.0)% | 1.3% |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

<sup>(1)</sup> See "—Non-GAAP Reconciliations" for a discussion of non-GAAP financial measures.

**Revenues - Three and Nine Months Ended September 30, 2025 compared to 2024**

Tiptree Capital - Other earns revenues primarily from net interest income and realized and unrealized gains and losses on the Company's investment holdings (including Invesque until the sale in April 2024).

Revenues for the three months ended September 30, 2025 were $1.5 million compared to $(1.5) million in the prior year period. Revenues for the nine months ended September 30, 2025 were $2.7 million compared to $2.9 million for 2024. The decrease for the year was driven by lower interest income on cash and cash equivalents and U.S. Treasury securities recorded in other income.

**Income (loss) before taxes - Three and Nine Months Ended September 30, 2025 compared to 2024** 

The income before taxes from Tiptree Capital - Other for the three months ended September 30, 2025 was $1.4 million, compared to the loss before taxes of $2.6 million in 2024. The loss before taxes from Tiptree Capital - Other for the nine months ended September 30, 2025 was $1.8 million, compared to the income before taxes of $0.6 million in the prior year period driven by the increased other expenses.

**Adjusted net income - Non-GAAP** <sup>(1)</sup>

Adjusted net income from Tiptree Capital - Other for the three months ended September 30, 2025 was $0.8 million, compared to adjusted net income of $42.0 thousand in 2024. Adjusted net loss for the nine months ended September 30, 2025 was $8.0 thousand, compared to the adjusted net income of $0.9 million in 2024, with the decrease driven by increased other expenses, and lower interest income on cash and cash equivalents and U.S. Treasury securities recorded in other income.

**Corporate**

The following table presents a summary of corporate results for the following periods:

**Results of Operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **2025** | **2024** | **2025** | **2024** |
| Employee compensation and benefits | $3349 | $1974 | $7287 | $5850 |
| Employee incentive compensation expense | 6946 | 3239 | 19105 | 16598 |
| Interest expense | 2083 |  | 5319 |  |
| Depreciation and amortization | 365 | 364 | 1083 | 1085 |
| Other expenses | 5772 | 2159 | 9764 | 6405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $18515 | $7736 | $42558 | $29938 |

---

Corporate expenses include expenses of the holding company for employee compensation and benefits, interest expense, and public company and other expenses. Corporate employee compensation and benefits includes the expense of management, legal and accounting staff. Other expenses primarily consisted of audit and professional fees, insurance, office rent and other related expenses.

Employee compensation and benefits, including incentive compensation expense, were $26.4 million for the nine months ended September 30, 2025, compared to $22.4 million for the prior year period, driven by the increase in accrued incentive compensation expense and one-time expenses associated with reduction in workforce. Of the incentive compensation expense in the nine months ended September 30, 2025, $5.3 million was stock-based compensation expense, compared to $7.2 million in 2024. The interest expense was $5.3 million for the nine months ended September 30, 2025. As of September 30, 2025, the outstanding borrowing on the facility was $74.4 million compared to no outstanding borrowings in 2024. Other expenses increased to $9.8 million for the nine months ended September 30, 2025 as compared to the prior year period driven primarily by deal-related expenses.

**Provision for Income Taxes**

The total income tax expense of $22.7 million and $16.3 million for the three months ended September 30, 2025 and 2024, respectively, is reflected as a component of net income (loss). For the three months ended September 30, 2025 and 2024, the Company's effective tax rate was equal to 59.2% and 44.4%, respectively, with both significantly higher than the U.S. statutory income tax rate of 21.0%, primarily due to the impact of outside basis deferred taxes on Tiptree's investment in Fortegra.

The total income tax expense of $56.7 million and $48.8 million for the nine months ended September 30, 2025 and 2024, respectively, is reflected as components of net income (loss). For the nine months ended September 30, 2025 and 2024, the Company's effective tax

------

[**<u>**Table of Contents**</u>**](#toc_page)

rate was equal to 48.7% and 45.6%, respectively, with both significantly higher than the U.S. statutory income tax rate of 21.0%, primarily due to the impact of outside basis deferred taxes on Tiptree's investment in Fortegra.

On April 15, 2024, the Company sold its 16.98 million shares of Invesque for $0.6 million of proceeds resulting in a capital loss carryforward for tax purposes of approximately $106.8 million.

Tiptree owns less than 80% of Fortegra and is required to record deferred taxes on the outside basis on its investment in Fortegra. This deferred tax liability represents the tax that would be due, before consideration of loss carryforwards, if Tiptree were to sell all of its Fortegra stock at its carrying value on Tiptree's balance sheet. As of September 30, 2025, the deferred tax liability relating to Fortegra was $109.2 million, which was an increased of $24.5 million from the year ended December 31, 2024, of which $5.7 million of expense was recorded in OCI, and $18.8 million of expense was recorded as a provision for income taxes. As of September 30, 2024, the deferred tax liability relating to Fortegra was $81.5 million, which was an increased of $19.8 million from the year ended December 31, 2023, of which $3.1 million of expense was recorded in OCI, and $16.7 million of expense was recorded as a provision for income taxes. Excluding the impact of these deferred taxes, the effective tax rates for the nine months ended September 30, 2025 and 2024 were 32.5% and 29.9%, respectively.

**Balance Sheet Information**

Tiptree's total assets were $6.4 billion as of September 30, 2025, compared to $5.7 billion as of December 31, 2024. The $721.5 million increase in assets is primarily attributable to the growth in the Insurance segment.

Total stockholders' equity was $741.4 million as of September 30, 2025, compared to $656.8 million as of December 31, 2024, with the increase primarily driven by comprehensive income for the nine months ended September 30, 2025. As of September 30, 2025, there were 37,820,120 shares of common stock outstanding as compared to 37,255,838 shares as of December 31, 2024, with the increase driven by the vesting of share-based incentive compensation and exercise of options.

As of September 30, 2025, Fortegra was owned approximately 78.9% by Tiptree Holdings, 17.6% by Warburg and 3.5% by management and directors of Fortegra, before giving effect to the exercise of outstanding warrants and management options, and the conversion of outstanding preferred stock.

The following table is a summary of certain balance sheet information:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
| *($ in thousands)* |  | **Tiptree Capital** | **Tiptree Capital** |  |  |
|  | **Insurance** | **Mortgage** | **Other** | **Corporate** | **Total** |
| Total assets | $6114642 | $212864 | $69509 | $19254 | $6416269 |
| Corporate debt | $330000 | $— | $— | $74438 | $404438 |
| Asset based debt | 41287 | 78377 |  |  | 119664 |
| Tiptree Inc. stockholders' equity <sup>(1)</sup> | $540004 | $55874 | $68909 | $(159613) | $505174 |
| <u>Non-controlling interests:</u> |  |  |  |  |  |
| Fortegra preferred interests | 77679 |  |  |  | 77679 |
| Common interests | 158565 |  |  |  | 158565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | $776248 | $55874 | $68909 | $(159613) | $741418 |

---

<sup>(1)</sup> Included in Corporate equity is the deferred tax liability on the outside basis on Tiptree's investment in Fortegra of $109.2 million as of September 30, 2025.

**<u>NON-GAAP MEASURES AND RECONCILIATIONS</u>**

**Non-GAAP Reconciliations**

In addition to GAAP results, we also use the non-GAAP financial measures adjusted net income and adjusted return on average equity as measures of operating performance and as part of our resource and capital allocation process, to assess comparative returns on invested capital. Management believes these measures provide supplemental information useful to investors as they are frequently used by the financial community to analyze financial performance and to compare relative performance among comparable companies. Adjusted net income and adjusted return on average equity are not measurements of financial performance or liquidity under GAAP and should not be considered as an alternative or substitute for earned premiums, net income or any other measure derived in accordance with GAAP.

***Adjusted Net Income — Non-GAAP***

We define adjusted net income as income before taxes, less provision (benefit) for income taxes, and excluding the after-tax impact of various expenses that we consider to be unique and non-recurring in nature, including merger and acquisition related expenses, stock-based compensation, net realized and unrealized gains (losses) and intangibles amortization associated with purchase accounting, all of

------

[**<u>**Table of Contents**</u>**](#toc_page)

which is reduced for non-controlling interests. The calculation of adjusted net income excludes net realized and unrealized gains (losses) that relate to investments or assets rather than business operations. Adjusted net income should not be viewed as a substitute for income before taxes calculated in accordance with GAAP, and other companies may define adjusted net income differently. Adjusted net income (before NCI) is presented before the impacts of non-controlling interests.

We present adjustments for amortization associated with acquired intangible assets. The intangible assets were recorded as part of purchase accounting in connection with Tiptree's acquisition of Fortegra Financial in 2014, and additional services businesses from 2019 to 2024. The intangible assets acquired contribute to overall revenue generation, and the respective purchase accounting adjustments will continue to occur in future periods until such intangible assets are fully amortized in accordance with the respective amortization periods required by GAAP.

***Adjusted Return on Average Equity — Non-GAAP***

We define adjusted return on average equity as adjusted net income expressed on an annualized basis as a percentage of average beginning and ending stockholders' equity during the period. See "—Adjusted Net Income—Non-GAAP" above. Adjusted return on average equity should not be viewed as a substitute for return on average equity calculated in accordance with GAAP, and other companies may define adjusted return on average equity differently.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| *($ in thousands)* |  | **Tiptree Capital** | **Tiptree Capital** |  |  |  |
|  | **Insurance** | **Mortgage** | **Other** | **Corporate** | **Corporate** | **Total** |
| Income (loss) before taxes | $55223 | $202 | $1366 | $| (18515) | $38276 |
| Less: Income tax (benefit) expense | (18378) | (314) | (313) | $| (3661) | (22666) |
| Less: Net realized and unrealized gains (losses) <sup>(1)</sup> | (24761) | 530 | (275) |  |  | (24506) |
| Plus: Intangibles amortization <sup>(2)</sup> | 3362 |  |  |  |  | 3362 |
| Plus: Stock-based compensation expense | 4133 |  |  |  | 1494 | 5627 |
| Plus: Non-recurring expenses <sup>(3)</sup> | 9417 |  |  |  | 3084 | 12501 |
| Plus: Non-cash fair value adjustments <sup>(4)</sup> | 16967 |  |  |  |  | 16967 |
| Plus: Impact of tax deconsolidation of Fortegra <sup>(5)</sup> |  |  |  |  | 5943 | 5943 |
| Less: Tax on adjustments <sup>(6)</sup> | 3580 | 138 | 70 |  | (52) | 3736 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $49543 | $556 | $848 | $| (11707) | $39240 |
| Less: Impact of non-controlling interests | (10476) |  |  |  |  | (10476) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $39067 | $556 | $848 | $ | (11707) | $28764 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $49543 | $556 | $848 | $| (11707) | $39240 |
| Average stockholders' equity | $753591 | $55931 | $75031 | $| (152159) | $732394 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity <sup>(7)</sup> | 26.3% | 4.0% | 4.5% | NM% | NM% | 21.4% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| *($ in thousands)* |  | **Tiptree Capital** | **Tiptree Capital** |  |  |  |
|  | **Insurance** | **Mortgage** | **Other** | **Corporate** | **Corporate** | **Total** |
| Income (loss) before taxes | $47209 | $(89) | $(2603) | $| (7736) | $36781 |
| Less: Income tax (benefit) expense | (12114) | 32 | 104 |  | (4330) | (16308) |
| Less: Net realized and unrealized gains (losses) <sup>(1)</sup> | (2218) | 1877 | 2764 |  |  | 2423 |
| Plus: Intangibles amortization <sup>(2)</sup> | 3859 |  |  |  |  | 3859 |
| Plus: Stock-based compensation expense | 4195 |  |  |  | 1762 | 5957 |
| Plus: Non-recurring expenses <sup>(3)</sup> | 119 |  |  |  |  | 119 |
| Plus: Non-cash fair value adjustments <sup>(4)</sup> | 946 |  |  |  |  | 946 |
| Plus: Impact of tax deconsolidation of Fortegra <sup>(5)</sup> |  |  |  |  | 5907 | 5907 |
| Less: Tax on adjustments <sup>(6)</sup> | (1954) | (461) | (223) |  | (860) | (3498) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $40042 | $1359 | $42 | $| (5257) | $36186 |
| Less: Impact of non-controlling interests | (8314) |  |  |  |  | (8314) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $31728 | $1359 | $42 | $ | (5257) | 27872 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $40042 | $1359 | $42 | $| (5257) | $36186 |
| Average stockholders' equity | $577776 | $53272 | $59943 | $| (53856) | $637135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity <sup>(7)</sup> | 27.7% | 10.2% | 0.3% | NM% | NM% | 22.7% |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| *($ in thousands)* |  | **Tiptree Capital** | **Tiptree Capital** |  |  |  |
|  | **Insurance** | **Mortgage** | **Other** | **Corporate** | **Corporate** | **Total** |
| Income (loss) before taxes | $160421 | $230 | $(1755) | $| (42558) | $116338 |
| Less: Income tax (benefit) expense | (43862) | (283) | (642) |  | (11869) | (56656) |
| Less: Net realized and unrealized gains (losses) <sup>(1)</sup> | (33310) | 1327 | 441 |  |  | (31542) |
| Plus: Intangibles amortization <sup>(2)</sup> | 10047 |  |  |  |  | 10047 |
| Plus: Stock-based compensation expense | 7231 |  |  |  | 5253 | 12484 |
| Plus: Non-recurring expenses <sup>(3)</sup> | 13623 |  | 1350 |  | 3084 | 18057 |
| Plus: Non-cash fair value adjustments <sup>(4)</sup> | 17560 |  |  |  |  | 17560 |
| Plus: Impact of tax deconsolidation of Fortegra <sup>(5)</sup> |  |  |  |  | 18603 | 18603 |
| Less: Tax on adjustments <sup>(6)</sup> | 3480 | (91) | 598 |  | (1259) | 2728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $135190 | $1183 | $(8) | $| (28746) | $107619 |
| Less: Impact of non-controlling interests | (28396) |  |  |  |  | (28396) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $106794 | $1183 | $(8) | $ | (28746) | $79223 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $135190 | $1183 | $(8) | $| (28746) | $107619 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average stockholders' equity | $700867 | $55901 | $52401 | $| (110074) | $699095 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity <sup>(7)</sup> | 25.7% | 2.8% | (0.0)% | NM% | NM% | 20.5% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| *($ in thousands)* |  | **Tiptree Capital** | **Tiptree Capital** |  |  |  |
|  | **Insurance** | **Mortgage** | **Other** | **Corporate** | **Corporate** | **Total** |
| Income (loss) before taxes | $135270 | $1192 | $602 | $| (29938) | $107126 |
| Less: Income tax (benefit) expense | (35604) | (244) | (704) |  | (12247) | (48799) |
| Less: Net realized and unrealized gains (losses) <sup>(1)</sup> | (7582) | 428 | 726 |  |  | (6428) |
| Plus: Intangibles amortization <sup>(2)</sup> | 11557 |  |  |  |  | 11557 |
| Plus: Stock-based compensation expense | 5999 |  |  |  | 7190 | 13189 |
| Plus: Non-recurring expenses <sup>(3)</sup> | 3455 |  |  |  |  | 3455 |
| Plus: Non-cash fair value adjustments <sup>(4)</sup> | 6018 |  |  |  |  | 6018 |
| Plus: Impact of tax deconsolidation of Fortegra <sup>(5)</sup> |  |  |  |  | 16729 | 16729 |
| Less: Tax on adjustments <sup>(6)</sup> | (4622) | (145) | 246 |  | (1752) | (6273) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $114491 | $1231 | $870 | $| (20018) | $96574 |
| Less: Impact of non-controlling interests | (23747) |  |  |  |  | (23747) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income | $90744 | $1231 | $870 | $ | (20018) | $72827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted net income (before NCI) | $114491 | $1231 | $870 | $| (20018) | $96574 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average stockholders' equity | $529486 | $52771 | $91263 | $| (57137) | $616383 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted return on average equity <sup>(7)</sup> | 28.8% | 3.1% | 1.3% | NM% | NM% | 20.9% |

---

<sup>(1)</sup> Net realized and unrealized gains (losses) added back in Adjusted net income excludes net realized and unrealized gains (losses) from the mortgage segment and unrealized gains (losses) on mortgage servicing rights.

<sup>(2)</sup> Specifically associated with acquisition purchase accounting. See Note (7) Goodwill and Intangible Assets, net, for the period ended September 30, 2025.

<sup>(3)</sup> For the three and nine months ended September 30, 2025 and 2024, included in other expenses were expenses related to legal, banker and other expenses including expenses associated with preparation of the registration statement for the withdrawn Fortegra initial public offering in 2024, and $5.7 million of incentive fees related to realized and unrealized gains on equities and alternatives securities in 2025 periods.

<sup>(4)</sup> For the three and nine months ended September 30, 2025 and 2024, non-cash fair-value adjustments represent a change in fair value of the Fortegra Additional Warrant liability.

<sup>(5)</sup> For the three and nine months ended September 30, 2025 and 2024, included in the adjustment is an add-back of $5.9 million and $18.6 million, respectively, and $5.9 million and $16.7 million, respectively, related to deferred tax expense from the WP Transaction.

<sup>(6)</sup> Tax on adjustments represents the tax applied to the total non-GAAP adjustments and includes adjustments for non-recurring or discrete tax impacts.

<sup>(7)</sup> Total Adjusted return on average equity after non-controlling interests was 22.9% and 24.8% for the three months ended September 30, 2025 and 2024, respectively, based on $28.8 million and $27.9 million of Adjusted net income over $502.6 million and $449.2 million of average Tiptree Inc. stockholders' equity. Total Adjusted return on average equity after non-controlling interests was 21.9% and 22.1% for the nine months ended September 30, 2025 and 2024, respectively, based on $79.2 million and $72.8 million of Adjusted net income over $481.5 million and $439.4 million of average Tiptree Inc. stockholders' equity.

**Book Value per share - Non-GAAP**

Management believes the use of this financial measure provides supplemental information useful to investors as book value is frequently used by the financial community to analyze company growth on a relative per share basis. The following table provides a reconciliation between total stockholders' equity and total shares outstanding, net of treasury shares.

------

[**<u>**Table of Contents**</u>**](#toc_page)

---

| | | |
|:---|:---|:---|
| *($ in thousands, except per share information)* | **As of September 30,** | **As of September 30,** |
|  | **2025** | **2024** |
| Total stockholders' equity | $741418 | $656200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Non-controlling interests | 236244 | 194254 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity, net of non-controlling interests | $505174 | $461946 |
| Total common shares outstanding | 37820 | 36790 |
| Book value per share | $13.36 | $12.56 |

---

**<u>LIQUIDITY AND CAPITAL RESOURCES</u>**

Our principal sources of liquidity are unrestricted cash, cash equivalents and other liquid investments, the Tiptree Credit Agreement and distributions from operating subsidiaries, including income from our investment portfolio and sales of assets and investments. We intend to use our cash resources to continue to fund our operations and grow our businesses. We may seek additional sources of cash to fund acquisitions or investments. These additional sources of cash may take the form of debt or equity and may be at the parent, subsidiary or asset level. We are a holding company, and our liquidity needs are primarily for compensation, professional fees, office rent and insurance costs.

Our subsidiaries' ability to generate sufficient net income and cash flows to make cash distributions will be subject to numerous business and other factors, including restrictions contained in agreements for the strategic investment by Warburg in Fortegra, our subsidiaries' financing agreements, regulatory restrictions, availability of sufficient funds at such subsidiaries, general economic and business conditions, tax considerations, strategic plans, financial results and other factors such as target capital ratios and ratio levels anticipated by rating agencies to maintain or improve current ratings. We expect our cash and cash equivalents and distributions from operating subsidiaries, our subsidiaries' access to financing, and sales of investments to be adequate to fund our operations for at least the next 12 months, as well as the long term.

As of September 30, 2025, cash and cash equivalents, excluding restricted cash, were $366.1 million, compared to $320.1 million as of December 31, 2024, an increase of $46.0 million, primarily driven by the issuance of debt at the holding company.

Our mortgage business relies on short term uncommitted sources of financing as a part of their normal course of operations. To date, we have been able to obtain and renew uncommitted warehouse credit facilities. If we were not able to obtain financing, then we may need to draw on other sources of liquidity to fund our mortgage business. See Note (9) Debt, net in the notes to our condensed consolidated financial statements for additional information regarding our insurance and mortgage borrowings.

We believe that cash flow from operations and the proceeds of the Merger will provide sufficient capital to continue to grow the business and fund interest on the outstanding debt, capital expenditures and other general corporate needs over the next several years. As we continue to expand our business, including by any acquisitions we may make, we may, in the future, require additional working capital for increased costs. For purposes of determining enterprise value, we consider corporate credit agreements and preferred trust securities, which we refer to as corporate debt, as corporate financing and associated interest expense is added back. The below table outlines this amount by debt outstanding and interest expense at the insurance company and corporate level.

**Corporate Debt**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *($ in thousands)* | **Corporate Debt Outstanding as of <br>September 30,** | **Corporate Debt Outstanding as of <br>September 30,** | **Interest Expense For the Nine Months Ended September 30,** | **Interest Expense For the Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Insurance | $330000 | $260000 | $22199 | $17491 |
| Corporate | 74438 |  | 5319 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $404438 | $260000 | $27518 | $17491 |

---

On February 7, 2025, we entered into the Tiptree Credit Agreement, pursuant to which Tiptree Holdings borrowed $75.0 million to, among other things, fund working capital and general corporate purposes. The principal of, and all accrued and unpaid interest on, all loans under the Tiptree Credit Agreement will mature on February 7, 2028. We expect this credit agreement to be repaid from proceeds of the Merger.

As of September 30, 2025, a total of $55.0 million was outstanding under the revolving line of credit in Fortegra as compared to no outstanding borrowings under the revolving line of credit as of December 31, 2024. The maximum borrowing capacity under the agreements as of September 30, 2025 and 2024 was $200.0 million.

On November 7, 2024, Fortegra issued $150.0 million of 9.25% Fixed Rate Resetting Junior Subordinated Notes due November 2064 ("the 2024 Notes"). The proceeds of the 2024 Notes were used to repay outstanding indebtedness under the Company's credit agreement,

------

[**<u>**Table of Contents**</u>**](#toc_page)

for insurance company growth capital and general corporate purposes. Beginning on November 15, 2029, the Company may redeem the 2024 Notes at par plus accrued and unpaid interest.

**Consolidated Comparison of Cash Flows**

---

| | | |
|:---|:---|:---|
| *($ in thousands)* | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Cash and cash equivalents provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $123366 | $170799 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (122891) | (146198) |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | 58051 | (17980) |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash | 4770 | 5188 |
| Change in cash, cash equivalents and restricted cash | $63296 | $11809 |

---

*Operating Activities*

Cash provided by operating activities was $123.4 million for the nine months ended September 30, 2025. In 2025, the primary sources of cash from operating activities included growth in insurance premiums written resulting in increases in policy liabilities and unpaid claims, and unearned premiums, which were offset by increases in accounts receivable, and reinsurance recoverables, and a decrease in deferred revenues.

Cash provided by operating activities was $170.8 million for the nine months ended September 30, 2024. In 2024, the primary sources of cash from operating activities included growth in insurance premiums written resulting in increases in policy liabilities and unpaid claims, deferred revenues and unearned premiums, which were partially offset by increases in accounts receivable and prepaid reinsurance premiums and decreases in reinsurance payables.

*Investing Activities* 

Cash used in investing activities was $122.9 million for the nine months ended September 30, 2025. In 2025, the primary use of cash was the purchase of investments exceeding the proceeds from sales and maturities of investments, partially offset by proceeds from notes receivable exceeding the issuance of notes receivable.

Cash used in investing activities was $146.2 million for the nine months ended September 30, 2024. In 2024, the primary use of cash was the purchases of investments outpacing proceeds from sales and maturities, in addition to the issuance of notes receivable exceeding proceeds from notes receivable.

*Financing Activities*

Cash provided by financing activities was $58.1 million for the nine months ended September 30, 2025. In 2025, the cash provided was primarily proceeds from the senior secured credit facility at Tiptree Holdings in amount of $75.0 million, partially offset by the payment of common and preferred dividends.

Cash used in financing activities was $18.0 million for the nine months ended September 30, 2024. In 2024, the cash used was primarily repayments of corporate borrowings at Fortegra and the payment of common and preferred dividends, partially offset by a non-controlling interest contribution to Fortegra.

**<u>CRITICAL ACCOUNTING POLICIES AND ESTIMATES</u>**

The preparation of our financial statements in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Actual results could differ materially from those estimates. There have been no material changes to the critical accounting policies and estimates as discussed in Part II, Item 7A in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**Recently Adopted and Issued Accounting Standards**

For a discussion of recently adopted and issued accounting standards, see the section "*Recent Accounting Standards"* in Note (2) Summary of Significant Accounting Policies of the notes to the accompanying condensed consolidated financial statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>Item 3. Quantitative and Qualitat</u><u>ive Disclosures About Market Risk</u>**

Our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 described our Quantitative and Qualitative Disclosures About Market Risk. There were no material changes to the assumptions or risks during the nine months ended September 30, 2025.

**<u>Item 4. Con</u><u>trols and Procedures</u>**

**Evaluation of Disclosure Controls and Procedures**

The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company's disclosure controls and procedures (as such term defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report. The Company's disclosure controls and procedures are designed to provide reasonable assurance that material information is recorded, processed, summarized and reported accurately and on a timely basis. Based on such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company's disclosure controls and procedures are effective.

**Changes in Internal Control over Financial Reporting**

There have not been any changes in the Company's internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d- 15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>PART II. O</u><u>THER INFORMATION</u>**

**<u>Item 1. Legal Pr</u><u>oceedings</u>**

Our legal proceedings are discussed under the heading "Litigation" in Note (19) Commitments and Contingencies in the Notes to the condensed consolidated financial statements in this report.

**<u>Ite</u><u>m 1A. Risk Factors</u>**

For information regarding factors that could affect our Company, results of operations and financial condition, see the risk factors discussed under Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. There have been no material changes in those risk factors. The following risk factors are in addition to those set forth in our Annual Report on Form 10-K.

 ***The announcement and pendency of the Merger and the other transactions contemplated by the Merger Agreement, whether or not completed, creates uncertainty about our future, which could have a material adverse effect on our business, financial condition and results of operations, including the Retained Business.*** 

The announcement and pendency of the Merger and the other transactions contemplated by the Merger Agreement may adversely affect the trading price of Tiptree common stock, our business and our relationships with clients, customers and employees. Third parties may be unwilling to enter into material agreements with respect to our businesses that remain after the Merger (the "Retained Business") or may seek to change existing business relationships. New or existing customers and business partners may prefer to enter into agreements with our competitors who have not expressed an intention to sell their business because customers and business partners may perceive that such new relationships are likely to be more stable. Additionally, employees working in the Retained Business may become concerned about the future of the Retained Business, as applicable, and lose focus or seek other employment. In addition, while the completion of the Merger is pending, we may be unable to attract and retain key personnel and our management's focus and attention and employee resources may be diverted from operational matters. The occurrence of any of these events, individually or in combination, could have a material adverse effect on our business, financial condition and results of operations. Additionally, we have incurred substantial transaction costs and diversion of management resources in connection with the Merger, and we will continue to do so until the final closing or termination of the Merger.

***The Merger is subject to the Tiptree stockholder approval and other closing requirements, and may not be completed as anticipated, or at all.*** 

The Merger may constitute a "transfer of assets" under Section 3-105 of the Maryland General Corporation Law, and we are therefore seeking the approval of the Merger and the other transactions contemplated by the Merger Agreement by our stockholders, which is a condition to the closing of the Merger. The regulatory approvals conditions in the Merger Agreement are also conditions to the obligation of the parties to consummate the Merger.

The total proceeds realized by Tiptree from the Merger are contingent upon receiving the Tiptree stockholder approval and satisfying other closing conditions as of the closing date. There can be no assurances that Tiptree will receive the Tiptree stockholder approval and satisfy the conditions to closing. Any delay in receiving the Tiptree stockholder approval and satisfying the other closing conditions may increase the risk that the Merger will be terminated pursuant to the terms of the Merger Agreement, or reduce the benefits that Tiptree expects to realize.

The Merger Agreement provides certain termination rights to Purchaser and to Tiptree. If an adverse recommendation change by the board of directors of Tiptree (the "Tiptree Board") occurs prior to receipt of the Tiptree stockholder approval, Purchaser has the right to terminate the Merger Agreement. If Tiptree engages or participates in discussions or negotiations regarding an unsolicited superior proposal from a third party prior to receipt of the Tiptree stockholder approval, Tiptree has the right, under certain circumstances, to terminate the Merger Agreement and enter into a definitive transaction agreement providing for such superior proposal.

***Tiptree will incur significant transaction costs in connection with the Merger.***

Tiptree has incurred and is expected to continue to incur a number of non-recurring costs associated with the Merger. These costs have been, and will continue to be, substantial and, in certain cases, will be borne by Tiptree whether or not the Merger is completed. A substantial majority of non-recurring expenses will consist of transaction costs and include, among others, fees paid to legal and financial advisors. Any litigation that may result from the announcement, pendency or completion of the Merger has the potential to impose additional substantial expenses on Tiptree. If the Merger is not completed, Tiptree will have incurred substantial expenses for which no ultimate benefit will have been received. Tiptree has incurred out-of-pocket expenses in connection with the Merger for legal and accounting fees and financial printing and other costs and expenses, much of which will be incurred even if the Merger is not completed. If the board of directors of Tiptree has determined in good faith (after consultation with its outside legal counsel

------

[**<u>**Table of Contents**</u>**](#toc_page)

and financial advisors) that an acquisition proposal constitutes a Superior Proposal (as defined in the Merger Agreement), then Tiptree may terminate the Merger Agreement to enter into an agreement with respect to such Superior Proposal, subject to compliance with the procedures specified in the Merger Agreement and payment of a termination fee of $49.5 million.

***Tiptree will have broad discretion in the use of the proceeds from the Merger and may use proceeds in ways that stockholders may not approve.*** 

Tiptree will have broad discretion in the use of the net proceeds it receives from the Merger and may use proceeds in ways that some stockholders may not approve. Tiptree intends to use proceeds from the Merger for working capital and general corporate purposes, including to pay transaction expenses, to pay taxes on the transactions contemplated by the Merger Agreement, to repay existing debt of Tiptree, to engage in opportunistic stock repurchases and/or pay dividends, to purchase additional assets or businesses and/or for any other purpose that the Tiptree Board deems appropriate. Because of the number and variability of factors that will determine our use of the net proceeds from the Merger, their ultimate use may vary substantially from their currently intended use.

Tiptree management may not spend the net proceeds in ways that improve Tiptree's results of operations or enhance the value of Tiptree common stock. The failure by Tiptree's management to apply these funds effectively could result in financial losses that could have a material adverse effect on Tiptree's business or cause the price of Tiptree common stock to decline. Tiptree management may invest the net proceeds from this offering in a manner that does not produce income or that loses value.

***Any Leakage will decrease the proceeds that Tiptree will receive in the Merger, and if there is Additional Leakage, Tiptree may not receive its pro rata portion of the Leakage Reserve Holdback Amount.***

Any Leakage, including any Transaction Expenses but excluding Permitted Leakage (as defined in the Merger Agreement) that occurs after June 30, 2025, and at or prior to the closing will decrease the Aggregate Closing Purchase Price (as defined in the Merger Agreement) and therefore the proceeds that Tiptree will receive in the Merger. Moreover, if, following the closing, it is determined that there was Additional Leakage (as defined in the Merger Agreement), Tiptree may not receive its pro rata portion of the Leakage Reserve Holdback Amount (as defined in the Merger Agreement). Because Leakage is defined to include payments, liabilities or obligations of or by Fortegra and its subsidiaries, the amount of any Leakage may be influenced by factors outside of Tiptree's control.

***Tiptree does not expect to distribute cash to its stockholders in connection with the Merger, and any return to its stockholders is expected to come, if at all, only from potential increases in the price of Tiptree common stock.*** 

Tiptree does not expect to distribute cash to its stockholders in connection with the Merger. The Tiptree Board has previously repurchased, and may from time to time repurchase, shares of Tiptree common stock and/or pay cash dividends. Factors that may impact our decisions regarding the method, timing and amount of a return of capital, if any, include economic and market conditions, our financial condition and operating results, cash requirements, capital requirements of our operating subsidiaries, legal requirements, regulatory constraints, investment opportunities at the time any such payment is considered, and other factors the Tiptree Board deems relevant. Furthermore, the specific timing and amount of any dividend payments are subject to declaration on future dates by the Tiptree Board in its sole discretion. There can be no assurances that we will complete any return of capital to our stockholders.

***If the proposed Merger is not completed, we may explore other potential transactions, but alternatives may be less favorable to us.*** 

Completion of the Merger will require significant time, attention, and resources of our senior management and others within Tiptree, potentially diverting their attention from other business opportunities that might benefit us. If the proposed Merger is not completed, Tiptree may explore other strategic alternatives with another party or parties. An alternative transaction may have terms that are less favorable to us than the terms of the proposed Merger, or we may be unable to reach agreement with any third-party on an alternate transaction that we would consider to be reasonable. Any future "transfer of assets" of Tiptree or other similar transaction may be subject to further stockholder approval, and there is no guarantee that Tiptree would be able to obtain such stockholder approval in favor of any such sale or other transaction.

***The failure to complete the Merger may impact our business, financial condition and results of operations.***

If the Merger is not completed for any reason, Tiptree's business, financial condition and results of operations may be impacted. To the extent that the market price of Tiptree common stock reflects positive market assumptions that the Merger will be completed and the related benefits will be realized, the failure to complete the Merger may result in a decrease in the market value of Tiptree common stock and may impair Tiptree's ability to achieve its objective of enhancing the value of its assets to Tiptree stockholders.

***Even if the Merger is completed, we cannot provide any assurances that we will realize the financial benefits we currently anticipate from the Merger.*** 

We cannot provide any assurances that we will realize the financial benefits we currently anticipate from the Merger. Any failure to realize the financial benefits we currently anticipate from the Merger could have a material adverse impact on our future

------

[**<u>**Table of Contents**</u>**](#toc_page)

operating results and financial condition and could materially and adversely affect the trading price or trading volume of Tiptree common stock. Our results of operations currently are not, and may not be in the future even if the Merger and the other transactions contemplated by the Merger Agreement are consummated, sufficient to service our indebtedness and to fund our other expenditures, and we may not be able to obtain financing to meet these requirements. Even if the Merger and the other transactions contemplated by the Merger Agreement are consummated, if we experience a default under Tiptree's existing credit agreement or instruments governing our future indebtedness, our business, financial condition and results of operations may be adversely impacted.

Tiptree also expects to recognize significant taxable gain upon completion of the Merger, which reflects expected treatment of the proposed Merger as a taxable sale of Fortegra common stock by Tiptree for U.S. federal income tax purposes.

***After completion of the Merger, Tiptree's future results of operations will be dependent solely on the Retained Business, Tiptree will have substantially fewer assets, Tiptree may be more susceptible to adverse events, and Tiptree may not be able to use the proceeds from the Merger as intended.***

If the Merger is completed, Tiptree will no longer hold any Fortegra shares or have any interest in the future earnings or growth of Fortegra, and Tiptree's future results of operations will be dependent solely on the Retained Business and differ materially from Tiptree's previous results of operations. After completion of the Merger, Tiptree will be subject to concentration of the risks that affect our Retained Business and Tiptree will have substantially fewer assets and may experience significant decreases in earnings and cash flow and increases in operating costs or other expenses. Following the Merger, Tiptree will continue to be a public company with ongoing costs associated with public company operations, which will be a greater percentage of our revenues. The market price of Tiptree common stock may significantly decrease, and Tiptree common stock may be more susceptible to market fluctuations. In addition, if there are significant adverse changes in Tiptree's business prospects, the industries in which Tiptree operates, or in market and economic conditions generally, Tiptree may not be able to use the proceeds from the Merger as currently intended because the proceeds may be required for operations or other needs that we do not currently anticipate. Any downturn in the Retained Business or future prospects following the closing of the Merger, or if Tiptree fails to bring overhead costs in line with our reduced operations following the closing of the Merger, could have a material adverse effect on Tiptree's future operating results and financial condition and could materially and adversely affect the market price of Tiptree's securities.

***After completion of the Merger, the continuing costs and burdens associated with being a public company will constitute a much larger percentage of Tiptree's revenues.*** 

If the Merger is completed, Tiptree will remain a public company and will continue to be subject to the listing standards of the Nasdaq and SEC rules and regulations. While all public companies face the costs and burdens associated with being public companies, the costs and burden of being a public company will be a significant portion of Tiptree's revenues, which will be reduced if the Merger is completed.

***The opinion obtained by the Fortegra Board from Barclays and relied upon by the Tiptree Board does not and will not reflect changes in circumstances after the date of such opinion.*** 

On September 24, 2025, Barclays Capital Inc. ("Barclays") rendered its oral opinion (which was subsequently confirmed in writing) to the Fortegra Board that, as of the date of its written opinion and based upon and subject to the qualifications, limitations, assumptions and other matters stated in its opinion, the aggregate consideration of $1.65 billion in cash in the Merger is fair, from a financial point of view, to holders of Fortegra common stock. Changes in the operations and prospects of Fortegra, including financial forecasts relating to Fortegra, general market and economic conditions and other factors, many of which may be beyond Tiptree's control, and on which the opinion of Barclays was based, may alter Fortegra's value and affect the conclusions reached in the opinion. Fortegra has not obtained, and does not expect to request, an updated opinion from Barclays. Barclays' opinion does not speak to the time when the Merger will be completed or to any date other than the date of such opinion. As a result, the opinion does not and will not address the fairness, from a financial point of view, of the consideration to be received by holders of Fortegra common stock in connection with the Merger at the time the Merger is completed or at any time other than the time the opinion was rendered.

***Securities class action and derivative lawsuits may be brought against Tiptree in connection with the Merger, which could result in substantial costs and may delay or prevent the Merger from being completed.***

Securities class action lawsuits and derivative lawsuits are often brought against public companies that have entered into acquisition, merger or other business combination agreements that could prevent or delay the completion of the Merger and result in significant costs to Tiptree, including any costs associated with the indemnification of directors and officers. Even if such a lawsuit is without merit, defending against these claims can result in substantial costs and divert management time and resources. An adverse judgment could result in monetary damages, which could have a negative impact on Tiptree's liquidity and financial condition.

Lawsuits that may be brought against Tiptree or Tiptree's directors could also seek, among other things, injunctive relief or other equitable relief, including a request to enjoin Tiptree from consummating the Merger. It is a condition to the completion of the

------

[**<u>**Table of Contents**</u>**](#toc_page)

Merger that no temporary restraining order, preliminary or permanent injunction or other judgment or order, injunction, ruling, decision, assessment, award, administrative order, judicial decision or decree entered or issued by, or in agreement with, any governmental authority to which Fortegra or any of its Subsidiaries is a party or to which it is subject, issued by a court of competent jurisdiction that prevents the consummation of the transactions contemplated by the Merger Agreement has been issued and remains in effect, and no statute, rule, regulation or other law has been enacted, enforced or promulgated by any governmental authority which would restrain, enjoin or otherwise prohibit the consummation of the transactions contemplated by the Merger Agreement Consequently, if a plaintiff is successful in obtaining an injunction prohibiting completion of the Merger, that injunction may delay or prevent the Merger from being completed within the expected timeframe or at all, which may adversely affect Tiptree's business, financial position and results of operation.

**<u>Item 2. Unr</u><u>egistered Sales of Equity Securities and Use of Proceeds</u>**

**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**

Share repurchase activity for three months ended September 30, 2025 was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Period** | **Purchaser** | **Total<br>Number of<br>Shares<br>Purchased**<sup>(1)</sup> | **Average<br>Price<br>Paid Per<br>Share** | **Total Number of Shares<br>Purchased as Part of<br>Publicly<br>Announced Plans or<br>Programs** | **Approximate Dollar Value<br>($ in thousands) of Shares That<br>May Yet Be Purchased<br>Under the Plans or<br>Programs**<sup>(1)</sup> |
| July 1, 2025 to July 31, 2025 | Tiptree Inc. |  | $— |  |  |
| August 1, 2025 to August 31, 2025 | Tiptree Inc. |  | $— |  |  |
| September 1, 2025 to September 30, 2025 | Tiptree Inc. |  | $— |  |  |
|  | Total |  | $— |  | $11945 |

---

<sup>(1)</sup> On November 2, 2020, the Board of Directors of Tiptree authorized Tiptree's Executive Committee to repurchase up to $20 million of its outstanding common stock in the aggregate from time to time.

**<u>Item 3. Def</u><u>aults Upon Senior Securities</u>**

None.

**<u>Item 4. Mi</u><u>ne Safety Disclosures</u>**

Not Applicable.

**<u>Item 5.</u> <u>Other Information</u>**

None.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>Item 6. Ex</u><u>hibits, Financial Statement Schedules</u>** 

---

| | |
|:---|:---|
| The following documents are filed as a part of this Form 10-Q: |  |
| <u>Financial Statements (Unaudited):</u> |  |
| [<u>Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024</u>](#consol_bs) | [<u>F-</u>](#consol_bs)<u>3</u> |
| [<u>Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024</u>](#consolidated_statements_of_operations) | [<u>F-</u>](#consolidated_statements_of_operations)<u>4</u> |
| [<u>Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 2024</u>](#consol_stmt_of_oci) | [<u>F-</u>](#consol_stmt_of_oci)<u>5</u> |
| [<u>Condensed Consolidated Statements of Changes in Stockholders' Equity for the periods ended September 30, 2025 and 2024</u>](#consol_stmt_of_eqty) | [<u>F-</u>](#consol_stmt_of_eqty)<u>6</u> |
| [<u>Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024</u>](#cf) | [<u>F-</u>](#cf)<u>8</u> |
| [<u>Notes to Condensed Consolidated Financial Statements</u>](#financial_fns) | [<u>F-</u>](#financial_fns)<u>9</u> |
| <u>Exhibits:</u> |  |
| The Exhibits listed in the Index of Exhibits, which appears immediately following the signature page, is incorporated herein by reference and is filed as part of this Form 10-Q. |  |

---

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>EXHIBIT INDEX</u>**

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| 2.1 | [<u>Merger Agreement between and among Tiptree, The Fortegra Group and DB Insurance Co., Ltd. (previously filed as Exhibit 10.1 to the Registrant's Current Report on Form 8-K (File No. 001-33549) filed on September 26, 2025 and herein incorporated by reference).</u>](https://www.sec.gov/Archives/edgar/data/1393726/000119312525218437/tipt-ex10_1.htm) |
| 10.1 | [<u>Form of Tiptree Voting Agreement (previously filed as Exhibit 10.2 to the Registrant's Current Report on Form 8-K (File No. 001-33549) filed on September 26, 2025 and herein incorporated by reference).</u>](https://www.sec.gov/Archives/edgar/data/1393726/000119312525218437/tipt-ex10_2.htm) |
| 10.2 | [<u>Form of Fortegra Voting Agreement (previously filed as Exhibit 10.3 to the Registrant's Current Report on Form 8-K (File No. 001-33549) filed on September 26, 2025 and herein incorporated by reference).</u>](https://www.sec.gov/Archives/edgar/data/1393726/000119312525218437/tipt-ex10_3.htm) |
| 31.1 | [<u>Certification of Executive Chairman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</u>](tipt-ex31_1.htm) |
| 31.2 | [<u>Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</u>](tipt-ex31_2.htm) |
| 31.3 | [<u>Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</u>](tipt-ex31_3.htm) |
| 32.1 | [<u>Certification of Executive Chairman pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</u>](tipt-ex32_1.htm) |
| 32.2 | [<u>Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</u>](tipt-ex32_2.htm) |
| 32.3 | [<u>Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</u>](tipt-ex32_3.htm) |
| 101.INS | XBRL Instance Document\*  |
| 101.SCH | XBRL Taxonomy Extension Schema Document\*  |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Attached as Exhibit 101 to this Quarterly Report on Form 10-Q are the following materials, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024, (ii) the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024, (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 2024, (iv) the Condensed Consolidated Statements of Changes in Stockholders' Equity for the periods ended September 30, 2025 and 2024, (v) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 and (vi) the Notes to the Condensed Consolidated Financial Statements.

------

[**<u>**Table of Contents**</u>**](#toc_page)

**<u>SIGNA</u><u>TURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, Tiptree Inc. has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **Tiptree Inc.** |
| Date:  | October 31, 2025 | By:/s/ Michael Barnes |
|  |  | Michael Barnes |
|  |  | Executive Chairman |
| Date:  | October 31, 2025 | By:/s/ Jonathan Ilany |
|  |  | Jonathan Ilany |
|  |  | Chief Executive Officer |
| Date: | October 31, 2025 | By:/s/ Scott McKinney |
|  |  | Scott McKinney |
|  |  | Chief Financial Officer<br>(Principal Financial Officer and<br>Principal Accounting Officer) |

---

------

## Exhibit 31.1

**EXHIBIT 31.1**

CERTIFICATIONS

I, Michael Barnes, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Tiptree Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | October 31, 2025 | /s/ Michael Barnes |
|  |  | Michael Barnes |
|  |  | Executive Chairman |

---

------

## Exhibit 31.2

**EXHIBIT 31.2**

CERTIFICATIONS

I, Jonathan Ilany, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Tiptree Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | October 31, 2025 | /s/ Jonathan Ilany |
|  |  | Jonathan Ilany |
|  |  | Chief Executive Officer |

---

------

## Exhibit 31.3

**EXHIBIT 31.3**

CERTIFICATIONS

I, Scott McKinney, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Tiptree Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | October 31, 2025 | /s/ Scott McKinney |
|  |  | Scott McKinney |
|  |  | Chief Executive Officer |

---

------

## Exhibit 32.1

**EXHIBIT 32.1**

Certification Pursuant to Section 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Tiptree Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael Barnes, the Executive Chairman of the Company, certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that;

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Michael Barnes |
| Michael Barnes |
| Executive Chairman |

---

Date: October 31, 2025

------

## Exhibit 32.2

**EXHIBIT 32.2**

Certification Pursuant to Section 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Tiptree Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jonathan Ilany, the Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that;

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Jonathan Ilany |
| Jonathan Ilany |
| Chief Executive Officer |

---

Date: October 31, 2025

------

## Exhibit 32.3

**EXHIBIT 32.3**

Certification Pursuant to Section 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Tiptree Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Scott McKinney, the Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that;

(i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Scott McKinney |
| Scott McKinney |
| Chief Financial Officer |

---

Date: October 31, 2025

------